ࡱ>  JM?@ABCDEFGHI\ bjbj Mjbjb($P Jj#z(((((tMJQ<Rɔ˔˔˔˔˔˔$jUbLtMUU((#iiiU ((ɔiUɔii2VT(0ͧ3b+aF.0JՋ.qdt\"%ShTJiLT<TSSSf2SSSJUUUUSSSSSSSSSB H:    ABSTRACT Endogenous fungal endophthalmitis is a complex ocular condition resulting from fungal seeding in the bloodstream and is associated with many predisposing risk factors, particularly intravenous drug abuse. Candida albicans is a pathogenic yeast responsible for causing endogenous fungal endophthalmitis. Candida organisms seed the choroid and retina of an infected individual forming vision-threatening lesions; with disease progression the organisms propagate the vitreous cavity. The initial signs of infection are not obvious to most patients causing a delayed diagnosis. Delayed diagnosis of endogenous fungal endophthalmitis increases morbidity and complicates clinical treatment. The prognosis of endogenous fungal endophthalmitis is dependent upon the fungal species, level of intraocular involvement, and the timing of interventions. Reporting a history of intravenous drug use is vital when presenting for ophthalmic evaluation. Physicians must to rely on a variety of tools in order to make a proper diagnosis. Patients must also be educated about the manifestations of endogenous fungal endophthalmitis. Although the IDSA guidelines are a standard clinical tool for diagnosis and treatment, the physician should evaluate every case in to determine the proper course of treatment. Antifungal resistance is an emerging health issue. Antifungal resistance is similar in nature to antibiotic resistance; it is prevalent in tertiary centers where complicated medical care is necessitated often with indwelling medical devices. Fluconazole resistant cases of Candida infections are increasing. The public health concerns with endogenous fungal endophthalmitis are poor prognosis, antifungal resistance, susceptible population, and intravenous drug use. TABLE OF CONTENTS  TOC \o "2-4" \h \z \t "Heading 1,1,Appendix,1,Heading,1"  HYPERLINK \l "_Toc491768836" preface  PAGEREF _Toc491768836 \h x  HYPERLINK \l "_Toc491768837" 1.0 Introduction  PAGEREF _Toc491768837 \h 1  HYPERLINK \l "_Toc491768838" 1.1 Endophthalmitis  PAGEREF _Toc491768838 \h 1  HYPERLINK \l "_Toc491768839" 1.1.1 Exogenous Endophthalmitis  PAGEREF _Toc491768839 \h 2  HYPERLINK \l "_Toc491768840" 1.1.2 Endogenous Endophthalmitis  PAGEREF _Toc491768840 \h 3  HYPERLINK \l "_Toc491768841" 1.2 Endogenous Fungal Endophthalmitis  PAGEREF _Toc491768841 \h 3  HYPERLINK \l "_Toc491768842" 1.2.1 Causative Organisms: Candida and Aspergillus  PAGEREF _Toc491768842 \h 4  HYPERLINK \l "_Toc491768843" 1.2.2 Risk Factors  PAGEREF _Toc491768843 \h 5  HYPERLINK \l "_Toc491768844" 1.2.3 Clinical Manifestation  PAGEREF _Toc491768844 \h 6  HYPERLINK \l "_Toc491768845" 1.2.4 Diagnosis  PAGEREF _Toc491768845 \h 8  HYPERLINK \l "_Toc491768846" 1.2.5 Treatment  PAGEREF _Toc491768846 \h 10  HYPERLINK \l "_Toc491768847" 1.3 intravenous drug use  PAGEREF _Toc491768847 \h 12  HYPERLINK \l "_Toc491768848" 1.3.1 Injection Drugs  PAGEREF _Toc491768848 \h 13  HYPERLINK \l "_Toc491768849" 1.3.2 Endogenous Fungal Endophthalmitis and Intravenous Drug Use  PAGEREF _Toc491768849 \h 16  HYPERLINK \l "_Toc491768850" 2.0 Methods  PAGEREF _Toc491768850 \h 17  HYPERLINK \l "_Toc491768851" 3.0 Results  PAGEREF _Toc491768851 \h 19  HYPERLINK \l "_Toc491768852" 4.0 discussion  PAGEREF _Toc491768852 \h 25  HYPERLINK \l "_Toc491768853" APPENDIX: ADDITIONAL TABLES  PAGEREF _Toc491768853 \h 30  HYPERLINK \l "_Toc491768854" bibliography  PAGEREF _Toc491768854 \h 34 List of tables  TOC \h \z \c "Table"  HYPERLINK \l "_Toc491768855" Table 1. Pre-Disposing Risk Factors for Endogenous Fungal Endophthalmitis  PAGEREF _Toc491768855 \h 21  HYPERLINK \l "_Toc491768856" Table 2. Culture Isolation Methods  PAGEREF _Toc491768856 \h 22  HYPERLINK \l "_Toc491768857" Table 3. Mycology of Endogenous Fungal Endophthalmitis  PAGEREF _Toc491768857 \h 22  HYPERLINK \l "_Toc491768858" Table 4. Clinical Summary of Risk Factors  PAGEREF _Toc491768858 \h 30  HYPERLINK \l "_Toc491768859" Table 5. Treatment and Visual Outcomes  PAGEREF _Toc491768859 \h 32 List of figures  TOC \h \z \c "Figure"  HYPERLINK \l "_Toc491768860" Figure 1. Diagram of the Human Eye.  PAGEREF _Toc491768860 \h 7  HYPERLINK \l "_Toc491768861" Figure 2. Number of Deaths from Heroin in the United States.  PAGEREF _Toc491768861 \h 14  HYPERLINK \l "_Toc491768862" Figure 3. Endogenous Fungal Endophthalmitis Cases at UPMC Eye Center  PAGEREF _Toc491768862 \h 19  HYPERLINK \l "_Toc491768863" Figure 4. Endogenous Fungal Endophthalmitis in an Intravenous Drug User  PAGEREF _Toc491768863 \h 24 preface I would like to thank my mentor Dr. Andrew Eller for providing direction and endless knowledge throughout this process. I would like to thank my academic advisor Dr. Jeremy Martinson for guidance with this essay and through my MPH career. I would also like to thank Rick Bilonick for helping me with the statistical analysis. Introduction Endophthalmitis fungal endophthalmitis is a vision-threatening condition of public health significance that occurs secondary to intravenous drug use and several other systemic risk factors. Pathogenic yeasts and molds are responsible for causing endogneous fungal endophthalmitis.34 Endophthalmitis initiates the host inflammatory response. The classic signs of inflammation (rubor, calor, tumor, and dolor) appear as exudation, leukocyte emigration, and vascular changes within the infected eye.8 Candida species are important pathogens due to their versatility and ability to survive in different conditions. The current belief is that fungal organisms play an active role in the pathophysiology of the disease process using virulence factors.3 Endophthalmitis Endophthalmitis is an inflammatory ocular infection that involves the intraocular cavity and surrounding structures including the vitreous, choroid, retina, macula, and anterior segment (Figure 1.). There are two types of endophthalmitis: exogenous and endogenous. Exogenous endophthalmitis is a microbial infection that results from and outside source; a majority of endophthalmitis cases are exogenous. Endogenous endophthalmitis is a fungal or bacterial infection resulting from hematogenous seeding of pathogens.4 Endogenous fungal endophthalmitis was once considered a rare infection but it is becoming more common in developed countries.5 Fungi are difficult to eradicate because of their commensal nature which poses a public health issue. Exogenous Endophthalmitis Exogenous endophthalmitis results from an external source, typically a complication of intraocular surgery, intravitreal injection, or trauma. The host defense mechanisms become overwhelmed when a large number of pathogens are introduced into the eye. Both acute (24 to 48h post event) and chronic forms (4 to 6 weeks post event) of exogenous endophthalmitis may occur. The rate of exogenous endophthalmitis infections varies regionally and annually. Most recently, the rate of endophthalmitis after cataract surgery was reported as 0.1% and after penetrating eye trauma (i.e. trauma or intravitreal injection) as 1% to 18%.3 Clinical signs of exogenous endophthalmitis usually appear acutely and include pain, discharge, eyelid swelling, blurred vision, corneal and conjunctiva edema, and anterior chamber cells with hypopyon.8 Patients presenting with these symptoms require immediate diagnostics and clinical treatment. Treatment for exogenous endophthalmitis includes oral antibiotics, intravitreal injection of antibiotics, ophthalmic steroid drops, and intravitreal or periocular injection of steroid. The major pathogenic strains associated with exogenous endophthalmitis are coagulase-negative Staphylococci, Staphylococcus aureus, streptococci, Bacillus, gram-negative Bacilli, Streptococcus pneumoniae, Haemophilius influenza, Enterococci, Propionibacterium acnes, and Actinomyces neuii.34 Rarely, fungi cause a post-operative infection following cataract surgery but they are ordinarily associated with endogenous infections. Endogenous Endophthalmitis Endogenous endophthalmitis results from hematogenous spreading of the pathogen, usually fungi, to the eye causing ocular seeding.4 Endogenous bacterial infections are possible but are not common with bacteria only accounting for 2% to 8% of all endogenous cases and accounting for than 50% of endogenous endophthalmitis cases. The majority of patients diagnosed with endogenous endophthalmitis also have predisposing risk factors.7 Endogenous endophthalmitis usually occurs secondary to a conditions such as concurrent infection, immunosuppression, intravenous drug use, or an implanted medical device. Although endogenous endophthalmitis only accounts for 5% to 15% of all endophthalmitis cases, they tend to be the most severe.3 Diagnosis of endogenous endophthalmitis is often difficult and delayed due to the lack of systemic symptoms, low-grade ocular symptoms, negative diagnostic tests, and initial misdiagnosis.18 Endogenous endophthalmitis is a complex ocular condition resulting from fungal seeding in the bloodstream and is associated with many predisposing risk factors, particularly intravenous drug abuse. Endogenous Fungal Endophthalmitis Fungal endophthalmitis is not considered a reportable disease although physicians can report concerns of outbreaks to their local or state health department. The most common fungal organisms that cause this disease are Candida albicans, Aspergillus spp., and Candida spp.; C. albicans is responsible for 75% to 80% of all fungal endophthalmitis cases.8 Endogenous fungal endophthalmitis is a challenging clinical issue. Early diagnosis and prompt treatment are necessary to achieve a desirable outcome. Up to 50% of endogenous fungal endophthalmitis are misdiagnosed or delayed.2 Causative Organisms: Candida and Aspergillus Candida species are commensal yeasts and the most common cause of endogenous fungal endophthalmitis.10 There are 20 species of Candida capable of causing disease in humans but over 90% of human infections are caused by five strains: C. albicans, C. parapsilosis, C. tropicalis, and C. dubliniensis.5 Candida albicans is responsible for causing an overwhelming majority of invasive fungal infections and endogenous fungal endophthalmitis cases.5,12 C. albicans is a dimorphic fungus capable of growing yeast cells and filamentous cells.4 Candida albicans is part of the normal human microbiome and lives asymptomatically in the gastrointestinal tract, genitourinary tract, and oral mucosa of healthy individuals.8 Individuals that have alterations in their host immune response, host microbiota, and local environment are susceptible to Candida albicans invasion, overgrowth, and infection. Factors that influence this include antibiotic use, stress, change in pH, immunosuppressant use, and concurrent infection.5 Many C. albicans infections are a result of biofilm production on human tissues or indwelling medical equipment.4,11 As soon as the biofilm forms on the indwelling medical equipment it has the ability to disperse into the bloodstream and cause systemic infection.11 Candida albicans infections of mucous membranes or skin can invade the bloodstream and disseminate to other organs and tissues, specifically the eye. Candidemia has been reported the fourth most common nosocomial bloodstream infection in the United States.10 In the United States, the Centers for Diseases Control (CDC) performs prospective, population-based surveillance for candidemia.17 The surveillance is performed through the Emerging Infections Program (EIP) at seven sites: Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee. The CDC performs confirmatory testing on all Candida samples for species identification and antifungal susceptibility; epidemiologic trends are also monitored. The CDC does not perform surveillance for Candida endophthalmitis.17 Aspergillus spp. is a common mold found in the environment and the second most common cause of endogenous fungal endophthalmitis.34 There are five species known to cause endogenous fungal endophthalmitis: A. candidus, A. fumigatus, A. flavus, A. niger, and A. terreus. Aspergillus fumigatus is the most common pathogenic species in humans.8 Aspergillosis is commonly caused by inhalation of Apergillus spores.4 The method of transmission in Aspergillus endophthalmitis unknown. Aspergillus infections are not a reportable diease Those with predisposing risk factors such as immunosuppression, organ transplant, and steroid use are prone to infection.6 Risk Factors There are many known risk factors that predispose development of endogenous fungal endophthalmitis. Individuals that undergo major surgery, particularly gastrointestinal surgery are susceptible to hematogenous spread of Candida spp. Post-operative care often requires long-term antibiotics either intravenously or orally. This leads to alterations in the gut microbiome and immunosuppression which increases the likelihood of fungal infection. Intravenous catheters, intravenous infusions, central lines and indwelling medical devices predispose the patient to infection with Candida spp. leading to candidiasis. Additional predisposing systemic risk factors include diabetes, liver disease, renal failure, cancer, sepsis, endocarditis, organ transplantation, recent hospitalization, and intravenous drug abuse.5,6 Patients without obvious systemic infection or other known risk factors may have their endophthalmitis misdiagnosed. Endogenous endophthalmitis is rarely reported in otherwise healthy individuals without predisposing risk factors.4 In a published review of 76 fungal endophthalmitis cases, Edwards et. al found the following risk factor associations: 88% had intravenous infusions, 84% had intravenous antibiotics, 63% had major surgery, 54% were treated with steroids, 46% had indwelling catheters, and 8% were immunosuppressed.8 This study indicates that the intravenous route is associated with highest risk for endogenous fungal endophthalmitis. Clinical Manifestation Endogenous fungal endophthalmitis elicits an intraocular inflammatory response. As the condition progresses, especially if left untreated, inflammation increases and causes an increase in accompanying symptoms.6 The most frequent complaint of patients presenting for evaluation prior to being diagnosed with endogenous fungal endophthalmitis is decreased or blurry vision. Other predominant symptoms include floaters, photophobia, eye redness, and eye pain.3,12 Patients may not detect the symptoms upon initial infection due to the nature of the disease. Symptoms of endogenous fungal endophthalmitis arise over numerous days or weeks.10 The ophthalmic vascular network connects to the internal carotid artery and is a pathway for fungal organisms to enter the eye by hematogenous spread.6,10 Endogenous fungal endophthalmitis affects the posterior segment (Figure 1., choroid, retina, macula) first and as the disease progresses it begins to affect the anterior segment (Figure 1., iris, pupil, cornea) of the eye starting with the vitreous. Endogenous Candida endophthalmitis initiates upon fungal seeding in the choroid and subsequent lesion formation.4,10  Figure  SEQ Figure \* ARABIC 1. Diagram of the Human Eye. By the National Eye Institute, distributed under a CC-BY 2.0 license. Endogenous Candida endophthalmitis is characterized by invasion of inflammatory cells in the vitreous.10 C. albicans infiltrates the retina the area appearing as small white lesions. As infection progresses most of the inflammatory response occurs in the vitreous appearing as fluffy white micro-abscesses surrounding Candida organisms.16 The micro-abscesses first occur as chorioretinal lesions and then extend to the surrounding retinal tissue and vitreous as vitritis. Often referred to as a string of pearls, the as fluffy white strand-like clusters are a hallmark characteristic of endogenous fungal endophthalmitis and are often used as a diagnostic indicator.3 Patient complaints of floaters are related to the presence of fungal vitreous abscesses. Endogenous fungal endophthalmitis cases are severe causing additional ophthalmic complications. Retinal detachment is the most common complication of endogenous fungal endophthalmitis. Other common complications are epiretinal membrane, macular edema, and hypotony.4 Endogenous Aspergillus endophthalmitis has an acute clinical onset of retinal lesions, intraocular inflammation, and blurred vision.12 Clinical characteristics of Aspergillus endophthalmitis include a yellow/white inflammatory lesions in the retina and choroid, large areas of retinal necrosis, and chorioretinitis.1,16 Aspergillus lesions can be local or diffuse.6 Aspergillus endophthalmitis has a higher mortality rate than Candida endophthalmitis.4,6 Diagnosis Diagnosing endogenous fungal endophthalmitis is usually complicated and requires multiple tools including laboratory tests, extensive review of medical history, systemic work up, and a dilated ophthalmic exam. In some instances, diagnosis can also be done based on ophthalmic examination alone.5 Patients complaining of pain, redness, photophobia, and blurry vision should be evaluated by a retina specialist. They undergo a comprehensive eye exam which includes visual acuity, intraocular pressure, dilated fundus exam, slit lamp exam, and pupillary reaction. Ophthalmic findings are assessed in combination with the patients medical records in order to make an early clinical diagnosis.8 In order to establish the source of infection and concomitant organ involvement a systemic workup must be completed in conjunction with an infectious diseases specialist. They will review the patients medical history and presenting symptoms, and recommend additional tests based on their findings.13 Additional tests may include complete blood count (CBC) with differential, fungal blood culture, echocardiogram to assess for endocarditis, and blood tests for hepatitis C virus (HCV), human immunodeficiency virus (HIV), and renal failure.8 The infectious disease specialist will also monitor the patient throughout the course of their treatment and can assist in making treatment decisions in conjunction with the retina specialist. The most important laboratory-based diagnostic tests are culture of the intraocular fluid and gram stain.4,7 Sabouraud with gentamicin agar plates are a standard for fungal isolation from ocular specimen due to their ability to suppress the growth of concomitant organisms. Sabouraud agar plates have a low pH which inhibits bacterial growth and enhances fungal colonization. Chocolate agar and blood agar plates are also used for culturing intraocular fluid species. Fungal cultures are examined daily over a 21 period for the presence of mold colonies and yeast colonies.17 In order to isolate the intraocular fungus for culture a fluid sample must be obtained by the ophthalmologist. A fungal sample can be obtained by needle aspiration of the anterior chamber (anterior chamber (AC) tap), needle aspiration of the vitreous (vitreous tap), vitreous biopsy, or removal of the vitreous fluid (vitrectomy).3 With a reported culture positivity rate of 70%2, vitrectomy samples are the most reliable out of all the previously mentioned methods. The fungal organisms adhere to the retina surface and are usually not able be aspirated by a needle in the anterior chamber or vitreous. Vitrectomy requires surgical intervention and some patients with endogenous fungal endophthalmitis are not medically stable enough to have surgery, refuse to have surgery, or do not follow-up for scheduled clinical exams. This makes it even more difficult to obtain diagnostic samples to treat an already complicated disease. Patients that are chronically ill patients or are intravenous drug users may neglect to seek treatment for their ocular symptoms which can lead to permanent damage and vision loss. Treatment Antifungals are given to kill or inhibit the growth of fungal pathogens and each class has its own mechanism action. Conventional antifungals can be separated into four chemical classes: azole, polyene, pyrimidine, and echinocandin.11 Azoles and polyenes are the most commonly used and most efficacious antifungals for treating endogenous fungal endophthalmitis.10 Antifungals in the azole and polyene class act on the fungal cell membrane and echinocandins work to disrupt the fungal cell wall. Azoles and polyenes target the membrane phospholipid bilayer which contains interpolated enzyme proteins and ergosterol molecules. Polyenes such as amphotericin B act by binding to ergosterol and acts as a fungicidal leading to cellular leakage and altered membrane function. Azoles such as fluconazole and voriconazole act to inhibit the ergosterol synthesis pathway leading to depletion of ergosterol and disrupt membrane permeability.11 The treatment of endogenous fungal endophthalmitis often requires a combination of systemic and intraocular medication administration. Infectious Disease Society of American (IDSA) guidelines for the treatment of Candida endophthalmitis should be followed.14 There are not a large variety of antifungals available on the market and only a few are known to be effective against endogenous fungal endophthalmitis, leading to an increased potential for drug resistance.11 Antifungal drug resistance is an emerging public health issue. Antifungal susceptibility testing can be used maximize therapeutic outcome and mitigate drug resistance.7 Candida albicans is usually susceptible to fluconazole but drug resistance is increasing. For those cases that are found be fluconazole resistant it is likely that they will also be voriconazole resistant since they are in the same drug class.10 The therapeutic course of treatment will be determine based on the results of the susceptibility test. Systemic antifungals should be used to treat all cases of endogenous fungal endophthalmitis because systemic treatment not only targets the source of infection but it also prevents further spread to other organs, most importantly the fellow eye.8 IDSA guidelines dictate the recommended dose and course of treatment for each drug.14 Traditionally, after initial diagnosis the first oral antifungal treatment given is fluconazole. Voriconazole is also a member of the azole class it was the first approved and most successful triazole. The main benefit of treating with voriconazole is that its a very broad spectrum antifungal, but the conversely it has a long list of drug interactions.11 Voriconazole can be administered by oral or intravenous route for systemic treatment while fluconazole can only be administered orally. Both fluconazole and voriconazole achieve high concentrations in the vitreous when administered systemically. The use of systemic amphotericin b (intravenous route) has been associated with renal and hematologic toxicity so patients with a history of renal disease must be monitored closely. 8 In severe cases a combination of antifungals must be administered systemically and intraocularly. Intraocular treatment is clinically necessary with severe endogenous endophthalmitis presentation. IDSA guidelines indicate use of systemic antifungals plus intravitreal injection for patients with macular involvement.14 Patients that present with choroid or retinal lesions, vitritis, macular lesions, or retinitis require immediate treatment with intravitreal antifungal injections of amphotericin B or voriconazole.5,8,14 Intravitreal injections are repeated as necessary until the condition resolves. In a seven year retrospective study about endogenous fungal endophthalmitis Kim et al.5 reported that 25% of eyes treated with intravitreal antifungal injection alone had a two-line visual acuity improvement from pre-treatment. Kim et al. also reported that 71% of eyes that underwent a vitrectomy with intravitreal antifungal injection had a two-line visual acuity increase.5 Vitrectomy is recommended for those patients presenting with multiple macular fungal abscesses, severe vitritis, and poor visual acuity.14 Pars plana vitrectomy (PPV) is a surgical intervention that removes vitreous gel (Figure 1.) from the infected eye. Once the vitreous gel is removed saline solution or silicone oil is injected into the ocular cavity to replace the fluid. PPV allows for removal of fungal abscesses in the vitreous cavity and posterior segment, subsequently decreasing burden of infection.6 Intravitreal antifungal injections are commonly administered during the vitrectomy procedure.4 Infectious Disease Society of American (IDSA) guidelines for the treatment of Aspergillus endophthalmitis recommends use of systemic voriconazole in additional to intravitreal voriconazole or amphotericin B.15 Systemic therapy in combination with ophthalmic intervention is recommended for all cases of endogenous Aspergillus endophthalmitis. Pars plana vitectomy is the recommended surgical intervention.6,15 intravenous drug use Intravenous drug use is a pathway for pathogens and other contaminants to enter the bloodstream.Endogenous fungal endophthalmitis commonly occurs secondary to intravenous drug use.Intravenous drug users are a high-risk population for fungal infection.Previous studies have reported that intravenous drug users often misuse drug substitutes such as methadone, suboxone, and buprenorphine for injection purposes.2,34 Over the past decade, there has been an increase reported overdoses related to intravenous drug abuse.The drug of choice for most intravenous drug users in the last decade is heroin followed by cocaine. Injection Drugs Injection drugs have become the drug of choice in the United States. The June 2016 National Heroin Threat Assessment Summary released by the Drug Enforcement Agency (DEA) showed a 248% increase in the number of heroin-related overdose deaths from 2010 to 2014.The Northeast and Midwest areas of the United States are particularly susceptible to the growing opioid epidemic.32 According to the Center for Disease Control and Prevention (CDC), 1.6% of Americans have used heroin at one point in their lives.30 Heroin is an extremely addictive substance; the rise of abuse has is related to a larger substance abuse problem. The effects from intravenous use are particularly intense which contributes to the rise in the epidemic.25 The CDC reports that the probability of heroin addiction greatly increases if the individual is addicted to another substance. Heroin addiction is 40-times more likely to occur if an individual is addicted to prescription opioid pain killers. Other substances that increase the likelihood of heroin addiction include alcohol (two times more likely), marijuana (three times more likely), and cocaine (15 times more likely).30 Recently, there have been many theories about why heroin use has increased. One of the main theories is addiction to opioid painkillers. Research has shown that those who are addicted to prescription painkillers are far more likely to be addicted to heroin than others.24 Prescriptions narcotics are very expensive and have been overprescribed, especially within the last decade. Due to the increasing incidence of prescription overdoses physicians decreased prescribing of narcotics such as OxyCotin and Vicodin which led to an increase in heroin use. Not only is this an epidemic, it has become a public health crisis.23 Heroin is much easier to purchase and administer than prescription pain pills. With prescription pills, one must crush the pill up into a powder so that it can be used, injected or snorted.24 Heroin on the other hand, is delivered as a fine powder that is ready for immediate use. Heroin comes in both brown and white form. The brown form is less pure and is nearly insoluble in water. In order to inject brown heroin a mixing agent such as lemon juice or another acidic solvent must be used.25  Figure  SEQ Figure \* ARABIC 2. Number of Deaths from Heroin in the United States. By the National Center for Health Statistics, CDC Wonder Heroin is also much easier to access due to an abundance of it being pushed into the United States from Mexico.31 According to The National Institute of Drug Abuse (NIDA) at a molecular level heroin and many of the opioid painkillers are nearly indistinguishable from each other. The characteristic chemical structure of heroin interacts with certain opioid receptors targeting the brain's reward centers, and inducing the euphoria and relaxation.24 Heroin use increases the risk of morbidity and mortality an individual. Injecting drug users are a group of individuals at higher risk than most for contracting viruses such as hepatitis C and human immunodeficiency virus (HIV). Increased use of heroin causally increased the number of overdoses.25 Heroin overdoses have increase over the last decade (Figure 2); they have more than tripled between 2010 and 2015. According to the CDC, the majority of heroin users are between the ages of 18 and 25 years old, and are non-Hispanic white.33 Although heroin is the most common injected drug, the CDC reported that cocaine was responsible for the second most drug overdose deaths in 2014. A drug surveillance study also reported that cocaine is the second most trafficked illegal drug in the world.33 Cocaine produces a desirable effect causing a pleasurable feeling which does not last long. This causes many people to believe that cocaine is a safe drug and non-addictive; which leads to reoccurring, long term use addiction over time. Statistics from hospitals, law enforcement, and treatment providers show that cocaine is involved in crime, accidents, health problems, and needless deaths just as any other drug.22 According to the 2012 National Survey on Drug Use and Health (NSDUH), 4.7 million Americans aged 12 and older used cocaine. Cocaine abuse occurs in both genders and among various ethnic groups of the United States.27 Research has also shown that the rise of cocaine and drug use is possibly the result of music and movies that promote the use of it and other drugs as an acceptable form of entertainment today.29 Endogenous Fungal Endophthalmitis and Intravenous Drug Use Infections are a serious complication of drug abuse. Endogenous fungal endophthalmitis is a mounting complication of intravenous drug abuse. Intravenous drug users are also at risk for endocarditis, human immunodeficiency virus, hepatitis B virus, and hepatitis C virus. Fungal infection likely results from intravenous injection of contaminated or adulterated drugs and unsterile injection practices. Additives used to mix heroin prior to injection mau induce immunomoduatory effects. 34 Intravenous drug user often share and re-use needles; use of unhygienic needles leads to hematogenous dissemination of Candida spp. Fungal endophthalmitis also occurs when the user licks the injection needle prior to administering the substance.28 Patients diagnosed with endogenous fungal endophthalmitis secondary to intravenous drug abuse may present with different clinical symptoms of those with systemic fungal infections.34 The varying clinical presentation of intravenous drug users with endogenous fungal endophthalmitis include anterior segment involvement and minimal posterior segment inflammation. In 2010, PP. Connell et al.9 found that 65.9% of culture-positive endogenous fungal endophthalmitis cases were linked to intravenous drug users. The 2010 study led to a statewide Australian public health campaign aimed at reducing the incidence of endogenous fungal endophthalmitis among intravenous drug users.9 Methods A retrospective chart review was conducted using data from University of Pittsburgh Medical Center (UPMC) Eye Center. Clinical information was collected on patients diagnosed with endogenous fungal endophthalmitis between January 1, 2008 and December 31, 2016. A retrospective chart review of electronic medical records was conducted identifying patients diagnosed with endogenous endophthalmitis from January 1, 2008, to December 31, 2016, at University of Pittsburgh Medical Center (UPMC) Eye Center. IRB Approval was received from the University of Pittsburgh Human Research Protection Office (HRPO) formerly known as the University of Pittsburgh Institutional Review Board (IRB). In accordance with International Classification of Diseases (ICD) guidelines, patients diagnosed between January 1, 2008 and October 14, 2015 were identified using ICD-9 (ninth revision) codes and patients diagnosed October 15, 2015 to December 31, 2016 were identified using ICD-10 (tenth revision) codes. The following ICD-9 codes were used: 360.19 for other endophthalmitis, 360.01 for acute endophthalmitis, and 360.03 for chronic endophthalmitis. The following ICD-10 codes were used: H44.1 and H44.19 for other endophthalmitis. Patients presenting with exogenous endophthalmitis or endogenous bacterial endophthalmitis were excluded. Only patients eighteen years or older who had a diagnosis of endogenous fungal endophthalmitis were included. Cases of endogenous fungal endophthalmitis did not need to be culture based or culture proven to be included. Medical records were reviewed for patient demographics data, medical history, visual acuity pre- and post-treatment, presenting symptoms, treatment modalities, clinical findings, and culture data. The final outcome measure was post-treatment best corrected visual acuity. For statistical analysis, Snellen visual acuity data was converted to logarithm of minimal angle of resolution (logMAR) standard units.5,7 As described by Sridhar et al.7, logMAR values of 1.85 for count fingers (CF), 2.3 for hand motion (HM), 2.7 for light perception (LP), and 3.0 for no light perception (NLP) were assigned. A mixed effects model with a random intercept was fitted to visual acuity (in logMAR units) as a function of status (before vs. after), age, and sex using the method of maximum likelihood. The R programming language for statistics and graphics (Version 3.4.1 (20170630))20 and the nlme R package21 were used to fit the mixed effects model. Results A total of 58 eyes from 53 patients were diagnosed with endogenous fungal endophthalmitis at the University of Pittsburgh Medical Center (UPMC) Eye Center between January 1, 2008 and December 31, 2016. The mean age of included patients was 41 years and the median age was 35 years (range 18 years to 85 years). Thirty-eight patients (71.7%) were males and 15 patients (28.3%) were females. Five patients (8.6%) had bilateral endogenous fungal endophthalmitis. Thirty patients (56.6%) had left eye involvement. Eighteen patients (34.0%) had right eye involvement. The number of endogenous endophthalmitis cases diagnosed at UPMC Eye Center varied greatly over the eight-year study period: 2008 (1 cases; 1.9%), 2009 (3 cases; 5.7%), 2010 (6 cases; 11.3%), 2011 (4 cases; 7.5%), 2012 (4 cases; 7.5%), 2013 (12 cases; 22.6%), 2014 (5 cases; 9.4%), 2015 (14 cases; 26.4%), and 2016 (4 cases; 4.5%).  Figure  SEQ Figure \* ARABIC 3. Endogenous Fungal Endophthalmitis Cases at UPMC Eye Center All 53 patients had identifiable pre-disposing risk facts for endogenous fungal endophthalmitis (Table 1). The most common medical condition was hepatitis C (22 patients; 41.5%). The second most common medical condition was diabetes (10 patients; 18.9%). Eight patients (15.1%) were hospitalized within six month of developing endogenous fungal endophthalmitis. Seven patients (13.2%) had a history of fungal endocarditis. Five patients (9.4%) were being treated for renal disease including chronic kidney disease, renal failure, and end stage renal disease. One patient (1.9%) received an organ transplant (heart) within one year of being diagnosed with endophthalmitis. Five patients (9.4%) had placements on indwelling medical devices. Seven patients (13.2%) were receiving immunosuppressive therapy. Four patients (7.5%) had a surgical procedure (including abdominal and gastrointestinal procedures) within six months of developing fungal endophthalmitis. Four patients (7.5%) had an active oral infection (oral thrush or tooth abscess) at the time of diagnosis. Nine patients (17.0%) were diagnosed with systemic fungemia and were being actively treated at the time of endophthalmitis diagnosis. The most common pre-disposing social risk factor to endogenous fungal endophthalmitis is intravenous drug use. Forty-four patients (83.0%) reported a current use of intravenous drugs. Presenting ophthalmic symptoms included pain in 31 (53.4%) out of the 58 eyes, redness in 31 eyes (48.3%), floaters in 12 eye (20.7%), excessive tearing in 4 eyes (6.9%), and photophobia in 12 eyes (20.7%). The most common ophthalmic symptom was blurry vision; all 58 eyes (100%) from 53 patients had blurry vision at presentation. The median time between onset of symptoms and clinical presentation was 11.5 days (range 4 days to 56 days). A representative endogenous fungal endophthalmitis case is shown in Figure 4. Table  SEQ Table \* ARABIC 1. Pre-Disposing Risk Factors for Endogenous Fungal Endophthalmitis FactorNumber of Patients (%)Intravenous Drug Use44/53 (83.0%)Hepatitis C22/53 (41.5%)Diabetes10/53 (18.9%)Systemic Fungemia9/53 (17.0%)Recent Hospitalization8/53 (15.1%)Immunosuppression7/53 (13.2%)Endocarditis7/53 (13.2%)Indwelling Medical Device5/53 (9.4%)Renal Disease5/53 (9.4%)Recent Surgery4/53 (7.5%)Oral Infection (Thrush or Abscess)4/53 (7.5%)Organ Transplant1/53 (1.9%) Forty-five out of 58 cases were cultured for fungal species identification. The remaining 13 cases were diagnosed based on clinical presentation or other predisposing risk factors. Thirty-two (71.1%) out of 45 cases were culture-positive. Thirteen cases (28.9%) were culture-negative. Vitrectomy isolation methods yielded a positive result for 28 out of 37 cultures (75.7% culture positivity). Vitreous tap isolation methods produced a positive culture results in four out of five cases (80.0% culture positivity). In separate cases, one blood culture and one anterior chamber (AC tap) were used for culture isolation; both resulted in negative cultures. One eye was cultured and examined by histology post-enucleation; the culture was negative. The culture isolation methods used are outline in Table 2. The 32 cases positive-culture cases were analyzed for species identification. Yeast species (66.9%) including Candida albicans and Candida tropicalis were more common than mold (2.2%) species including Aspergillus fumigatus (Table 3). Thirty (66.7%) of the yeast isolates were Candida albicans isolates and one (2.2%) was Candida tropicalis. There was only one (2.2%) isolate of Aspergillus fumigatus identified. Table  SEQ Table \* ARABIC 2. Culture Isolation Methods Culture IsolationCulture PositiveCulture NegativeTotalVitrectomy28937AC Tap011Vitreous Tap415Blood Culture011Post Enucleation011Total32 1345 Note: 13 cases (eyes) were not cultured. Table  SEQ Table \* ARABIC 3. Mycology of Endogenous Fungal Endophthalmitis OrganismCases% of culture isolatesYeast (n=31)66.9% (31/45) Candida albicans30 66.7% (30/45) Candida tropicalis12.2% (1/45)Mold (n=1) Aspergillus fumigatus12.2% The visual acuity for the onset of endophthalmitis is unknown for most patients. The median pre-treatment logMAR visual acuity was 1.30 (range 0.00 to 3.00). Only 37 out of 58 eyes were available for post-treatment visual acuity measurements. One eye was not measureable due to enucleation. Twenty patients with unilateral disease were lost to follow-up. The median post-treatment logMAR visual acuity of the remaining 37 patients was 0.70 (range 0.00 to 3.00). Post-treatment visual acuity was a predictor of outcome. A mixed effects model with a random intercept was fitted to visual acuity (in logMAR units) as a function of status (before vs. after), age, and sex using the method of maximum likelihood. The fixed effects estimates showed that there was a statistically significant decrease in visual acuity with an estimated decrease of about 0.47 logMAR units (95% CI:0.74 to 0.20 logMAR, P=0.0010). Visual acuity declined slightly with age (0.005 logMAR per year) and was slightly lower for males (by 0.17 logMAR) but the effects for neither age nor sex were statistically significant. The standard deviation of the random effect (random intercept) was 0.48 logMAR (95% CI: 0.33 to 0.71 logMAR) and indicated a large amount of heterogeneity among the patients given that the fixed intercept was 1.7 logMar. Additional variables including fungus species, culture isolation, social risk factor (intravenous drug use) were added to the mixed effects model in order to test their relationship. There was no statistical significant association between post treatment and any of the additional variables: culture isolation methods (P=0.0055), culture growth (P=0.0017), fungal species (P=0.0023), and intravenous drug use (P=0.0019). Throughout the course of treatment, 41 of 58 eyes were treated with pars plana vitrectomy. Forty-nine cases were treated with oral antifungals, specifically fluconazole (35 cases) and voriconazole (12 cases); two cases initiated treatment with fluconazole but then switched to voriconazole. Seven cases of endogenous fungal endophthalmitis were treated solely with oral fluconazole. Injection of intravitreal antifungals was administered in forty-eight cases, specifically voriconazole (9 cases) and amphotericin B (37 cases); two cases received combination of both intravitreal injections. Twenty cases required multiple intravtreal injections of amphotericin B. Treatment method was not predictive of visual acuity outcome. Twenty-four (64.9%) of 37 eyes developed ophthalmic complications during the course of treatment for endophthalmitis: 14 had a retinal detachment, 1 eye developed a white cataract, and 9 eyes developed an epiretinal membrane (ERM). One eye required enucleation due to the severity inflammation and ocular infiltration upon presentation. A complete summary of clinical, treatment, and visual acuity data can be found in Appendix A,  Figure  SEQ Figure \* ARABIC 4. Endogenous Fungal Endophthalmitis in an Intravenous Drug User A 28 year-old male intravenous drug user presented with 20/500 visual acuity in the right eye. Patient complained of blurred vision, pain, and redness onset 3 weeks prior. Dilated fundus examination revealed vitritis with inferior vitreous abscess (string of pearls). The patient had a vitrectomy with culture; the cultures grew Candida albicans. The patient received intravitreal injections of amphotericin B. The patient a retinal detachment as a complication of the infection. Post-treatment visual acuity was 20/200. discussion Endogenous fungal endophthalmitis is complex disease caused by the hematogenous seeding of pathogens in the eye. Previous studies reported that the most common pathogen causing endogenous fungal endophthalmitis is Candida albicans.2-9 Sridhar et al.7 reported that yeasts accounts for 76.4% of cases and mold accounted for 27.4% of cases; Candida albicans was the most prevalent species. Kim et al.5 reported that yeasts accounted for 91.2% of cases a majority being Candida albicans and molds accounted for 2.9%. In accordance with previous trends this study found that the most common organism were yeasts (68.9%). One cause of endogenous fungal endophthalmitis was caused by Candida tropicalis. Thirty of the 32 culture positive cases were caused by Candida albicans (66.7%). One case was caused by the mold Aspergillus fumigatus. The patient diagnosed with Aspergillus endophthalmitis was referred for ophthalmic examination after diagnosis of invasive Aspergillosis post- complicated gastrointestinal surgery. The common presenting symptoms of endogenous fungal endophthalmitis are blurry vision and eye redness.4 In this study the most common presenting symptoms were blurry vision (58 cases; 100%), eye pain (31 cases; 53.4%) and red eye (28 cases; 48.3%). Thirty-eight patients were men and 15 were women. Fifty-one out of 53 patients were white and one patient was black. Post-treatment visual acuity was used a predictor of outcome. The fixed effects estimates showed that there was a statistically significant decrease in visual acuity with an estimated decrease of about 0.47 logMAR units (95% CI:0.74 to 0.20 logMAR, P=0.0010). Visual acuity declined slightly with age (0.005 logMAR per year) and was slightly lower for males (by 0.17 logMAR) but the effects for neither age nor sex were statistically significant. No other variables were statistically significant. The effects of this model may be confounded by small sample size and missing data due to 20 patients being lost to follow-up. PP. Connell et al.2 reported that culture positivity did not correlate with declined post-treatment visual acuity. An overwhelming majority of patients (83.0%) in this study were intravenous drug users. The most frequently reported substance was heroin followed second by cocaine. Nationally reported data indicates a surge in drug in injection drug use from 2010 to 2015.33 The number of cases of endogenous fungal endophthalmitis diagnosed at UPMC Eye Center during this time period indicate a similar trend (Figure 3). The number of cases reported in 2013 (12 cases, 22.6%) and 2015 (14 cases, 26.4%) account for half of cases diagnosed between 2008 and 2016. In 2015, it was estimated that 20.5 million Americans (12 years or older) had a substance abuse disorder. Heroin addiction affected 591,000 individuals in 2015 and will continue to increase. Prescription narcotics were the main substance of choice affecting 2 million individuals. Drug overdose is the leading cause of accidental death in the United States; heroin overdose rates have tripled.32 In a seven year study by PP. Connell et al.,2 19 of out of 21 patients were diagnosed with endogenous fungal endophthalmitis secondary to intravenous drug use. In this eight year study, 44 out of 53 patients were diagnosed with endogenous fungal endophthalmitis secondary to intravenous drug use. Pre-disposing risk factors for endogenous fungal endophthalmitis are well known and can be used diagnostic guidelines. Hepatitis C (41.5%) infection was the most common pre-disposing risk factor among this group. Injecting drug users are known to be at risk for Hepatitis C infection.25 Diabetes (18.9%) was the second most common pre-disposing factor. It is thought that diabetes patients are more susceptible to fungal endophthalmitis because their vitreous humor has a higher glucose content allowing the organism to flourish.10 Nine patients presented with an existing diagnosis of systemic fungemia. Other pre-disposing risk factors were: recent hospitalization (8 cases; 15.1%), immunosuppression (7 cases; 13.2%) , endocarditis (7 cases; 13.2%), indwelling medical device (5 cases; 9.4%), renal disease (5 cases; 9.4%), recent surgery (4 cases; 7.5%), oral infection (4 cases; 7.5%), and organ transplant (1 case; 1.9%). Conversely, Sridhar et al.7 reported that patients with endogenous fungal endophthalmitis with positive cultures were significantly associated with immunosuppression and intravenous exposure (intravenous drug use or indwelling medical device). Surgical intervention was the most frequently use course of treatment ( 41 cases). Fluconazole was the antifungal of choice being used to treat 35 out of 58 cases. Two cases initiated treatment with fluconazole and later switch to voriconazole. Seven cases of endogenous fungal endophthalmitis were treated solely with oral fluconazole. Injection of intravitreal antifungals was administered in 48 cases, specifically voriconazole (9 cases) and amphotericin B (37 cases); two cases received combination of both intravitreal injections. Twenty cases required multiple intravtreal injections of amphotericin B. Treatment method was not predictive of visual acuity outcome. Forty-five cases of endogenous fungal endophthalmitis were cultured for species. Intraocular fluid was isolated for 43 out of 45 patients, one patient had a blood culture, and one patient had culture and histology post-enucleation. Vitrectomy (37 cases) was the most frequent method used for culture isolation and resulted in 28 positive cultures and nine negative cultures. Anterior chamber (AC) tap was used in one case and the culture was negative. Vitreous tap was used less frequently than vitrectomy but resulted in positive cultures for four out of five cases. Rao et al.16 reported that there was no significant difference in the clinical presentation and manifestations of endogenous fungal endophthalmitis between culture positive cases, culture negative cases, and cases that were not cultured. Twenty patients were lost to follow-up throughout the course of treatment. Twenty-four (64.9%) of 37 patients developed ophthalmic complications during the course of treatment for endophthalmitis: 14 had a retinal detachment, 1 eye developed a white cataract, and 9 eyes developed an epiretinal membrane (ERM). One eye required enucleation due to the severity inflammation and ocular infiltration upon presentation. Intravenous drug use was a common secondary factor in endogenous fungal endophthalmitis cases that results in complication. Only one patient with a retinal detachment was not an intravenous drug user; this patient had a whipple procedure for adenocarcinoma two months prior to presentation and had systemic fungemia. Intravenous drug users can minimize their risk by not sharing, reusing, or licking needle. Distributing alcohol swabs to intravenous drug users is another preventative measure that would minimize Candida spp. invasion. The prognosis of endogenous fungal endophthalmitis is dependent upon the fungal species, level of intraocular involvement, and the timing of interventions. Reporting a history of intravenous drug use is vital when presenting for ophthalmic evaluation. Prompt diagnosis decreases morbidity. Physicians must to rely on a variety of tools in order to make a proper diagnosis. Patients must also be educated about the manifestations of endogenous fungal endophthalmitis. Although the IDSA guidelines are a great clinical tool for diagnosis and treatment the physician should evaluate every case in to determine the proper course of treatment. Intravenous drug users are good candidates for intravitreal antifungal injections due to their lasting effect. As seen in this study intravenous drug users are frequently non-adherent and are lost to follow-up. APPENDIX: ADDITIONAL TABLES Table  SEQ Table \* ARABIC 4. Clinical Summary of Risk Factors IDAgeSexRaceDiagnosis DateEye(s)Social Risk FactorsSystemic Risk FactorsCounty129MWJun-16OSIVDUHCV, complicated abdominal surgery 2016, recent long term antibiotic useElk261FWJul-16OSIVDUDiverticulitis of colonCambria327FWOct-15OSIVDUHSV, HCV, EBV, recent hospitalization for hepatic failureGreene435MWSep-15OSIVDUNoneClearfield557FWAug-13OSIVDUDiabetes, Stage III CKD, HCVBeaver627FWMar-15OSIVDUHx endocarditis secondary to IVDUColumbiana, OH729FWDec-13ODIVDUHCVAllegheny833FWNov-15ODIVDUHCV, concurrent systemic fungemiaBlair945MWOct-16ODIVDUHCV, hx cellulitis with hospitalization and systemic fungemia 3/2016Blair1033MWMay-16ODIVDUnoneButler1180MWApr-15OUNoneDiabetes, immunocompromised, whipple procedure 2/2015 for adenocarcinoma, 4/2015 candidemia related to port infectionWestmoreland1245MWDec-14OSIVDUDiabetes, Concurrent abscessed tooth Westmoreland1328MWJan-15ODIVDUNone, refused systemic work-upWashington1426MWMar-15OSIVDUChronic HCV, endocarditis 4/2015Allegheny1528MWFeb-15ODIVDUHCVCambria1626MWJun-14ODIVDUHCVCambria1729MWDec-13OSIVDUNoneClarion1828MWSep-14OSIVDUH/o Endocarditis secondary to IVDUAllegheny1927MWJul-13OSIVDUHCVButler2061MWJul-13OSIVDUDiabetes, HCV, Inpatient for leg abscess 3/2013Washington2135MWAug-13OSIVDUHCV, oral infectionsAllegheny2244MWOct-13ODIVDUNoneWashington2322MWNov-13ODIVDUHCVWestmoreland2420MWApr-13OSIVDUNoneLawrence2566FWFeb-09OSNoneCirrhosis, Sarcoidosis, CKD, longstanding IV catheter, recent hospitalizationAllegheny2679MWNov-10OUNoneCandidal sepsis and blood fungemia secondary to back surgery in 5/2010Allegheny2727FWOct-08ODIVDUHCV, oral thrush 10/2008Allegheny2874MWNov-09ODNoneEnd stage renal disease, fistula access, DiabetesClearfield2938MBMay-09OSNoneHip (fungal) osteomyelitis 5/2009, immunosuppression post- cardiac transplant, Diabetes, HCVAllegheny3039MWFeb-10OSIVDUNoneAllegheny3178MWJun-10ODNoneCandida Endophthalmitis secondary to extraction of abscessed tooth Allegheny3228MWJun-10OSIVDUDiabetesAllegheny3334MWAug-16ODIVDUDiabetesAllegheny3432MWDec-10ODIVDURenal Cancer, Positive Lyme IgGAllegheny3542FWDec-10OUIVDUHospitalized for respiratory failure and septic shock, intubation tube, endocarditis, diabetes, HCVFayette3647FWJan-11OSIVDUNoneAllegheny3718MWJul-11OSIVDUNone, refused systemic work-upClarion3824MWJul-11OSIVDUHCVMcKean3941MWJul-11ODIVDUHCV, hx endocarditisButler4053FWJan-12OSNoneRA immunosuppression, hx of fungemiaWestmoreland4126FWJan-12OUNoneSMA syndrome with PICC line, systemic fungemiaJefferson4227MWJun-12ODIVDUHCVBeaver4385MWMay-12OSNoneComplex intestinal perforation, Aspergillus sepsisAllegheny4469FWMay-13OSIVDUCOPD, oral thrush 4/2013Allegheny4557FWAug-13OSIVDUDiabetes ,CRF, HCV, Autoimmune insufficiencyBeaver4656MWSep-13OUIVDUComa for 1 year prior to presentation with prolonged ventilation,hx of sepsis from epidural and endocarditisAllegheny4761MWJul-14ODIVDUDiabetesButler4828MWJun-15OSIVDUHCVWestmoreland4935MWSep-15OSIVDUNone, refused systemic work-upAllegheny5027FWMar-15OSIVDUEndocarditisColumbiana, OH5136MWMar-15OSIVDUTraumatic injuryPleasants, WV5228MWJan-15ODIVDUHCV, AsthmaWashington5319MBNov-15OSIVDUHCVGreeneAbbreviations: OS = left eye, OD = right eye, OU = both eyes, IVDU = intravenous drug user, HCV = hepatitis C virus, hx = historyCKD = chronic kidney disease, CRF = chronic renal failure, PICC = peripherally inserted central catheter Table  SEQ Table \* ARABIC 5. Treatment and Visual Outcomes IDAgeSexEyeDiagnosis DateVA Pre TxVA Post TxDate ResolvedSurgicalOralIVTCuture IsolationFungal Species129MOSJun-16HM*PPVVVVitrectomyC. albicans261FOSJul-1620/400*PPVVVitrectomyC. albicans327FOSOct-1520/20020/40Jan-16PPVVitrectomyC. albicans435MOSSep-1520/400*PPVFAVitrectomyC. albicans557FOSAug-1320/25020/200Nov-13PPVVAVitrectomyC. albicans627FOSMar-1520/400*PPVFA(2)VitrectomyC. albicans729FODDec-13HMHMAug-14PPVAVitrectomyC. albicans833FODNov-15LPHMDec-15PPVVVVitrectomyC. albicans945MODOct-1620/100*PPVVVVitrectomyC. albicans1033MODMay-1620/250*PPVVVitrectomyC. albicans1180MODApr-1520/40020/25Nov-15PPVAVitrectomyC. albicans1180MOSApr-1520/20020/70May-16PPV (2)FA(2)VitrectomyC. albicans1245MOSDec-1420/80*PPVVVitrectomyC. albicans1328MODJan-1520/500 *PPVVA(3)VitrectomyC. albicans1426MOSMar-1520/20020/40Jul-15PPVVVitrectomyC. albicans1528MODFeb-15HM*PPV (2)VV, AVitrectomyC. tropicalis1626MODJun-1420/200*PPVVVVitrectomyC. albicans1729MOSDec-1320/600*FA(2)Vitreous TapC. albicans1828MOSSep-1420/80020/25Oct-14PPVFA(4)VitrectomyC. albicans1927MOSJul-1320/100*PPVFA(2)VitrectomyC. albicans2061MOSJul-13CF20/50Sep-13PPVFVVitrectomyC. albicans2135MOSAug-1320/60*PPVF, VAVitrectomyC. albicans2244MODOct-13LP*PPVFA(2)VitrectomyC. albicans2322MODNov-13HMLPDec-13PPVFA(3)VitrectomyNegative2420MOSApr-1320/40020/20Nov-13PPVF, VAVitreous TapC. albicans2566FOSFeb-0920/5020/80Jun-09F ANot Done2679MODNov-10CFCFNov-11FANot Done2679MOSNov-10HM20/200Nov-11PPVFANot Done2727FODOct-0820/40020/400Jan-09PPV (2)F,VVitrectomyC. albicans2874MODNov-0920/70*ANot Done2938MOSMay-0920/4020/20: Oct-09FA(3)Not Done3039MOSFeb-1020/80NLP Sep-10FANot Done3178MODJun-1020/40020/30Sep-11PPVFAAC TapNegative3228MOSJun-1020/20020/100Jan-11PPVFVitrectomyNegative3334MODAug-16CF20/80Dec-16PPVFA(2)VitrectomyNegative3432MODDec-1020/100*FBlood CultureNegative3542FODDec-10NLPFeb-11EnucleationFEnucleationNegative3542FOSDec-10LP20/25Feb-11FNot Done3647FOSJan-1120/20020/100Jul-11PPVFA(2)VitrectomyC. albicans3718MOSJul-1120/12520/400Dec-11FA(2)VitrectomyNegative3824MOSJul-1120/20020/40Nov-11PPVFANot Done3941MODJul-11HMCFNov-11PPVVA(2)Vitreous TapC. albicans4053FOSJan-12CFCFMay-12FAVitreous TapNegative4126FODJan-1220/6020/20Mar-12FNot Done4126FOSJan-1220/2020/20Mar-12FNot Done4227MODJun-12LP *PPV (2)FA(3)VitrectomyNegative4385MOSMay-1220/40020/60Jul-13PPVVA(2)VitrectomyAspergillus4469FOSMay-13CF20/200Aug-13FAVitreous TapC. albicans4557FOSAug-1320/25020/200Jan-14PPVVAVitrectomyC. albicans4656MODSep-1320/2020/25Aug-14FNot Done4656MOSSep-1320/200CFAug-14FNot Done4761MODJul-1420/40020/30Sep-14PPVFV, ANot Done4828MOSJun-15HM*PPVFA(2), VVitrectomyNegative4935MOSSep-1520/80*PPVAVitrectomyC. albicans5027FOSMar-15CF20/400Dec-15PPVFA(2)VitrectomyNegative5136MOSMar-15CF20/400Aug-15PPVFA(2)VitrectomyNegative5228MODJan-1520/50020/200Feb-15PPVVA(3)VitrectomyC. albicans5319MOSNov-1520/800*PPVVA(3)VitrectomyNegative* Patients were lost to follow-up.Abbreviations: OS = left eye, OD = right eye, OU = both eyes, HM = hand motion, LP = light perception, NLP = no light perceptionCF = count finger, PPV = pars plana vitrectomy, V = voriconazole, F = fluconazole, A = amphotericin B(number) = total number of injections  bibliography 1. .Aspergillus Endophthalmitis in Intravenous-Drug Users--Kentucky. (2001, May 01). [Electronic Journal]. MMWR, 39(3), 48-49. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/00001547.htm. 2. Connell P.P., ONeill E.C., Islam F.M., Buttery R., McCombe M., Essex R.W., Roufail E., Lash S., Wolffe B., Clark B., Chiu D., Campbell W., Allen P., (2010). Endogenous Endophthalmitis Associated with Intravenous Drug Abuse: Seven-Year Experience at a Tertiary Review Center. Retina, The Journal of Retinal and Vitreous Diseases, 30(10), 1721-1725. doi:10.1097/IAE.0b013e3181dd6db6 3. Durand, M.L. (2017). Bacterial and Fungal Endophthalmitis. Clinical Microbiology Reviews, 30(3), 597-613. doi:10.1128/cmr.00113-16 4. Wu, L., & Tapia-Herrera, G. (2009). Fungal Endophthalmitis. Current Fungal Infection Reports, 3(1), 55-61 5. Kim, D.Y., Moon, H.I., Joe, S.G., Kim, J., Yoon, Y.H., & Lee, J.Y. (2015). Recent Clinical Manifestation and Prognosis of Fungal Endophthalmitis: A 7-Year Experience at a Tertiary Referral Center in Korea. Journal of Korean Medical Science, 30(7), 960-964. doi:10.3346/jkms.2015.30.7.960 6. Sadiq, M.A., Hassan, M., Agarwal, A., Sarwar, S., Toufeeq, S., Soliman, M.K., Nguyen, Q. D. (2015). Endogenous endophthalmitis: diagnosis, management, and prognosis. Journal of Ophthalmic Inflammation and Infection, 5(32). doi.org/10.1186/s12348-015-0063-y 7. Sridhar, J., Flynn, H.W., Kuriyan, A. E., Miller, D., & Albini, T. (2013). Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. Journal of Ophthalmic Inflammation and Infection, 3(1). doi:10.1186/1869-5760-3-60 8. Peymam, G.A., Lee, P.J., Seal, D.V. (2004) Endophthalmitis Diagnosis and Management. United Kingdom: Taylor & Francis. 9. Connell P.P., ONeill E.C., Fabinyi D., Islam F.M., Buttery R., McCombe M., Essex R.W., Roufail E., Clark B., Chiu D., Campbell W., Allen P. (2011), Endogenous sendophthalmitis: 10-year experience at a tertiary referral centre. Eye, 25(1), 6672. doi:10.1038/eye.2010.145 10. Sachdeva, M.M., & Durand, M.L. (2014). Candida Endophthalmitis. Current Fungal Infection Reports, 8(4), 271-276. doi:10.1007/s12281-041-0206-x 11. Sardi, J., Scorzoni L., Bernardi T., Fusco-Almeda, A.M., & Mendes Giannini, M. (2013). Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology, 62, 10-24. doi:10.1099/jmm.0.045054-0 12. Safneck, J.R. (2012). Endophthalmitis: A review of recent trends. Saudi Journal of Ophthalmology, 26, 181-189. doi:10.1016/j.sjopt.2012.02.011 13. Patel, S.N., Rescigno, R.J., Zarbin, M.A., Langer, P., & Bhagat, N. (2014). Endogenous Endophthalmitis Associated With Intravenous Drug Abuse. Retina, 34(7), 1460-1465. doi:10.1097/iae.0000000000000084 14. Pappas, P.G., Kauffman, C.A., Andes, D.R., Clancy, C.J., Marr, K.A., Ostrosky-Zeichner, L., . . . Sobel, J. D. (2015). Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Clinical Infectious Diseases,62(4), e1-50. doi:10.1093/cid/civ933 15. Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., . . . Bennett, J. E. (2016). Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Clinical Infectious Diseases,63(4), e1-e60. doi:10.1093/cid/ciw326 16. Rao, N., & Hidayat, A. (2001). Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. American Journal of Ophthalmology, 131(2), 244-251. http://dx.doi.org/10.1016/S0002-9394(01)00968-0 17. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Invasive Candidiasis Statistics. (2017, January 25). Retrieved from https://www.cdc.gov/fungal/diseases/candidiasis/invasive/statistics.html 18. Lingappan, A., Wykoff, C. C., Albini, T. A., Miller, D., Pathengay, A., Davis, J., & Flynn, H., Jr. (2012). Endogenous Fungal Endophthalmitis: Causative Organisms, Management Strategies, and Visual Acuity Outcomes.American Journal of Ophthalmology,153(1), 162-166.e1. http://dx.doi.org/10.1016/j.ajo.2011.06.020 19. USA.gov, National Eye Institute. (n.d). Diagram of the Eye [Infographic]. Retrieved from: http://www.nei.nih.gov/health/coloboma/images/eye_with_labels.jpg, Public Domain, https://commons.wikimedia.org/w/index.php?curid=9852248 20. R Core Team (2017). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.Rproject. org/ 21. Pinheiro J, Bates D, DebRoy S, Sarkar D and R Core Team (2017). _nlme: Linear and Nonlinear Mixed Effects Models_. R package version 3.1131, URL: https://CRAN.Rproject.org/package=nlme. 22. U.S. Department of Health and Human Services, National Institute on Drug Abuse (NIDA). (2013, May 1). Cocaine. Retrieved from https://www.drugabuse.gov/drugs-abuse/cocaine 23. U.S. Department of Health and Human Services, National Institute on Drug Abuse (NIDA). (2014, May 14). America's Addiction to Opioids: Heroin and Prescription Drug Abuse. Retrieved from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2016/americas-addiction-to-opioids-heroin-prescription-drug-abuse 24. U.S. Department of Health and Human Services, National Institute on Drug Abuse (NIDA). (2016, January 27). What Science tells us About Opioid Abuse and Addiction. Retrieved from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2016/what-science-tells-us-about-opioid-abuse-addiction 25. U.S. Department of Health and Human Services, National Institute on Drug Abuse (NIDA). (2017, July). Heroin. Retrieved from https://www.drugabuse.gov/publications/drugfacts/heroin 26. U.S Department of Health and Human Service, National Center for Health Statistics (NCHS). (2017, January 06). Overdose Death Rates. [Infographic]. Retrieved from https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates 27. U.S. Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Information. (2013, October). Retrieved from https://www.deadiversion.usdoj.gov/drug_chem_info/cocaine 28. Melnychuk, E.M., Sole, D.P. (2016). A Rare Central Nervous System Fungal Infection Resulting From Brown Heroin Use. Journal of Emergency Medicine, 52(3), 314-317. http://dx.doi.org.10.1016/j.jermed.2016.09.11 29. Resnik, H., Gardner, S. E., Lorian, R. P., & Marcus, C. E. (1990).Youth and Drugs: Society's Mixed Messages. U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Use and Mental Health Administration, Office for Substance Abuse Prevention 30. USA.gov, Centers for Disease Control and Prevention. Increases in Heroin Overdose Deaths 28 States, 2010 to 2012. (2014, October 03). Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6339a1.htm 31. Mosendz, P. (2017, March 03). America's Heroin Epidemic Starts in Mexico. Retrieved from https://www.bloomberg.com/news/articles/2017-03-03/america-s-heroin-epidemic-starts-in-mexico 32. U.S. Drug Enforcement Administration (DEA), U.S. Department of Justice. (2016, June). National Heroin Threat Assessment Summary Update. Retrieved from, https://www.dea.gov/divisions/hq/2016/hq062716_attach.pdf 33. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention. Understanding the Epidemic. (2016, December 16). Retrieved from https://www.cdc.gov/drugoverdose/epidemic/index.html 34. Kauskik, K.S., Kapila, K., Praharaj, A.K. (2011). Journal of Medical Micobiology, 60, 408-422. DOI 10.1099/jmm.0.27540-0      PAGE x  PAGE 37 ENDOGENOUS FUNGAL ENDOPHTHALMITIS: EIGHT-YEAR EXPERIENCE AT A TERTIARY REFERRAL CENTER by Melessa N. Salay B.A., Washington & Jefferson College, 2007 Submitted to the Graduate Faculty of Infectious Diseases and Microbiology Department Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Public Health University of Pittsburgh 2017 UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH This essay is submitted by Melessa N. Salay on August 11, 2017 and approved by Essay Advisor: Jeremy J. Martinson, DPhil ______________________________________ Assistant Professor Infectious Diseases and Microbiology Human Genetics Graduate School of Public Health University of Pittsburgh Essay Reader: Andrew W. Eller, MD. ______________________________________ Professor Ophthalmology School of Medicine University of Pittsburgh Copyright by Melessa N. Salay 2017 Jeremy J. Martinson, DPhil ENDOGENOUS FUNGAL ENDOPHTHALMITIS: EIGHT-YEAR EXPERIENCE AT A TERTIARY REFERRAL CENTER Melessa N. Salay, MPH University of Pittsburgh, 2017 Table 4 Continued Table 5 Continued  ( C J  % ' :ANOƸƦƗƦƐƐƐƐƦƉzsogcghvt6jhvt6Uh heeh hj,hj,h$kh;v hO h c h*\hO" hQ5hO"hQ5hO"6 hO"6 hO"5h;vhO"5jhO"UmHnHuhO"h-jh-UmHnHuhAjh@mUmHnHuhY;NjhAUmHnHu%Bo9 $  $  $  $ gdnegddgd;v ^`gdN`gdo@`gdO"dgdo@`gd)+OPQmnopwxyߵr\rߵ*jh^hU^,0JUmHnHu-ht:hU^,5;CJOJQJaJmHnHuh<mHnHu#j}hU^,UmHnHujhU^,UmHnHuhU^,mHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu$jh^hU^,0JUmHnHu     !"<=>?@ABCD`a|qq_#jqhU^,UmHnHuhU^,mHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu-ht:hU^,5;CJOJQJaJmHnHu$jh^hU^,0JUmHnHuh<mHnHujhU^,UmHnHu#jwhU^,UmHnHuabchiɳɨ|׳s]ɳɨK|#jehU^,UmHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh<mHnHu#jkhU^,UmHnHujhU^,UmHnHuhU^,mHnHu*ht:hU^,5CJOJQJaJmHnHuh^hU^,0JmHnHu$jh^hU^,0JUmHnHu*jh^hU^,0JUmHnHu %&'(+,MNOijklmnopqݹݹxxf[݃ݹE*jh^hU^,0JUmHnHuh<mHnHu#j_hU^,UmHnHuhU^,mHnHu-ht:hU^,5;CJOJQJaJmHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu*ht:hU^,5CJOJQJaJmHnHu$jh^hU^,0JUmHnHujhU^,UmHnHu  3456߹߹yc߮Q#jShU^,UmHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh<mHnHu#jYhU^,UmHnHujhU^,UmHnHuhU^,mHnHuh^hU^,0J6mHnHu*ht:hU^,5CJOJQJaJmHnHuh^hU^,0JmHnHu$jh^hU^,0JUmHnHu6789:;WXYZ_`vwxݹݹǹ}rݹ\ݹǹ*jh^hU^,0JUmHnHuh<mHnHu#jMhU^,UmHnHuhU^,mHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu*ht:hU^,5CJOJQJaJmHnHu$jh^hU^,0JUmHnHujhU^,UmHnHu!   678:;<=>?[\}rr`#jA hU^,UmHnHuhU^,mHnHu*j h^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu*ht:hU^,5CJOJQJaJmHnHu$jh^hU^,0JUmHnHuh<mHnHujhU^,UmHnHu#jG hU^,UmHnHu=vf%0`gd gdj, $ gd] $  $  $  $ \]^abvwxɲɧ{ײr\Fɧ*ht:hU^,5CJOJQJaJmHnHu*j h^hU^,0JUmHnHuhU^,mHnHuh<mHnHu#j; hU^,UmHnHujhU^,UmHnHuhU^,mHnHu-ht:hU^,5;CJOJQJaJmHnHuh^hU^,0JmHnHu$jh^hU^,0JUmHnHu*j h^hU^,0JUmHnHuSTUopqstuvwx}rr`#j/ hU^,UmHnHuhU^,mHnHu*j h^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu*ht:hU^,5CJOJQJaJmHnHu$jh^hU^,0JUmHnHuh<mHnHujhU^,UmHnHu#j5 hU^,UmHnHu ɲɧ{ײr\ɲɧJ#j#hU^,UmHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh<mHnHu#j)hU^,UmHnHujhU^,UmHnHuhU^,mHnHu-ht:hU^,5;CJOJQJaJmHnHuh^hU^,0JmHnHu$jh^hU^,0JUmHnHu*j h^hU^,0JUmHnHu234589CDE_`acdefghӼӮӮrӼӮ\Lh^hU^,0J\mHnHu*jh^hU^,0JUmHnHu#jhU^,UmHnHuhU^,mHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu-ht:hU^,5;CJOJQJaJmHnHu$jh^hU^,0JUmHnHujhU^,UmHnHuh<mHnHu$%涟r`涟XTMT h$hhjhvt6U#jhU^,UmHnHu*jh^hU^,0JUmHnHuhU^,mHnHuh^hU^,0JmHnHu-ht:hU^,5;CJOJQJaJmHnHu$jh^hU^,0JUmHnHuh<mHnHu#jhU^,UmHnHujhU^,UmHnHuhU^,mHnHu%&<=>?[\]^ )ҳҨ|hRҨ*jh 'hU^,0JUmHnHu'ht:hU^,CJOJQJaJmHnHuh<mHnHu#j hU^,UmHnHujhU^,UmHnHuhU^,mHnHu*jh 'hU^,0JUmHnHuhU^,mHnHuh 'hU^,0JmHnHu$jh 'hU^,0JUmHnHuhjhU)*+-./012NOPQttbL*j|h 'hU^,0JUmHnHu#jhU^,UmHnHuhU^,mHnHu*jh 'hU^,0JUmHnHuhU^,mHnHuh 'hU^,0JmHnHu'ht:hU^,CJOJQJaJmHnHu$jh 'hU^,0JUmHnHuh<mHnHujhU^,UmHnHu#jhU^,UmHnHu5678^_`z{|~طɬə|fTɬəLjhU#jhU^,UmHnHu*jvh 'hU^,0JUmHnHuhU^,mHnHu'ht:hU^,CJOJQJaJmHnHu$jh 'hU^,0JUmHnHuh<mHnHu#jhU^,UmHnHujhU^,UmHnHuhU^,mHnHuh 'hU^,0JmHnHuhU^,hU^,0JmHnHu   /012Ӵө}iS*jjhi8 hU^,0JUmHnHu'ht:hU^,CJOJQJaJmHnHuh<mHnHu#jhU^,UmHnHujhU^,UmHnHuhU^,mHnHu*jphi8 hU^,0JUmHnHuhU^,mHnHuhi8 hU^,0JmHnHu$jhi8 hU^,0JUmHnHujh$Uh$2;nop78طɬə|fTɬə|#jhU^,UmHnHu*jdhi8 hU^,0JUmHnHuhU^,mHnHu'ht:hU^,CJOJQJaJmHnHu$jhi8 hU^,0JUmHnHuh<mHnHu#jhU^,UmHnHujhU^,UmHnHuhU^,mHnHuhi8 hU^,0JmHnHuhU^,hU^,0JmHnHu 89:D$%'ɻphd`\XTX\X\dMdMIh$k hj,hj,h\h;h h$hj,jh$U'ht:hU^,CJOJQJaJmHnHuh<mHnHu#jhU^,UmHnHujhU^,UmHnHuhU^,mHnHuhi8 hU^,0JmHnHuhU^,hU^,0JmHnHu$jhi8 hU^,0JUmHnHu*j^hi8 hU^,0JUmHnHu!"(6(,, /6/4W799gdgdtgd0gd( 2gdIgd.gdgdo@gd 8`gdo@gd`{gd+gd$k`gdj,gdj,-2Om!] !!!!!!!"""[#x#$$P%Q%%%üøóëã~~zh9hT`h`{H*hd9 hT`h`{h 8 h0he h0h`{h0h`{H*hZh`{H* h`{H*hrA h`{h`{h`{hZ)hsH* h+6hZ)h+h+6h+h+H*hZ)hZ)H*h?EhS4hsh+0%&&&&&&''' '8':'P'R'S']'_'v'|''''((6(((((() )))9)P))))*"*5*****++++f+++,!,hO hNhNH*hb$ hmH*hNhT`hmH*hd hT`hmhmh$h$H*h 8 h 8h`{hdhdH*h9 h96hT`h`{6h9h`{6h9h96 hT`h`{7!,B,I,,,,,,,`-l-----------.!.".$.// ////&/*/5/6/=/Z/////־{qj hI6^JhIh^hH*^JhIhIH*^J hI^Jh^hh^h^Jh^hh^h6^J hIh^h hI6hIhGh"KhC>)h.H*h.hT`hmH*ha hT`hm6 hT`hmhZphMhh?,_ hO h`{hb$hO h/(/// 0-0<0>0L0Q0`0a0b0d0t0000 1P1Q1R1S1c1222203133383C333<4>4@4P44}v}}v}lhIhH*^J hIH*^Jh^hh^h^Jh^hh^h6^J h^Jh( 2hH*^Jh^hh^Jh^hh6^J hH*^Jhh( 2H*^Jh^hh( 2H*^Jhyh( 2]mH sH h( 2mH sH h( 26]mH sH h^hh( 26^Jh^hh( 2^J&44?5@5B5D5[555566667<7C7T7V7W7b7777777#8λαΨvk`TIhh]hImH sH hh]hI]mH sH hIH*]mH sH h H*]mH sH h 63H*]mH sH hI]mH sH hI6]mH sH h!he^Jh!hq6^Jh!hq^Jh!hm6^Jh!hGg|H*^Jh!h ^Jh!hm^Jh!hH*^Jh!h^Jh!h^h^Jh( 2h^h]mH sH #8%8>8@8I8K8S8Y8e8f8{8888888888899.969798999;9õ斈|nb|VbHnh!hx6]mH sH h!hI]mH sH h!h"/]mH sH h!h"/6]mH sH h!hx]mH sH h"/h"/H*]mH sH h"/]mH sH hI6]mH sH hIH*]mH sH hh]hIH*]mH sH hP[]mH sH hh]hI]mH sH hh]hI6]mH sH hI]mH sH hI6mH sH hImH sH ;9U9k9999999::::::;;9;@;;;;;;<B<G<_<`<a<<<<< = =(=)=+=-==>>>>>&?D?E????ÿøøøøìøøøøøøÐììÈÄhCh!h"KH*h b6h"KH* h_/h"K h"KH*h) )h"KH*hdZ h) )h"K6 h) )h"Khh"Khth.]mH sH huhIH*]mH sH hI]mH sH h"/]mH sH h!h"/]mH sH 29??^BjDlDmDDDDGHJJLMwPRW#W[gd}gd*gdtgd[v $Z`Za$gd] $Z`Za$gd0$a$gdaz`gdgU\gdegd"Kgd"K?@@AAWB]BBB;CFCCCDDeDiDjDkDlDmDtDuDDDDDDDDDDDDDDDEWEYE\EgE2F9FDFFFGGHHHŽŽůhazhgU\5h;h;5 h05 h;5 h]5 hj5 hgU\5hjKmHnHujhgU\UhgU\h] hgU\H*jhgU\UmHnHu heH*hehe6hcheheH* hehe2H IIcIIIIIIIIIIIIh}H*hEh}H*h* hdh}H*hfh}H* h()0h}h7h}H*h3h} h}H*3[^cf^ijkmmrvvvwr"$0^`0a$gdW"$0^`0a$gd0 "d`gd>"$d[$\$`a$gd$"$d-DM [$\$`a$gd$gd}"$d-DM [$\$`a$gdo@gd}gd} jjklllllmmmmmm o oooooooooop>pmpopqqrrrrr)s,ssstttttĽݵ݂uݥuhc!hc!B*\ph!!!huhc!B*ph!!!hw)B*phh kB*phh#B*phh vB*phh; B*ph!!!huB*ph!!! hIh}h2h;hc!B*ph!!!h0B*H*phhc!hc!B*H*phhc!hc!B*phh} hEh},tKuMuuu}vvvvvvvvvvvvvvvwwwwϷsg\T\C hOvh>B*CJ\aJph!!!hWCJaJhOvhOvCJaJh]hOv5CJaJhjK5CJaJmHnHu jh]h>5CJUaJh]h>5CJaJh>B*\ph!!!jXhOvB*U\ph!!!hc!B*\ph!!!hc!hc!B*H*\ph!!!hc!hc!B*\ph!!!hc!hc!B*phhc!hc!B*H*ph!!!hc!hc!B*ph!!!wwwxxxxFyQyzz&z[zjzozxzyzzzzz{{d||ԿwwoboUG@ hc!hc!hc!hc!B*H*\ph!!!hc!hc!B*\ph!!!h-ah-aB*H*ph!!!h{B*ph!!!h0OB*ph!!!h-aB*ph!!!hB*ph!!!h{h{B*H*ph!!!h4c=B*ph!!!hO :B*ph!!!h9CqB*ph!!!hc!hc!B*ph!!!)hc!hc!B*H*fHph!!!q &hc!hc!B*fHph!!!q hc!hc!B*phhc!hc!B*H*phwxz@{e ʇ;܎ݎgd!Bgd?gd`gdC@gd}gdBgd`gd gd}"$d-DM [$\$`a$gd$"$d-DM \$`a$gd]|}}}~~w~x~z~{~|~~~=?@z{ ׀cdfg߁{wojw{ hH*hhH*hhC hCH*hh hEhBh&h9;h}h.h{ hc!B*ph!!!hc!hc!B*H*KH$\ph333hc!hc!B*]ph!!!hc!hc!H*hqs hc!hc!h{ B*ph!!!hc!hc!B*H*ph!!!hc!hc!B*ph!!!'߁^`deу );ŒŌʎَ뺳zszsl h hPhgYh+hh4MhVSh g}h=Qh3Xh;oCJaJmHnHuhuRiCJaJhyCJaJhyhyCJaJ*u֚ךؚ45VW}~ !RSrstyϜќ+EGSНҝڝܝ{gƟ"&8mɠոոոոոոոոոոոո h g}6hpThk.hd hw)h g}h.lhHh3XCJaJ#h|h3X5B*CJ\aJphhHh3XB*CJaJph#hHh3X5B*CJ\aJphh3X h3X5=ךؚgTTT$d$If`a$gdkd#$$IfTlF G gGU  t6 uqquqquqq  uqquqquqq 44 lBaEpytT gTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytT$&4gTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytT45GIVgTTT$d$If`a$gdkdз$$IfTlhF g gGU  t6    44 lBaEpytTVWnp}gTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytT}~gTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytTgTTT$d$If`a$gdkda$$IfTlhF g gGU  t6    44 lBaEpytTכٛgTTT$d$If`a$gdkd<$$IfTlhF g gGU  t6    44 lBaEpytTgTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytT gTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytT !DFRgTTT$d$If`a$gdkdͽ$$IfTlhF g gGU  t6    44 lBaEpytTRSdfrgTTT$d$If`a$gdkd$$IfTlhF g gGU  t6    44 lBaEpytTrstB}gbbUB$d$If`a$gd $$`a$gd3Xgd3Xkd$$IfTlhF g gGU  t6    44 lBaEpytT 5AHI^_`ac|}ˡ̡١ڡ#$+,-UVW]ñæxmfbhH. hjKhjKhUVh3XCJaJhUVhjKCJaJhjKCJaJh3XB*CJaJphhxEh3XB*CJaJphhxEh3XCJaJ#hYh3X5B*CJ\aJph#hxEh3X5B*CJ\aJph hu=h3X h3X5hjKmHnHujh3XUh3Xh g} h g}6$6kd$$IfTlJ\ g gTgg  t(6uqquqquqquqquqquqquqquqq44 lBa]p(ytT$d$If`a$gdáơȡˡ$d$If`a$gd$d$If`a$gdˡ̡ӡաI6#$d$If`a$gd$d$If`a$gdkd$$IfTl;\ g gTgg  t(644 lBa]p(ytTաס١ڡ6kd$$IfTl;\ g gTgg  t(644 lBa]p(ytT$d$If`a$gdڡ$d$If`a$gd$d$If`a$gdI6#$d$If`a$gd$d$If`a$gdkd$$IfTl;\ g gTgg  t(644 lBa]p(ytT6kd$$IfTl;\ g gTgg  t(644 lBa]p(ytT$d$If`a$gd$d$If`a$gd$d$If`a$gd!%I6#$d$If`a$gd$d$If`a$gdkd$$IfTl;\ G gTgg  t(644 lBa]p(ytT%(+,-6&d^`gdjKkd$$IfTl,\ g gTgg  t(644 lBa]p(ytT$d$If`a$gd-VW͢$d$If`a$gd $$`a$gd g} ^`gdjK]^stuvx͢΢1ABRSnwxyˣ "*,#%.MNPQnp˥3Giĵģģĵģğ||| h6h'h]h'hw)h5{hhT ^h| Eh=Q#h.lh g}6B*CJ]aJphh.lh g}B*CJaJphhZqVh g}CJaJ#h.lh g}5B*CJ\aJph h g}5h g}hjKmHnHuhH.jhH.U0͢΢ۢݢߢI6666$d$If`a$gdkd$$IfTlJ\: gcg  t(6uqquqquqquqquqquqquqquqq44 lBap(ytz?T I6666$d$If`a$gdkd$$IfTl;\: gcg  t(644 lBap(ytz?T135AI6666$d$If`a$gdkd$$IfTl;\: gcg  t(644 lBap(ytz?TABMOQRI6666$d$If`a$gdkd$$IfTl;\: gcg  t(644 lBap(ytz?TRSnprwI6666$d$If`a$gdkd$$IfTl;\: gcg  t(644 lBap(ytz?TwxyL'ٮID;61gdgdz`gd'gdZqVkd$$IfTl;\: gcg  t(6uqquqquqquqq44 lBap(ytz?TiΦ.NMm $%KLpr&':;>@AEܭ-xٮڮۮܮ¾¾¾ºhyh_%5CJaJh_%jh_%UmHnHujhOUmHnHuhfh40.hDhIOh=Qh!uh&h^ihzhw)hah h6h]h]hX: h6h'h'0ٮܮ=LMXZж4">$a$gdUV & Fgd yigd0;J`gdw)gd0gdVgd 9`gd5gdUg?gdUg?dh]^`gd9u $`a$gd< $Z`Za$gd0<=KLMXȱ/?@CESTUݲ.ɾ~y~qm~qh~y~y~d\Wd h AH*h Ah AH*h A h8:H*h5h8:h8:H* h8:6h8:hah0hUg? hUg?hUg?hUg?hUg?CJaJhOh_%6CJaJhOh_%CJaJ hOh_%h_%h_%CJaJhyh_%CJaJhjK5CJaJmHnHuhyh_%5CJaJ jhyh_%5CJUaJ".>]')P`kɴYZõ:;UW|~ζ϶ж1Q·UuĸŸDVWܹ½ʹʹ屭hM+hYhahaH*hLhah  h6hmahmahv/^h 9hU h~ H*h~ h~ H*h~ hAe6hAe hQ6 h)6h)hw) hk6hkh5h A h A66_v޻kno(C߿no>@LZ[ 34+-Ӿߺyuhj. hHh+hdhdH*hxThdh=hH hHH*hHhHH*h|t hKH*hKhKH*hKh+hdhw) hVH*hVhVH*hVhRT h0H*h0h0xh' hM+H*hM+hM+H*hYhM+,--C"$ f! !"=>DEZ[ͩ͢vv jh yihf5CJUaJh yihf5CJaJh!4haS0J# h yi0J# h0hV h0;Jh0;Jh+"hJh ahO'hVhL h0;J6h0;Jhg hl_h`hl_hl_H*hl_hcJhcthlTh%khw)h`([\]^h9<=>EFnuvw~/5ɾɬwkwkwkwkwkhtB*CJaJphh1B*CJaJphhI|h-B*CJaJphh!rhUg?CJaJh-5B*CJ\aJph#hI|h-5B*CJ\aJphhfhFCJaJhfhpCJaJh yihp5CJaJ jh yihf5CJUaJhjK5CJaJmHnHu*9$d$If`a$gd1$d$If`a$gd!rFf-$d$If`a$gd-$d$If`a$gdb.9=>@CEGNQVnvwy|~FfW6$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf2$d$If`a$gdt Ff>$d$If`a$gd1$d$If`a$gd!rFf:$d$If`a$gdt$d$If`a$gdb. /679<>@GJOqFfkG$d$If`a$gd1$d$If`a$gd!rFf&C$d$If`a$gdt$d$If`a$gdb.567>?QpqFKLMUVkqrs{|P\]^fg *123;<QXhtB*CJaJphh-B*CJaJphh1B*CJaJphh!rhUg?CJaJhI|h-B*CJaJphLFfO$d$If`a$gd1$d$If`a$gd!rFfK$d$If`a$gdt$d$If`a$gdb.FLMPSUW^afkrsvy{FfX$d$If`a$gd1$d$If`a$gd!rFf:T$d$If`a$gdt$d$If`a$gdb.{}"%*P]^adFf a$d$If`a$gd!rFf\$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1dfhorwFfiFfNe$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!r !&*23FfrFfm$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!r369;=DGLQYZ]`bdknsFfbv$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rXYZbc#$IRST\]r|}~8ABCKLTV6@ABh-B*CJaJphhtB*CJaJphh1B*CJaJphh!rhUg?CJaJhI|h-B*CJaJphLFf~$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFfz!#%,/4ISTWZ\^ehmFfv$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf1$d$If`a$gdtmr}~Ff$d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdt$d$If`a$gdb.8BCFIKMTFf$d$If`a$gd1$d$If`a$gd!rFfE$d$If`a$gdt$d$If`a$gdb.TW\Ff$d$If`a$gd1$d$If`a$gd!rFfϜ$d$If`a$gdt$d$If`a$gdb.6ABEHJLSV[Ff$d$If`a$gd1$d$If`a$gd!rFfY$d$If`a$gdt$d$If`a$gdb.BJKJSTU]^nvwCcpwxy6<=>h-B*CJaJphh!rhUg?CJaJhtB*CJaJphh1B*CJaJphhI|h-B*CJaJphLJTUX[Ff($d$If`a$gd!rFf$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1[]_finwFfm$d$If`a$gdt$d$If`a$gdUU$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdt$d$If`a$gd$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf pxy|Ff$d$If`a$gd1$d$If`a$gd!rFf<$d$If`a$gdt$d$If`a$gdb. Ff $d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdt$d$If`a$gdb.!6=>ADFHORW|Ff$d$If`a$gd$d$If`a$gd1$d$If`a$gd!rFfP$d$If`a$gdt$d$If`a$gdb.>FGk{| <HOXYZbcktuv~ #hI|h-6B*CJ]aJphh!rhUg?CJaJhtB*CJaJphh-B*CJaJphh1B*CJaJphhI|h-B*CJaJphEFfFf$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!r OYZ]`bdkns$d$If`a$gdFfd$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdb.$d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdtkuvy|~Ffx$d$If`a$gd1$d$If`a$gd!rFf3$d$If`a$gdt$d$If`a$gdb. Ff$d$If`a$gd1$d$If`a$gd!rFf$d$If`a$gdt$d$If`a$gdb. 4BCDLMn{|}_`|{{jhUaUhUa hh hahahajh yiUmHnHuhB*CJaJphhUg?B*CJaJphhI|hUg?B*CJaJphhtB*CJaJphh1B*CJaJphhI|h-B*CJaJphh!rhUg?CJaJ/"'4CDGJLNUX]n|}Ff$d$If`a$gd1$d$If`a$gd!rFfG$d$If`a$gdt$d$If`a$gdb.Ff$$d$If`a$gd1$d$If`a$gd!rFf $d$If`a$gdt$d$If`a$gdb._`lUkd$$Ifl&%  t 644 lap ytFf]$d$If`a$gdt$d$If`a$gdb.$d$If`a$gd1 B72gda $ & Fa$gdnUkd$$Ifl&%  t 644 lap yt$d$If`a$gdtUkdj$$Ifl&%  t 644 lap ytUg?.8CQZ_ctFf$d$If`a$gd^$d$If`a$gd^ $$`a$gdUVgdgda 0<=GNlxy/;<FMmyzŶŶŶŶŶŶŶŶŶŶ#h^h^6B*CJ]aJph)h^h^B*CJOJQJ^JaJphh^h^B*CJaJphh^h^CJaJ#h^h^5B*CJ\aJphhUahUa5hUajhUaUhjKmHnHu8FfF&$d$If`a$gd^Ff $d$If`a$gd^ !#%0<=?BDGNUWY]_aFf,$d$If`a$gd^$d$If`a$gd^alxy{~Ff7$d$If`a$gd^Ff1$d$If`a$gd^ "$/;<>ACFfC$d$If`a$gd^FfB=$d$If`a$gd^CFMPSZ^`bmyz|FfH$d$If`a$gd^$d$If`a$gd^ Ff>T$d$If`a$gd^$d$If`a$gd^FfN,89DKy<HIT[|DPQ\c$AMNY`#h^h^6B*CJ]aJph)h^h^B*CJOJQJ^JaJphh^h^B*CJaJphh^h^CJaJK!,89<?ADKRX_ginyFf_$d$If`a$gd^FfY$d$If`a$gd^Ff:k$d$If`a$gd^Ff{e$d$If`a$gd^ ")-/1<HILOQT[^`bjlqFfp$d$If`a$gd^$d$If`a$gd^q|Ffw|$d$If`a$gd^Ffv$d$If`a$gd^ !'.249DPQTWYFf$d$If`a$gd^Ff6$d$If`a$gd^Y\cjlnrtyFf$d$If`a$gd^$d$If`a$gd^$')+/Ff2$d$If`a$gd^$d$If`a$gd^Ffs/16AMNQTVY`cfmqsxFf$d$If`a$gd^Ff$d$If`a$gd^ Ff:$d$If`a$gd^Ffo$d$If`a$gd^"@ALSwx./:Adepw)*5<depw'(3:lmx&'#h^h^6B*CJ]aJphh^h^CJaJ)h^h^B*CJOJQJ^JaJphh^h^B*CJaJphK"%(/135>@ADGILSV]dhjlFf$d$If`a$gd^$d$If`a$gd^luwx{~Ffw$d$If`a$gd^Ff$d$If`a$gd^ #,./257Ff$d$If`a$gd^Ff6$d$If`a$gd^7:AGLSUWYbdehkmpw~Ff$d$If`a$gd^$d$If`a$gd^ Ff2$d$If`a$gd^$d$If`a$gd^Ffs )*-025<CEGIKM[dehkmpwFf$d$If`a$gd^Ff$d$If`a$gd^w{}Ff.$d$If`a$gd^Ffo$d$If`a$gd^ '(+.03:AHOQSXFf$d$If`a$gd^$d$If`a$gd^XclmpsuxFfk$d$If`a$gd^Ff$d$If`a$gd^ &'*-/Ff$d$If`a$gd^Ff* $d$If`a$gd^/29?ELNPR[]^adfipv|Ff$d$If`a$gd^$d$If`a$gd^'29]^ip'.R^_jq$NOZa LMX_Яh^hfB*CJaJph#h^h^6B*CJ]aJphh^h^CJaJ)h^h^B*CJOJQJ^JaJphh^h^B*CJaJphBFf&#$d$If`a$gd^$d$If`a$gd^Ffg"$'.18?ACER^_begjqFf.$d$If`a$gd^Ff($d$If`a$gd^qxFf":$d$If`a$gd^Ffc4$d$If`a$gd^$+18<>CFf?$d$If`a$gd^$d$If`a$gd^CLNORUWZadfhlnvFf_K$d$If`a$gd^FfE$d$If`a$gd^ FfV$d$If`a$gd^FfQ$d$If`a$gd^&-138CLMPSUX_fmtxzFf\$d$If`a$gd^$d$If`a$gd^Ff(h$d$If`a$gd^$d$If`a$gd^Ff[b)*,-l;<>qs5ж~zzzs hOV6h! zhOV6 hOV6h hOV6hk-hOV6hk-6]hOV6h] hOV6]hOV6hk-] hT h[h^jhd>UmHnHuhfB*CJaJphh^hfCJaJh^hfB*CJaJph)h^hfB*CJOJQJ^JaJph)$d$If`a$gdUkdZq$$Ifl%%  t 644 lap ytfFfm$d$If`a$gd^B/$d$If`a$gd^Ukdbr$$Ifl%%  t 644 lap ytf$d$If`a$gdUkdq$$Ifl%%  t 644 lap ytf)B:5gdT  & Fgd^Ukdjs$$Ifl%%  t 644 lap ytf$d$If`a$gd^Ukdr$$Ifl%%  t 644 lap ytf)pc 456QR d`gdk-0d^`0gd0Md^`gd]t0d^`0gdk-gdk-5VWXbde4VWY1acdS!" 689z5TUW TUGdeg hOV6h0MhOV6hk-mH sH hOV6h]thOV6hk-6hOV6hk-6]hOV6 hOV6hk- hOV6h! zhOV6h! z6]Iw9}0Bbz',RSTYȬ|h+ h+h85wh85wh hPh h!BhGh!Bh!Bh!BB*ph h!Bh!Bh>` h>`6h{VhHh0M hHhHhOV6h0M6] hOV6h0MhThOV6 hOV6hV hOV6hk-hOV6hk-6]/'TUY$0d7$8$H$^`0a$gd0$0d7$8$H$^`0a$gdP d7$8$H$gd!B0d7$8$H$^`0gd!B$a$gd>`$a$gdVgdV0d^`0gdV 9YZ[_bY^ RXIO &      ? h     & >       ʾҴΰh h[hPhP6] hhP h6hhP hPhPh!ShJ`h h2h85whh+hU hhCYZSTJK! "   n$0d7$8$H$^`0a$gdc!0d7$8$H$^`0gdP$0d7$8$H$^`0a$gdP$0d7$8$H$^`0a$gdd7$8$H$^`gd85w0d7$8$H$^`0gdd7$8$H$`gd      k l  !#$&')*67D H`gd$k$0d7$8$H$^`0a$gdi0d7$8$H$^`0gdP    1 j k l p  )*j!"$%'(*+,234589?@BCEFϻ~yt h+5 hk5jh+U*h2mHnHu*h2mHnHujh+Uh+hYjhYU hPhP h0h0h0h06 h06h0 hGh0 hihihTh$hihG hGhGhPh p-DEF$d`a$gd5 $`a$gd5 $`a$gd~$d`a$gdaS $`a$gdkrs hPhPhYhd>hd>hd>5CJaJh yih yih yi5CJaJ hG!5 h@mh+ho@hY;Nh+5hh+mHnHu hh+hAh+mHnHuh{h+5 h+5h+B{ $`a$gd$k $`a$gd~ $`a$gd|3 d`gdO"$d`a$gd~$d`a$gd5 $`a$gd5$d`a$gdaS7:KLOP`pq d`gd5 $`a$gd5$d`a$gd5 $`a$gd$k $`a$gdWj$d`a$gdaS ,EFGUs $`a$gd`{ $`a$gd_ $`a$gd`{ $`a$gd$k d`gd50d7$8$H$^`0gdP`gdd>`gd yi $`a$gd`{ E 000P1h:pvt6/ =!"#$% Dp?0P1h:p$k/ =!"#$% DpF@6g#JJFIFddDuckyd XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)Km&Adobed ExZQ; !1" @P0A2#B3p$`C47    !1AQa"2q#BRbr$@3C P႒Ss4%50TdcD&6wғ7`ptEF !1A Qaq"@20PBRb#3rC`p²Ss!1AQaq@P0 `p sw@a1̆6Rv1o~k^:NukI[3Fw5R~OWXiɾU#e>ύ q3R.XK%ӂ=ys*EbΖr2lxb] NyWkt,||4wknu#tD\#k]l^o6okDG{7g@c(ldJ{[arhsGzmtS%fûxozzu79;^hh`Cz#*Eo]uo5j}lv1oЍ݄>*o'n$:13ej7,&%לM;FdqTU%5>5F}2f[|17*ٜ>. }SϟC|f~e$̆uܼ*g^@~ȵ}ڧk5=1ϭ)5=8Ki)$(Gڞix_q/n+jsV6 k}Q]:N]Sqvc,Ef'y w ?.㧿}3Yo)Fg >%ī0Ąet:u߆:2>M{GϲΫuIlN;C_1gE @ clW>rx5; g'ȑt p6ӯ/[1;3Swjͽ~FxUV'wkOL& =BeQ^ޟacn>˄Ԍ%!ΆRϒe]93ˉ%1 ,_6UG q+ٶfUt{/MW\>i9f3sĀ9 Z()w]sXٯ{kgw<B֞ۿz=MIQ,pBU*|z9ؗF;^17kZ|vG;k>o.ۻx9F@}k{+׫]5Ӧ5ߟ{>#l'<xʦ]X\j[:t]NUoZtq/<Y?=zß~ߢx91+Y:Qzn6ʺƥS&v=']w%RɻޗȺIyGjv-?kqݓkY髝J=01Ԯ3'~iJ:~O>aI|j6ޕmOwujiyKӾ;O/Ku٬s/;ܑ^ k/v*aXn1gS=g_.-kqօLC9G0p2xԕcϏA~߿=Kg~w?l} &C9ݼCe=tuA j%u{ۇGVc\ߏ}[>Nݫh5^@JYU2.΅tk؅O +~U}\[p|ӫt]F3rʷOc_-k鲬.`m8ON!ҏڳ2Ƨol5EͶ͡^k0Yf3bnxO[6g{er:Q!F̓Wf?./@*)^۟z>ϼHq==w?;v;`Ж}.ۆ6cjSgfF+r:f(֞ϡ+{kie_;8.X K3e2i ףYJ>cX5YQBGNdifzCsk܏_hnw`EN7vP;!vW݌"EVGOym}}>n&>;5J_ cd̞ >ȫۯ=t6.2ޞ'G&ʽѽ-Io^זּ񻻧=~G;^ϻ9EрܲuGݳ8Ue>3{?!x;tv潓r{<`yNiReBX5(2-W6Bl<;eYowOVN%mNx =Gޭ煷`,K;8ܺjiWNT19Jq9&vhۺ{|GɓՒY}(2O|>¡*UeWN~O3ߘ- /,I<ɢKY.;XAg~q-`_('U^,xK;ifYEˣX?SÕ3@FtŌγ(L36qBY];FUvyzEt|gyޒ^~ٚ-.z;'߼wȍ,쥅,;VB+rPmBKͪ:8%۞=fKu%_z?z{sggVݶ}5Vt%y^Sc~pٞo95+)Nw-Gtz7aæq٫gyN w;_۾?W] >sڶoOȖ9KgK4CjBtF,c7LJkк['.F^Fϛ^{mwdv:ɦ\,.?q <.87-halKꌺqkh67oiLV#8}\oB~ٺ:krGA .SD~WTg?ny۝?'Mi^[;n}͝2ˣ(>]=L%mb9ykN~>m:8tߕ|=>nF0ypݰ7noT*ޥv5*ۿ8}ݽ)_Ku۽yc?j_,׎]s,FCZ]W7=-pd*^rοRVmZ_eu:pzUy{\?I n\Kӷf$wp,f=5ҍUͿC`q~W$;;ʿ{Wy0dך{:Zioɞ?֜ej7aݞɞ#R4v+ܩgyP9ǢC_lBS~]k:zkZW:Y6l>fA}Nn'ۊq"R=. bfU0jc/W3mǡt:7RQ!ߦGL,otΜK>v+^~ 8|>|g{_U|ɼfgܣ- Wg lmSŕ(,9ŗ6 NobdgYxPlps#C}Shtvv;Dgh2!~?hS?iWi1)`n,NI~>]-as-vG5];{6rky>i}!Еt0#N͞v/k3:2*㯷h/`NejmA+s ğ a 42Fo{ lN{=nnywl{6܇ vec|4pBW L>=||_q|m^cxg {櫉bG&cײౣd L &%;R0My<=Va+<9P>SGp-7)XƯj\\6 lmW%֌̇dM ɔSSPˣl5P)5df`B0h SDZ}0Hބu\CPcs'^uۜ[-}ݙ^vc| 4ݹ 7>vg_nҷr=Nst}Y.Yarlɻ֢=.mM \QwE"{jeAeovrDC>&L9x/S,ll"c؂nb3v9nnc6dO'||y1`=нE!Tl: )֩X.p*F=ש 1YjuI-6( O`j-@Hބr~9݅H݃% eAl{?8׷$")\spu/n';: 懍,{gε83'a.KB 1=,H+'עޓBixsk1ĒnxEܡOQwoeon:xﳶXXð1I x!k .&F"ssD]p Z x1ސvFhe_s ɓۙ!>)^ynϛgSVuk3=o4΀6ӂk|4g#AYҐ$ȠW꽧ڜ 8?Xڦy𜏳8l>Gm|'<ivn_x5>Y]kx<l1er]A33l}ܶ_s67-4v8y/HM QG=8')#*fmNƒ|o.O<΋VBewfL r*~!S +0ps}'vYnE\.r?k6gwbo#/o Mvm"3c' c}^_EB׌Kt,FOѬW?PCWҞhTnEN4SU{Ψ:x|o z|[H  {&6=APmu!k:qݓ?o!>݋KX(ޏnlQm#wYεr>iO8sֹa2Ҟא^TERҦ% ޤmű2Y"\'@9vnG n׏>>U$*>eɊH򢏷//[L|iyݡf톢|!pxoͤ΋˳+#iwvw1r%st|Ϲ[W9:y9g<>2a܌{ N{9>MyGzcxݦ0dp6xX1 ]ˊeQztERʜ^1E9 G-Ou|3GSLc.4w]n#GTs9 ׮u w^+3 !..j25p×q]wMCwlx{x[ۣ0=1_=^NG:>@ȞKo#;QÝhɏ&dƇD׶՝V,ƧS;g͹#dw/9z rvqwdG"*ؿn2ڍ78\FdMj`/sw[Ȥr>GzU9ģmBczĴ0?=5OÐ[݋Ӛ!\7QwTԪ?Ms[ "I sl21p^"#U@D땫9ɡ8׶:3%᝾eYɻ8Gdk7 2SrkeC< X2sdn61%ۉ9cËq>>> K<%qwa}frqk|[qփsu:D^)A ڧ0'uuݹ:l2V a`񲲦#@Y?hKj"v-{Ǐr$+z"BgTZ(ڄITaaK?.36|,_Ȑ˪Ŭj?i GDK.1Ëq![7|ss&.eԹ*"/$q㝳nt0L,L`7qsGrKٷSsOq6Q컷6ȝʐ'ġ !ej|p~Ӷ|Vs0NaQ{Eֳr vg8ig?h0r<]$`˗0lL0ŏҦK K&nn_j<9Iq%qNJ᝱ >98: dK&đ7a$x|vcaNj:<O?Ipr]&M.P.fFzff6)ح|a q`O @>29,x`fJqNlry*~W4_myf ~6kwv5ؼob_rA/kΕ;yƫ{<7ح'$WhGȇ> 0_vE7nx<,da7 EuWȚN }rxT+\U\>Hj녵 xy"GJB!#W9k'IDؤvWWȽPD̹zd !_zr%7#e#̎{DH xW PY^A+ V99U ZUP 5關tAP&UҵC͒RURU\~nEiViT(uTN&ɕL_6*z\[ SiPp !O TZR*\QuW9\˜Hល1^*BʒqCoEZ?ɧRktPIrA4TS?5#ɘ4mNJ_DՕPPGBC(JxF܃QmUE>V\BWpE*BVg#+FBcCk@ML=rLyVФROK=N4YQZ* ]D%L}SdP96KCPT: =FjkUEUE>ht6-˟"&I-9>ۚ=^^j!1=Pr@* PkRUOZ DQH80D X$s?ۣnr\j(6 ŴTkɄ5XDjT |~ =7Ap#O-`tɒUD"LKLy&:ӫ]T(F:jTس=›!U\8cҏ6(Zڽ 3vd\ޢSy Jȏ.@XK i1Q7EbaqA94G c`r\ds@IY=$s]sSBcIMzM7Fҙk 4f>aQm+BQYЭE@Udw9K|hƞ=OU VՓ4ڼS"Mm-m8^M06SOJB\:PLcSw̿uzjdU5 l\mrP *(أ@PwYE-e.0JhMmj> jkH*5QZST?fߩ!>emLfƌ: ulj eQ/RhTBDjz zcj2DKehi jU1ZG )Y*6tAZS9m:&SJkA@PDP^h!"zTRUJ෢Wҽ9'Nna~4DQd!%P 3̵4(ڀDEWjڊ#?XzM'ѓBhsO(y| ׎^].DTy./8JzmF4XDJ&6Q1VVk1!L˒Dd{drCw@yk_WjOcGuNkZrmcoY:||~ށ565 UVPY?iHB- )pbO 1䇬B$ش>9?$/VڰbZ)yR"&9@j M[TڡD:!DSMk^XteeNҡCq \GG#Z[RWܮEGCUTQ"֔Шt4N45=Щ)#D֦Zcb ]oEUkfcPбC)Ōt~\/$a77&;ܗ/q@mNz9J[֠jkP EDKs,|i2ڱz5yzQQAJzT/L\,v N|jV,gKPjZ Mho}^b\s|UWttLImW.A=)^^t^F#jҍ>])qxt2F^^W*UaT∟E5S0Sr'/f`J'qx6795N-u𪪹^UW"JM5oh U@VkyB'ըoKJMm*ҭDSꅍ) R*\U\UO/CR*IVXV (C^㋯v~OQ^LG3dm32 ^pBb/cGJ( ܎5.k +ڐ***&F=iW'5?M_ y_;5ak1=ȁSRzW+S"j C1瘰IQ8WUq4!G]Sשx+o qW$SbˎP)81ljz*|TYY000 u0w iV<*5+.WsU^^eMjϘ n> > #&Ua30=,bhVh^_5rWpWPjV *:s4sf|Oic[iPޯB Э ЃBTpn, f)lx; AAG|?$<ϙ 7 Ȧm~FdB# XJ7mU~Q*ղ׳69Kܞ~ziЫJE+JoaI3c=cppa )rO4z@ ǖ7C$dʈC76#6aY63uQ*/V6Fd,ܜ+S:| X}qF\7qG&QQ//ȮCtB1lczT |ZiV4(RQD1M|ُl/@ИPC(&<,6[4%=b=)1(z(_ <:dB`cҊiVGɟ/R^\S3g,bKYGBTD&_#`ƕ" 2iQWP8=u^ ~4@|+w4M(*汭s_>V`no9UʮW; D<-Wh5ɁG[<hjګQqO8Y^5D<8rPޮC7 ȍ͒ [1:)UQ>,꼓SFb ˿?Kfc ;$apVP*@TQG.#]Qui%?r/_ U C|)?TJ\<(ͻߞ^ ܨG[Ql01iWEHT_|^4%"GBg2#, мKJEEi@ڃiYPr0r{' xѱ $>.iFTaksZ\h(B5)H\T*Q/4ܜ/fuoa  (?C BUP"T@+g|yf2_N{sXsZp>)p "bOz ʥUUʮ.({ a̺kPtP\R9DQrpY_7%˱µ+ޑd >OZBI1"+)HE[T5ê5Vhk==k4Gm'8hZ9|B5QpUzTOf ңwY,kzBsXEWê*7灅gMHLx sK\CS7E ,toƘ+j-ǡ59FT\j:Q'sQ?'Ly3ŝI Nu?"4]A+%b5t@}qWxyzc4t;q{#kd|G<r/GB=~l;j1Zommp(tj39LKd^>K t6X7N $;XeVUeK3t45^5Z|WT.*ö'%Cʙ8ҵ\V(UXUTjf^RZ*i*4 ]0CXlh~ zs)n[?BqUSYZ{V[Z:bo*mw³$nRy{l4"RWNOaPL-(U_/3E]EyRxO"X7*- ԥiQdBM7QejMKz^]KS+ 83)޳[BaF wWHFuffL9,UשyJbcСHLPC-j 44-kZSU?3!.MT(sz&V`ASx;(QvTF*PT@N ^L2YiKVǗwz TN>lT@~T֘&؇=.t8Cbm_@ MbˢR{WS5GEnDr=j9!R* 8r!]! ,NpлQMm<ǐjD KlV15z5TˤQFiSl<]5*j{*#DP;P8 :gjĬj5j.&W.ƒ@u6 y(JR!0AM"Ĕ?JhWDsF^yָz3uğjU0UtA8=iu|EEjFcS䲍>VH^n# ;vm^f{4Eb>QMЮ)]QݘN;*<5ZB0SUy1ROK T\*!Zb4TnkicwvACʛ sּ+{z!5'&) *8 VVKo̡(\_=;d:lSI#=l^ݞ{vԌzfOڬmܫRu{1dP xȌIvLu]hQ _oEkqܮW*aw!huEVkFI5G>tz-~Ra )ctjLvQzHMv fϟz`5׾ɹ[^¬LPz8%˜a8t.9H8cV( You:=1\%T2nV5P?"^~ _ O& Ԏ(evjeZ{=+'*Y\qDS<oI .p9lUjAjN.=k\rJ/S6:F'VC& Oz &is_d(-O1PteבzFQUQ>j^XjuzC?Lgt{IsY=Mgd玥`]c73^kNLsͥޛj[Xwe?tZwG2اӹUw*:.2L5]M-KxJ &b:Wút> { 8"oWB{֒nqLNYP9B{ݚY6$wrq)n)ze}7z8iYޢM(nͭBR%ܟp1KX{pp/ MBCU6u@qUH&çWqWgUzCX S-۲z|9 ͨxO"Dl6shb7AG j4^e-iQb-\s^n|M.v*l?lU5Ry+QN:U0yhW* [(nGfx5;ĄW"ΚOc/5wr5'5Y/.ˇJ57FI%M5O!Ɋ S<:E Zo3NU[peF'ܻWBb֫{Dy(/XpS곥]5NÛ rpNB9҄d&⋣ 86 L3V @D=#<Z+Ơ?FhM=ѪV)>\>xSē6\3N6/6Iغyfb`}jYwdǒ4rҘTנ&" 1"ieۘSMU~H1&X[qFI4ឈ as13R'CJ#O }z2@iC!kɵ:Ƃ0ѩ9SohqT1ҥ/Ц_(hj5O _7fzZϭ $ؘb;U^o<)X@޸Иh>nyŅ6c1o9M.BڝhYحu' V*rPOLUPQՌ.;Bb䂎()\)hr5+KW:엛ח!|8οEA]2=CzɫOb$\>%4W+®Gww諿kɓL#@264|/GVėDh\?KAqTyP YO_{6u+V %jXQқ9}K}Q[Wy^t?tgxQ-ڑMO TGJ&­zQtԝ| A`qc{S鬯2zs37p% eTbm6oR^Eɕk ͔!a@E! JXKww}'y/3SwV{BQÃ-CY69Jw+KW]&ޘ=B7B&v&x6:^f)y?"=黆r,m±XV(̠w5r֯JX=j/t)e oǔwvyjh(ܮ`pIGp i_GFnӹ^՜Ayj\q e*T \x2׭V}N /oOҮaz]p!qen&\2t0\Dˮ \_ yc Ϝ+y傽>4 gw}΅<ۂ—r(ՌdPc cj KDypq-I= bZVӮ!%Syҵ¸n6i_ 9T'B-ҳCU:t*#f?}\3,Akc2ruk\.#RIAȃLC]v6&=+d9_S;$K )B)P49&ɽ0MssGhQT i[mca&'>9"ܙ.vyD]9:7,pȑu㯭YpY:\9iqN]A1ŵ}r`_yb [1۞ri&ka̺B/ƃ P[ bpKӦ"nMNEJՁ9lv ޿^.&110Z,G>ɬDRl̫Jnj ZП0VU K!+c\?J7_v1 ,zREW0 fW[ۦ_?G0U5iU:jH='>yEMuU9$ӡ8ZcqGn%.R#[lLDeӍ2nenV{CN,s=ul3o\H\zP?$KM~>-<j>A(yv4M] S1mG4,~Nhu 3O!h84q+G:Gs7f~UgJSJ[O1Py׉%!ԃkaUߙ .{M4Pul2yH(<%։7?'~q ןjZC\}F.hS<7_K^4͈Od}/FBpel[kJI#:|ӿ$'$$|d!)~@`8rbZbXh}8Ef8?ϺW=[:SZlvb4G`GMS.X2n^LT5kт囓ݪjx:zMT^lSlZt\ۣO?:Na@Td0?)\XWyNB҉-NQ~(SS8[`}<'"ڎ2]\ AF4#E4C `yR1;GKN%T@wq )q$or1 )t,㇙N Q!KiC qj)'?zNXGC{ޥIor (T+0⏝%ʦ:j'W9j}f4(18L7VI=NCD(PϴpyDAV𓶼57)̩Nx3t4CTc8ycu|8u:R>dSgEDcG1ޯ==(BA[g8 XݎUBd|C2|̩t$3:xJfh8+C_j[5KgKƿ7YuR+Zf8yVB;l84:ߕ'h**&7JƑox#{}$lޟo=~LQF4a)1k |ѱ(r3/Zb+t ]#6I~t Q]CT Cb)$ն]8 X+Z帢5uܤ-sf%;'ɕ02 YxhwN\18q1単S)4#ߗ{@~BA9Pva+ORfsC1pܓ2n6i-Da!&KPv3׮_HP /]"C\fHQސ+W{Ff7<̈Γ,[N6 X )Nc RrT/=:1^9/H RϿ ((VG$x[jI)h9eK!I~o+SH1P^N&#[aaR[g4[jSdS#JkZErۖ۽.#[a ±Yھ.|s#ѵ(8'q7>6riL莶 ַR UZqz+`-E<D5Jlf T2q'VeW̗Ua\&*R\3%nCHy.x!AM01-ee) ֱ w%>PFyeuvVx!JwߗqkjFy%]+_dlC˰u."[PhT҅<8jaAHr6YQ04Ĉ"ALY}T: HNHamߞD;ʍk U`T,zKE$:Y*e]ͻxcsh\5)fluQJʸQqZ\Ѫ$oJ[xŵ8ʁN݊'l:^Zۊ`mjC7s[In߉\Z9s;$:6$bdժ\%Ia (OJ 1ɒkqBiH6=6|9]@>}nW-WhP3p[һf J9.\lG~lv.s$F3̗Vط7S.kx #Kj)q֬’oPΊм(qCyۭ:ۭ8dB#x8B|$ xEM&WkD zJqP ! ;+u4nmfBjmϞRaǔzڢ Vݘ82RUMava1˄h8DԮcrdiZՊm Nբ?ږPƋp@~8(1:|sux^eUMdɦ"gÁwh]D~C$Ne8uL`urɜ?kvlrbJNC`{:Gh=1pPMihQEiֺIm#*'`÷=C[<iZqQÒ:s>A O@*}85"dTE+Ldu=?E[RqCj:kFU8A>O gq2Zhw;t;*LG:ɮQaQTmq];Mcu,+[/8کJP9|a sm&a)r<׋ErYq)IUB+ox~ˇ. p :M]*? ؏3t<5S j;0Д (B4@ BR,!#3{6́5X:`(GiX OH8!Cj;4ّ;:V>_:Ǎo[dQ-(=;~‘"xe/YA!)Bp^Pg+s_1OreC.qkDW2pH?į5uk'ĊٵYu9AKc8OtK]˘#ޜrݽ|Gh9HDAH"ú[Y!)nW7G08%2Ĝ"#$Zs6HO- ]tvڭe7HX=)3miR r{Kѥ)ytKonI‰V~[@S嵔Y#h)fm/IMt7[${Tu x[kTHOFF.9 nZ_}rer볭{D??W]mF kD?- 9Er [$2 x%_# #Xe\è6\#jc ()}J.9l¤ӲB_ik[yM Uj-֛BUT)W5(g Zَ'Å2MJ;i)f+ >`cf:s {H?TL{bN~yJsv9WcgzT5~#ܐ[;"\vR(p&ؔ#xฏSku !.B 2ᩭ;RRmOg$% N5&; N +1gICʝu`$]gkvVGhh!.jv8Q-Ig,tbmR[Kʀ 8$#DU'S'3k'5ٶ(! e+![zyKRۿ*R*JNۣB}22`Q*x[s"ĵ,][.IV~$xRdv/\PP߂<>))*M pw[yҭDmUÔ[1%-Ou8YpUa "2r,\8v,sH:rˆ̸&Tg@e<د-2eܗ 3WʎXPQ Cf;ʻ]܎~Nl;}.SJ,ѶFRlMIߏ>[ @*Tb;{e3&HbZptx]:4pr*ry~ԧx$Ӗ2 r m)j!o-[ v-θP_q/[4J]).2D0k*b*uÒOF ѥ) OS(ON3}4Jhʜ|eOZ&tc5S4MiANcHpF> ^9WF4(n\y^nqn:G FS}֌Gpr4Uu}T!΍TBꅥ+B%CROaE1ȽoXy (=J2Z$!o:׬Wf+OCaZEyaAHɵXmūhj | mm88H$+oWIG'$^[Lt+R,6קe-ȍpCJ i2$)Rg.jg# ős6=>~m#(%Q!iCyj;؛οL{};gn6{"#vc!%'MF/ݽxfed}KmwY2^C#Bti+]/1$ G/7d=mkys]ߪ+֫Q8Dj).pʛrv)x}d>ELrC[-*5j8>ݐ <~#,]D# mHq U+ 9BsIJ[֪ri.,o'7njF촮YG +!,4*6$68>5fdQN+ÙY1alPbC|fIo٬M:TgL0hxjYyi5#GIdݔÑJ|;ζMiDzSNa eDWg^x~ 8R)SuS巠g$$IVL>:z񪙧?7cRǎС):Vs'i٧S%va43kInLm}4G;d3%"sJw?VV9uÀy^$b9o2 NGqhxs3"E희wfu_8)/"|akRe>'XI'oWŝp[A@vwW-OGv(H HSZm}ME2'n\RY:{kMB8r-#R+^- l($nׯJq--%ep[JoIU;=~|'Ch񋧉svM#,Emf|<49ԥZ|d<%uIἇy1ƮK=N̐~|nܺӃ8OyƬ]&<];ui>pߞq][;ˊWb'-(Oo^i>LW=+fqpT ,5nBѳ6VYLD."uLτtwqtˈڋTMc[iL|sP9 lLζiЕcV'j)yly2!8oە䩴 642ڥ¼yI5O13'\$x^.paC] W+.ua:ݲdr5CjD'֭K8÷kJʓoZ!xO~A ȍZ)9stmJ#jc ڊ8'=Wug?=9>G.^قm^!Ɏd2#!\eshO#~+HJTT~NjrҾ!RdK'nGlm)+3EQ<>Ɗi oʙALeiȈ)62 1p(e $86*2#FYKjVꨄWe)iB8zQZZƴ?מ-PHDLcnm$:_&4$d:9*%l-#h!iĈqXulURդB7j]`xcm=8{+a٫]xkM`a:tiBjFcMwaYaCvukOŃF۩sB>,:(|͊]ziDy+RσS9|+JFN,+&IKZ(bii/ G%aPjmԑ.$,8y_V\Cj)AAfh݇ i AAmt i#0P}p\vT_f:rFPFd$Yv E{f<ҝxnOֈV'݋ZS \5]Ggk+cώnrݒtS W%׃BR#zt (5n}W{6"S8,O4v'lsA_L2d뤖--.U%ۥk p˗ȖWX9nKd_1b1m'yӷE S-f\lxe[9>I!*)qEf 4Mq̏HcoF|Y%sp( JXu{Z͎d] : m-GL=qF>jkm?4] -ī~mxj )qrh EHn'ÒHF䖘Smie|%?ɗFZ(ih-R a-sᣴQ5j,Ƥ'QB]魄TANHajF΃_!B:ݢ4W!ik-@6{<<)㴨ه^ϟqe)IV!E6&*W>wΌb9We>0+atcVdpk㴚<ٍ k G%cMQJbf!݆ VտꑖъN}aQS#aP'sӘqR\Sa., KH Q9 >%OP8KLyA4씽èVeRJ oL:mzVHKYIZQ{QV+)i4`j[N>E:SUԽ%4ԭFi5T.$T' `lua-BPӵJ೩M+ޥ2ʎ=m+ @q9V@Zw4;=ʘhVu7(Vi'f?D7:ގf5Pi^F+Ewl T-QԠiM>J:V[M(P[H†)_$8}Sk$>lT#=8e#Jgʏ¶ETv6ң׏26:`k ywTgNkӄ#?&8a䣧ʝCqAwV|f7+b896 tm1WFƒF#ve4$ʕU;=TiCg[5 Gq}v{NHqZZ[Ez;GƐ9awa<$P.{DN-9y:E1U!IkhmHA GFxeT)ƛZmOkp,WAnrع{M*) ^6@o(v9qwo&1owEo-^d<-0y~<]J'ޮWSPsO}j5\Hmrxu|`f5Ts-":);vl7e8r ?kiR\TdZTBRʙcR*IJp<"4vT*<ҷ:R;(@*QُptaۅRfy#Y@R-$ġŌWʧnKrЕhIqTyzHFZ`!7koR|^WI\$?MI6P9r['-IAvwz0@ c/N*se@zqC@>6Zߗ,{0q|yZ|6BW1C;@gF:{0kS9afEv iƯW^ndW?gvh<Χ}'O {dW9\6/j;aqJZmGfi}G7P:8 fuD`ړLk-QNZ2wXHhbh d -̍`ۨqɱ S7)nORR(#*\QdzBlhD396W7Ց(31"*)&3X5w]^CR`q6+d({[ֲ MS_b?\BzKۍ}6,.SӦ ?gD|| ULn=lz,BKVZΠ ΐWƋghE^O>!&+c#^1wǞz*(SCY͍5,UKHRU=61n*9H'0AIP BBҤd}'T) 5iWBy$Dy>lӌS1#bҐ"{M % SY;5$tr*qzlpj\umWEpp+w:LŖ7ܬW }8ApT:˫y@hSU|kᱴ$ӷ]4];eՂ7E$li'N6X'OˊbǓp~ʾ<2ۅTg@KϮ8{} DVA^O>9!JHOţxv9jN(P#Ĺ6p$[ :ߊ Cq'Rj+;P, 2#*ۏYh5BAy:nˋq͌REI B*Mlf2B Ɏ\-Ԛ{yꊆx\fK7f{H-ejO"ms^V>;%+2%XivL!< "T. :41o,g&^&;@AQ#hYI޷CD {b\tD[̋Q[eȎOIS趑cړ.a0 8\e$%}8Hc *cЕ-ԃHMTlBDxɍsŦkInژnH$:JVk"m,njQ 6i ۭ}~Zgj|rC^oyȸEiUXM˰fD-lƅ#\6Er"%R#pi0BU5Mk+=fS w%sDkĻWbY$˟-%Z_kjf '-ZrZܣZǫ2~)$5](GբSM?=*ۇLJ8U_:+ S|@>r@0/A`>Jlnai}6%-%yWjH'n=8Zh1-ƨ pT |'A Am(.$T'R|I yeUN-WDX I_BUy\N8#2:h>V^|?)寋)$Vv2eϺqEGUji u~댏k,i955Hґ03;{ޯ͏vWzvV⭇VnyCэ“X_b"ܘXE_+z#%|bۦmӢX3ms IG/: 4V~n--6ʞ @֪J| jj@)*ק^a%\4{iVUݩ?&5nxTW<k{r T z eDv@q@g -@ Λ|2ECfeqQ!Jig߄.7WXQa6\eҙ']~4 R@Óa sw/4- ~гL5*"0Y@R4%Rs0=44G+)N^ ?%`G-^ ha#7h{<,D/w~Z,m*I [))khR̐YowjyzbmqNml8,>=AYsRkOdLS]wa_A5R6Fxk#& ’%|zxJ^7SӕÊŃӖcwÆO#WP?Y$fTi )PEt=(s"@RQ}PPR5m-Kޡ1jbF%1k Nf$$; WKrijS :NJ_pM@0=OiWYd: AÖpefK`^iTiQ@1!nPS)wo ӈւ64"aEn̥JGi d^ƴҕ;po.-İ>{BGP84ugty)Q:rl;+W>SONtvW@eA폇<~`qT'<4eҚ#8r;%L.nW4RPZcBbƋ$8$>$W qt5J<0_eIm3Y%Ih[(+Սv9\-OWq.dVwnRt:8׷-ia |S'*Ԡ˄\8ԡRjSMIC}/[FZnYX ЎURMwmųĚ+% ˍ2).8Q:?D+MDW ZrGզ@ S!E'i-cҋ@ԪJ[N!rj@t){ƕqň;J:ѥ ^U/yUJ>DxӳɊzvT֞Jy[kOYzUzϓOUJWo9>mYZ)ySn'2™y:i@8\le*A)]>ْKٸ9bUCLI2+Vz#8ZhJe`!-Q]J:(JC.度%GTO%+)ʈbp4c4YpM (+ QW)X| (hJBMu67!9(#:jc͍ݖbtxgLe?qӞIcr~`Ǟ jHsa5H*EhSc&I,4KmtM)7Ƭ6? @69=Sd֠P$YQCP7B:ƉY(jklۅ>Dg#Rޅ-i9ZHC:†;EUħ%$Z8)۩#%qS}Fu0;ekUiE=jQ_&]e=l~'*l[/w+;psn:@m#Jƹ\Ls}u[0Saxxf7*[k@\[auEwЂJTs-'zVdps&Ň`uLcھH5IZW%ob1ۚ26T}qP]q ^vF̐u+ޠӚG 暭~280z:f:TVgNޮ]9n%O; ׷Jt5:Y5=}RR'FT'ˍ+n+fX`l^,m)tu|N9[BJqA BR6Nrqmo'^4!)0ľhL-,2z @ֿZwϔ }i%?9>f6NUޡ:SCCi=ޑƴ) OV׀FA)'wiZ?)ׂ4uD<¨qAS]=c#no)2xJhR6H@w|ل,"b A7`WAPxP҅ @_VN1%iR~jV#]cR+*P5i81:|q I#@>9҇?>"lWxیiIzgNK&Fzn_(Ul)Mʶt. 7?SN9 U'9}g>2ap̩`"r\|̂eweVFuW/'K=.nĎ"\j$f - oTMB,ھ`i@G^dvE z6BVڼ?TzRz5$1j-*\@Ⱦӷ駯HPR5!CaIGV2 SjݎƉQ]vظ68ڢ* !iR5jz|zpmP P]Hh-[d7ڏ|yqÂ5Ekxӄ qtH&ٹ5*8BiU Ł*]#AIӽ*Nj4qA1)Ǘ=p"Ym4"q|K;8EiwFb2smH:7P vY-d>GBK!fcƥ sWg! Nq+iPnIJhK,Ï^ҷS8R8Dś1`$JlaZF'nC;A-GOwgG\Cj?I=#@rNS r28G*uY#9XɄh44eiؤL\PՓUtm4_4#IЇQ?X`sI߭[}#O;8S'p6D=T%҃Nckgح']nۚoV5t-!K/ Jluwgy&~9>+kUZ@cqRgR\J^?l~vouwe6V펱 9 yeKJUr-BFK˅g df@9O9ۧ1)5< 0UNޢ4?m=\'r ʼv#!BX59!.b޻P-yY_Ɉ; OCxucd[Guvˍ(]+ޅw; a(EڬMЧnÎU Jz뜻qV:R]") [ZU1ꡋTIC >pwA>ڛXRgZ&Iwǝlpmhf}@9؊ץX٭ݛ2pmI] @ϣI>|KdTE{"l%t-M~v<53DՍ,4+U8a/\Va4Q:pQ%S5uCLi#Sn%\;=2H]Ҿҿh;ջ heHCmnJFCz 5!]N#zOU o)QҡrWǃ5|l|R$CK֩Lߊ3`j:-xZT6"0po(JhUՂ3) 6q_%ʎNkkӒT5S$85MԤ\QIXl0G݂L+PЅHB C.X!œP[sjIP:r rKQR.:;9dH(KYSPr% G"VQC,/ړ%:W JmXa1H%o#(N  PToƩΪJCIDpV>ڕ\f+#-#출6Q)ZEiqd%HƦW!CKҶ_&|zLoJqoZuN ӧ,E80Fgkv3W!s!,\z@95:>IC]?F=K,N@OIsFB9U#ӎ6澛ԑ&UOV fMNhCPҟKGo駲HۂG)TQ ?ED?h =>.2Y_A _n"< !L'Ǒ:b O 9m5}|,uy$9yߌ͟2%4CjmtQѢDuS]}1 ?>SJUz}rDА=Kmf;}> FW0W]~o*+81a#u̪V- FO8<۔ٓbiF]&]'-ƒS̥М3v/!2 ^\)҄(JBsgGବUaUIf/֋h`6k3:{V.&Oz>k p*-Hif,$iX*fŲbt.+ɏ EoMhAJTFb]L)W$5ʶ3(KqEIKjeU; "۷x8Ss6HqL䰴t.G *Cn׼4K1/#,d f,wIXo;PzBhlF-rz=iDv_T6!@\u2[rCŊ J|ψȪTUҗ?r К$Kiw鯺kDIyhggA1bP+a Y秂&[i-=ccB@?J9r3.'%CPbb䔒oI^( ]s0X*K!p mEx\,\ .ք^䩟a\Xsz8QHpI|1gǐ?OTRź8}kb|c'x X"FYgq8Ԅ!# cJx0$m) b <`L=^O8|hb|P!]Umta>['&Z4X#pRٷ-rY2  IX>C,&#pM8)D'+#fDKM{ X)XK>FZӖ{gF޻x,V7 " )z{#$azGh$=L\ze;zY-߾ iIGG %KȺkD PV Jw]B v!a8ReF [d0%ZcЎ,B_dL~\EbtP ܈5 Y` 4 &M4@ %::# & 2M @c%:t{#-.M9aJ[VwfyH,X.-]_KS39j&j3+\_XAo-`qVFkg J"I SA~Xfnc}yȧn&vE q8~!Q 09`KV?qq0. r\sj͓i^l/FU`^]?& 48CIL۽%(p:0+LŤЬ~j;.SqϐNn.O3ޏ$9`T{Jh^:G( ۾ۓ9$F)8-gQDd1~WFQcKnHC M,zSn?|ъX"PJrdmȯIT+ j3EiLd\ Xv  Y!&ߺ֣lߦ-2L/X ;0:C ‘Jn}/($<6eQ[X8_%b8Z U0M^qCc#jmi3H\@ֽF!)g8(l䯽X.P!'2V([sqp7/7vo|iX?>rPkK" jXYW<9Hs@ u+rR88^@V6@ 2SƼBP5 t4_cx<(H$80 gXE@dUa#nAIGO$XIEw5:/SC 5ݙLF 7la;QN1"<2jrL9b%qcPB8lGY; L7bsG5rs#d#]˼TRIkteDn&H #2y '3 Ah+G{ aLoh5Xe_r/&:zf!SwwUliA*t8ȏa*CBy< is è)<{. –.Dr"SSdRD8d\( jheeR ; S,MI`a3^XflA#GBգḾ[x2Z=9󕃵!@%TضgPUN%bWq{A_UFC|Q>pZzX%HѨwI3 Aq|@-wi?2RdɾCp8;XE9bK'$!x5*B^Tɓ Ng8Xfxt&DN[OGKCS+84՝58:q!mfDGN$0xɋRTOcgN,NJ4v+RcC< K*M1:G1NC-8>V7,,p8 Ď %56#sV ]YCxd{.̦e_f/4yްC%er=b?9NB& Y{N qUyne,|tHyܑwH ܜB&pCz3%}t`YD'Oa/N a*ly;Qap#`UN#zw1a,b7[ ZA(9S*|]S$ǭM^WSl{, ԻqhjIO\X Łx/F)7]r]2uW 0{N&EY߸'92:qQ9%p&+A[q"bq0?,I%еZ I)H1Q$F#53Ffr͒W7l€fu,&_RHy_lu!1~2(9ń 4ziS6N@-á}, h݋Hi %ds]kf`,$:ő3S$w;fEvH?$)Rpp-Z3-:=o,'cu^4%xZwEȋqD^+S@B8 KdPmV\(2'0{}B<Mq)NLF<a{KA:yCyqh&# ny2 hp+HK_w# xKLIiTsiM#j1}J3+sF+qAq^\DNt\-+!qP _ Jm#0i(C(8K N9%W`*A8M]q/2#9 EoE;[гa؞q /P322y2q3 ,99삓 BkҐ9lO5ÛUKHMjʌ>\in>ںEC逺a1e#4P: M| :IIM϶Kf͛}smp*xdPiˠch=Xw8 cy02jS1%OB9+Gk'5(8bvF+Mc-HA~bu+ғFs\|Mqh`$p˿AX$kRjE@U䦜ݷƜ>w=T)>aH A!f|h, s[^%KÝA6Ymq,$ĊMjpА,QzZ7#tg=d|uK-IH/:T栗<(NXՒ&To#h} 0au=Y ^n;xҜ dmzD/ gdn ]/PPT4KL<;BLY)9|aPPglӽ"Xj vZ=%=MZAE!A^$˾}pôsrA]>f^5}%1UPD*O\!W2M`(`GgSLKibRڸP=/,d-jD'̉TVTrZkEe}8t^19la3kof:@GO%LSSO}O-`$x0 ]qy{#<4J{aٯ aXCK%0LEc9z$  <9)"*TGJmwINq5!@Dۦw|H#mWv< |#^SCJ ' MbQ#98.YvB6," $ : )><(^G-G}:goR4'LOy."T%3!aDq'HAB %WU[)y@վᨕt$_Ğj،<(pzȰS9S=O0[caZ sF5Z*%9s{1=qMef$4iI][BrTϳ\ltc[+2̀"DKIU۪5뒕ݍj2u$S(Wd4 ]ȳU[*PGᮉ'Dܵdg$9@D#?|OhRa\GvdC%ʊf4D["Dd8M GnJI\=TPCeLJHCcbnBCu8Ҏd%M\?\%|`!$xL⧎G"JTa,^nH) +&j)Wk=2B)+*:+@hQp$ /c33dBN޷2$A60:5 Huȑ1aѐLW)\wNIV T"rx&x5cw Lg<,/F==FBS m;zrP8ό.eU^tN$2$өрY&p=f|`'LI/9kD!|F+YYtRNƺUF|+ ESN;H&s˯YO}$0AFLT, ưeA>BB~BA rn 0%2 86C2"#2!YMct[IN9̗׊<-Wz'5(Pdj;N0%& +Jo(tKĮJ;a){Q}ZT 3DKj/6DkS+25R1^"tfXTp #r"`$ќ #.(bڕ9bDHQUDd PNJI:y>϶6Z\(mqBh<7wY|wȧNE/?Kε$B|{ b\;Ī $t^s-%tLW*Q/ sW|do]+P|&84spK%"*jPT3% K6rf":$٨@JdDqiFJ4t1SϿ.AQD) ԈC6goLU O['!]&-%$(o^(F;cXCR2٢kb mw:Ga296(AI6^ޘ"i2 $,Y=0"\&MfYx1M:/oϙ使W hOPAvHU {D9PG>ubŴН<`X)[)j׌jKNۙvb̶#%e"4AXkְGl}B^> c2o.gߟ`= !}V &Zpݒ=so^g%Ŷ@Ң Ѳcg2Itwuy]'%XvgԡĮ]4M% -ln Y4wA,9(YH^;{CQN->pe^+KDwljNSu aTx8r{#t5I>UÉb<*!v |&#eQUa]PT:0b$OYT {m׭.)ftv&d4*F=T`Æ6q:9w,]}ATV bq. &Bjv͒g?+Z lw9rbj`z& Ő31x۳/^#I7y?Tq^Xy": mֺ5LfBE}pA]~u9 hq0;*@("PgETNoo: R"y hrqIAXp4^@C * Rp6KMԿ=!H;qQv kX(udj4DU-IL>2֋ Q_!ȿqHI{Qng4a~Qb{\1TDϬLv?|+ &%Kzńe \ \MGdQdf5ls*An"1(e%/ AYQ ^Ym藑J]Ag$G1j^D5ʥJN'[[.[X1:=~*vSTe()gϊ  CVKOw wĆHU sz'jT&--P$(; 0! c2 b5?g큤/eit4a" HfP'|< XYM=m{x%uThi8<8DYht.2pJbȃHF4.jUcxZ /ܓ0~񓡗G$x1U"Ӓxm{AJ Kibm^ēN[UdV3u~e'|z=mMT>5A]]eVsmQ7t-M%0њ5&m,t$Jݣ#204K: Pu,*Qa5rJ*4vOY#ۘfB~F9NLmJSL u0ȎS:3SԎ(ӹw.;+0@D#&q j* t >{N%IKOV+?!M~HoFSQM3y'sFbyN&Ms;uya__l/`Ps?xp2pO`Ky9xw.A~u^Ic:yI 1wK?N<ǫmq{#tcђ hkLk#>.QI}>o>[o1 xM}tN c`$M|'?[D92I>\s/>Imt:ps=YL%^Cdwu@K`@ҺAe䄰o-$Ûdq3 g錒JN- 4>',8SWVm N7,&>q"0ixi:r`0.4=̊H؟rM}?l]0=9C|~q$w5+=w-\cKU8\d+3 An~.2 5xP=зu}~9 pKd9Ȣb葼P%d# g}?cG ej`F™a*1b)g cI~p~.g$i8b:\` /7tz͓'28pdq.slYFǞ3˞ns,OW݀E92/ď^X'"]_QZpZe39n&1m= ($2<}/DEGX'ZÚϟ-ǶK0k%r\M 4M\xT`1UƬ!f%l:fik0dc<85LK1 n1lh}1`BIx,c3Ù\q@;1'oLliKyZ!gY E+4@r/.{aL,dl CY$ @7aQS=W0hky|p|!OD|a3 k<&)A(i𦲭w!Lc;7o ]=AO6x"&x t -j>q% }@$vЏ?} s_\b/~X%N!̸2\qdBsSO s`+og5_ߣ >7> W#Uw}ٙ.1=0{8 ewoh {xFI5` p~8DuƳx r9-.2Pa~" NCT޴bZŒ51X1o<,Q?:D>4IҬn' H  ߤ<>S߬u#"}N2P`Nmaq _.=3Xkxdz'=_Jo^Nb!wq8zd2x澝Y`2툍gz@Ӭ,oÒ ȅd8ۗu8e9}&?-G94c"f?Ÿ9Vߦ2&OALs25 938O ╈a15!0 ,pDj:Lwg࿹dG&>ܺk_*f("u)S_sdŽg `,/b2;.rũzrbFM|z,y,*U錞Z&x=k3,>zD%:e׮Q2Aي=^\038+_ BB3}p]xs/ß+e>痜48]`BXTd: LwX]r=B{OoO BRpNL9܉=mi.)zbA/YLgbI-Qx%-gVd p}F,/`;.E[%=g.: Azewޘ9B;1'Ý+ïX!\1M%3 vt}sL1 Tvk՜(Gˉ#x飑R+uB|F}"C#V_. > ?{F}?(3j ɡE >HYa!&p^(I/;gi;0S0&"N*iFz9#"dij9Ӝ@ hhEԘ~Z/_%k|A5~4Y^~DPxH l#BF73Y Cyx~s!7Odմ9 KA*9ToD܅z:T}YD<6?ϒMDz`ȱNvHh5xQ~ٶ3?8|_qO` ':9BXv&^߶H 7!c BΒGΏ9!Xxu_)qK;ՐJ=2dZ*T咺=ZFJWG1r>Z}8_]d_|yrj0LIDžxȘTG!VGblǓK|6A@@U6цV3k{7 x>%FS+5}|å{>glOQqiEP%=hu;@N6xOk `A|bp Ix= ·ʺ$<~r{ksT*>Ic5l 1''Lɜ1f&[.$E/7Vf 8|˽^n`ϜGR& vDopDzT)M P))= dFבf9^0𷅞ۏ  wߌ^t|?_lb%_bt8&LW_c/9ߜg `:ubGfҌ،yN<ì:a$I²leًN20dbMLg+pk'#FE0aBS;yƘlcg.TIvZW槀}N5 C1C͞?8tLppv CCܷy FJ@W9oY1_* gd'U ]?G%Z?O#D kprs6ĩc9x8`d6[}gv-iWx ?ϧ(nK-%3#dp8#_0A凭 zq76eۄD07}>`k21y%Dz;đ?ߴ䋨7G|agێk+`sS3I޼$(I/~=\ֳ{Z: GyNh߼2#c w5YWiȜqT>؊vX:;}%`Ħ^6|s챏2 ~O"y/K:uV8S8~|?g횈4dOʽ0вh~U%S}֏D{<>w ~~p_׶vF9X;;-B^,Ņ` .Ma9&nSչ!M_b>&ۄaDG\~s4 #OّYbdL^8VA5E|Cfĝ;7;;ńeT|;1 pgd0/ؘdαOIpSDgئ-bI 3Rq?Q8rpZ/;d`:0Gv~9ů3<~UaÑ޻X~H'+#8 "~q#B E>yD}~`OlK)& ^11d̘Ɲ2+%(=zBp}{$|dBI>3-h&x;7%?pAao/H4bY/oyL4['NIac~caI~f=Q=_ 4$fl+L695P92+xuG1E~P4ĐI`=1 1уŋdoLMɓ ɢz猉vTF>D:s&#፮#$?S!3]}E9okG\cr}Kč#=DŽy sL|C3-BnE 5 |#ΰ%nCgHC_|c'pO\%ty۬eqpÚt`O1E#;f88ARSx1"1L3ͣj&Kaɗ[9ys߶M \g׎FRrޮ84*rbC(&mܿ%o81,);e`k)f0!ϛx͹zxsu~?1|v3Iߏazxv4Kÿe 9~Lu8{c,a&IG0Yʼn.EOUdG{y1D}&}ȸ$B`,5 }D931bR\3+}9P|bE(u1zd䩯E+9xG1!LN;ɯ0 Vm!N!n160wzdcŎ7!}Iz]+~D/~h>6qsZEa$3N0#'p1K-;ry)/cyo9XP/Nt.f?l)PDl }XTd/(*k=yr<Q2'J b8ouLNM0߷!-\9'O<Vq?:g2C`2*dFb9Ƣġ^J%,O ~su*zX1CRSc9난$o4œ83o?6 T}p8}ߌn9> _8+%Dk'U^^Gq6k2a+4򟌩IVOe1w+gx}t:M=WIܯ:rj,\O bNy?z(X|],Ϣ?4}??_ݨq`]I^#!Ip $;#qcq/՚LdY؄ G+$+%uH0_ V K(\^㬝:Iq)?KKb$9ux|YY& &g=1DH޳ =t+}P10S{ȹTwKp0ZƗx䐒cbFם̋< ȵ"c} ]1-Cݹ?8U O|1DäK̵:TF=I,OIȈ &嬏yt|`:p9'lf#%ό nj822c:C4G)d߮$Tb;sIp\-B"(l'9J\_D#pd2MaLe1YK93&⌎!O!Y/wk 榐 0&ǁ[n/,˂Azۏ +,dm,|ŮG}Q~O8J!y7%c'{S|dzDqsdoV#\Ƌ&ךT) z9*l|&LSgӞINX2}P8Wi]~J7 1Xb'xL5s(}Fh#Km>:z{a1g!̏|`-LV:%3sۿNC8Odg`㚫$B92|ߦ 9(Ɍ(K^70x9/_$/YK#'dǫܖ%eOw1 Mȧ!slodz"Op8BG{y}'4&s#'M8>i#l9 l3 6;@`b#Y/=ܚm+}ro.?Gl|:49\y+ }ko|8ʴ?9&mqJ.^{ xf_u`C+pC?Yɛɬ-6`S\r>2=TKQ|0㌜R~7\߈"MC/2f.*uSTt`CcOK%/>Ϣ輳H Y8>j]hc4ɄwŒ>_۬AC.o_!6}}}s &pk{z&_\[/%E2X-lY0pkt[`@ 4y\E;AQ;vrU\/'O\D+sP{ `'|k'r=|ɭc?8tlI$I$!W.g 7$2I$I !4S>3-6 $I$I$LƪB$I$I 3"|[cI$I$I ?`~q̧)I$I{m@e֐;I$I8X"'m`I(TdI$I$n+ߖ >|TRI$B!ϥ5Bw֊ kI&9H1qz`m5I$I$Fs!=I$I4Y֣?+;5 $A$fCV#Tow|9J1 NjI$IA$0*XQ9vI$I$R>cZʃ;|m56I$I @ d_ 8T46'xI$I$I$0иEYtI$I$I$-TqO-1$I$I$I$5]l"l'T$H$I$I$I$n4*zO2 3z$I$I$*zկ0)ĂI$I$I$I$YH8$I$I$I$I$I$aA̪I$I$I$I$I$I$֠9 dM$I$I$I$I I@˒I$I$I$I$I$I$%,DI$I$I$I$I$I$I$I$i$I$I$I$I$I$I$I$I$I$I?L]:Cd(|n& ,S}9HR[C"I9Xt*L]?A~Qya<__ZӪFDox D*>jKmm7پ-UBQ$=UI@F eTJ,ZQ !d!LRa$<Vgu^%Q7;ģ&О[miq%@A%و!2  l LA`^`SP)^@ U7xʁ"Q9|`$s2~7$ %7  MKG$bPoK6N k Bjq &~A޷ L*mYE|!#Ur@A)ICI,Ee`[T:hmT9kÀ !!#\\#(N_g|@Ccܾ>p#Ƣ䝀@ܧ%rN&Q @br+GP#K @H2T(Gxćr˳ϐ8q0V*p`a~%aI/jv lwgJroCӗi1W$\_ ]ԝ b1~`T#<AJA "f#8 0(!CKs( (I5hK"M2jHJAP#FaB~22H--nJ*KYMfd%xz C=# 4?{BtMZkf#>O!)1{4apr P]\emR4s?BS6f1&̈́Xpx0G`Țd)Z$跼bI5(5!A"zFL IjI%&" ˄&EvŇX%@S3lq`z&g [ 1@($Q:4!0:Һ&l/~HXAE#;fU L$QI l&D}@ ~뢮4JDӒxdev$d 28P\,SקR0.-9g}'ǁɫC&v2;+aʳܰ܉`yA}[!]15,W=q+l͙ 5JDcW?hUfWyR*>IDg[Ekg0)(L,!!&83! $ D*.7@ /'ŴDDFآnI#@\@0+l*NNR"T(0$FDnK RSYYR@8B>"#b(YG L4S=F iDKC#fPT% 'Uh 諔..SCP}齒Nl}qT8'fpp_1IG&[d<=gzνXE99-z foq erJDfBh)P]aET;mr?\إ,0Y'$%ZH$Q+p&Ao-k'UrϕHk AGJ8 Qd2J $!(huCX%E:GՆԶbt`"0r$Q&x3UHcE6#">L,Urhl< #N'Y:Y 'i:lsdTfYH,JBrDmr#@I)[P({(0(O Tv$APKlHl?,jISgF),$Nr=G ) h4 ЎUSl8)5@έ&@ pUZmp3rws!q"AhHr#P8睷c$ѲqpdNƅ(x"&~X2h V 2\*ِb>U'[ğf.@ONc%3-̖o P8 A0::aX 1:l(-1R$fJC"n[1f@ ZTkS+K-pRAaEdpHs~kJ̝DdxH gWl*ApXf.hl1Zgjs\8АQH3޳ Y؃c "((A˼nTȃъ9Ù + fF,h'PϘ^b]ja#-2xeP8PWȠaF1/ $e䰰7kQD6@L3/jM%:5 z0'CCˑzqAR!>~FNhac)l,Q:@M=w6$M! 3_v-M.<NMoSj`#"Gnґ$jtY)P n1TÖ&.Lh@AD^6,ěy!:4(BX !Gb'@ $V":qP-|`P Y"KLmb5\SI),e V2H0Zr(I }**L,gLȍ@2&X@bM$)) " HɎD c%J 8J;(H@S7-`Y9>~~LpS6 kK"+I#IA_޿PPp xLtaQc1l2)׳b"@p8d!B4 !"I|LQIb5$B%DV[FQܧ\Idu0P  DL=!Shr( HkxE#H" p醌ĀJIw6-9yL%'6g(Ho\ P$8Y@! hRnYeiI/ˆ37:xNI #&VXaw(rfGJiB K)#b Z}62) K` :S(ml($1.txi 0)rZ.C&3lb6$%jֺYp ڛu8 k Ff)1HqBCNћ 2&"FAh t_f"&%pge h6Į@l Cda'1>0Z⑖)_+@{.&eyY %!EkaZQW&IJ4!5|z\l­ph4x^HH{A$# ^]aq = 8 `"ޠdrzBKLCwT0yIà'$SJqUlʫ#ͤD!xdPIa8%$D VH4AYȸIlPf-OoRUP⬳c"I1u&2* ҽؗu Q.%Aws 摸A% ujØÈt3]yyC}0 ,4 . t$LSN"MrQKD:JdIF8$1 Q1'˒Q1PrAdӨNJ8 .PZ* H]cZ2aʫ(Ah;1l%iaԉͣX `}l  hC~% e FIvd0 6%P]ײq\" K=-?&qG<ԋX. Db%<:vUBŃnDžY,Ci,Ę( mf'F9==h' :H,.6 )`Ȇ`HA<1"`#t7 2l*RJm"`"2D%+,Z4o1DӉzhH^  DX0}2%f UAے(/x@YaTd_9P%DH"h0,psM7 2*x2T,7\*)L0 NO ]((BkH=<Ѓ&B{a(KlU^W -QJ|&vI 8M!_ x[KK"`i] @ʺ 0PHd$YS$e 1N[d,F8Hwq%dz*[Ĺa0)1ٙ Rd8A(7VhKrxh 9Ke7B`f氄TO[2 x5 ɨ3>QAVB $^6| $217^DKAH@Xd# ÒlUL cx`|CfvҤd[2c"b8ҙPD1*@0LNA fƓl)bYrflW-qȊ΋J7c@(LQa 1S:M,BD x/pNI hQc$8^!2 `^S"b^XPqOyH#X ' e B&dT4[&լ԰,a "Z>1Rٕsq L@OWT Fz5!lZ 5%v6#-8 T#$,Qi2(ܦF%MIPQ! ?LNN0Tq);/T]EIld@Qi5Z>oLXSX xM"%R3ɫQ3a%CĤ18Wq)e{2}‹,\߬`ۀXFV!`awJ KF E x2x1t^jw(Ŧ3F҂"}rJb9wZ2 0%J UPEo3z~MG }3KVc`=瞓SE١򤼋C 8ѡ?03zҽakn# zGdW"$ PS2gF&#p&"?OȑemfhXAa LfMi)0MJ;N$AvY&}[e \ba1O0mtE'%Wcj0,nAx@Y^k;Sk$ln`Š,HqŠC    dAZ!u$i.^pԊ%Y}`8JA"[ hEԘ/ȂۃQ &`Zd;2vSk/LM2l 0fqOyuȮ$_I9jX^JCF'%K "®~]n$(T=HDI(mYd VqkwbKxP,/dby rEN&ALAB҄qrABH; `d q&(0b  *dPD`b嬖 &ı$#x( pM 4aSQRU(Yؑ`U@P;cЕo=M(2BJ=!rCiaUfHTj1zMV"A">2"v%g!Ida$(h18a @H1˼@ @{AҘuJsSRxʾ$MtJH1U $X@‡jFY dݺ))Cal5j"qb9,$ #YdH\<DJ2%w5@pgZD6 =FE D% 0$  #H9X!3v020:0X7ZO9t)$5*DBA#0ƛ@m f5iINL'%6nZXۦ 11hV7HD&y,X Z0Z#"!dnv`"㬼QE!$(I(bsM"  wK *qnF $ @J`JwSs"f8*f` @|h/lUl8E,3( "!3'̉ٸ)pm͸>m\Ciam`e|~F9$u16lx9aEB$f3Fб„LHmp+ 8Ԡ ɳIHe>inDʂ$Z!AC+PJ5+N%±|s#uAs$f iA8:n$&e2yАLnuv 1V +%L֤ l^ /g5(bf7.!sٔ!JӢMZ()%(  2Ny8n+l8vï;s@~guCeR%7bLhǑ&5[iBN$HF4!D0k`0t TRL` 7 %$&P5PADGL *͇JA&;!H ("UeABLJD-5 hE2ec#Dc"F6+yL @ "$\SY tr 1 ,{ s$r$\.EĄ ^Ch(HJ!# PO**1Ұ!3p<ӄDiƜ;Qp`\1Kkv ݔ828*"lL0"Y2B#W}A3q*w7#&O̐Fź̞LVV0E"Й0eLJ\+ AT(xFk8 TQ.B*kIr9~Uة" K P*K:td[& Av׀v:md kDqZ2e'IIL7f@Hlb܊IHO7M2X€% 0 D6H3uN@%U^ewdѰ,ⷼ 0 tbJm& L2bMR"@#eU s"{"\R6vK , wؙ"$mArkqJ`mbeBo pI$q]*ۉ^ey}U 20@Ri ܦ!6Cg 0BI  eJ*P@L`BEi XBT'hMW-a}_XŵPQ~;X2dŔ<8I<sSB]{)0*vj'SLi\2"dpr%DDqizJ"،LJE3Lp7CpI0M&11 툪DHՄ X@$K̄{ã!@ԘQ "9y3^0i T bZM9$*{Ze(iؗ 4$va G()iz2lJ7K7DaBV*T@#jQƺ%d צh $"yktCmP@jalk\;4!a`sBQd9H`i(WؙUJ=0k;PMR:W%#0jӡρ01ȑLu֢ aaWRD30 zh n7-i7/$-dLY2.V*BmYJlMvdLsWQ}+G]+.B>J0j%':  3l#(0;B#c wLNi@R 7:օbh VeYQ%i I/y1!%Hhҩ"$< Mm YB,`ox0R]\jq𕴪ALbՑhB!Jc"e܃GaLHYEw6¬!VsEp. J7bD B.8 )-q*$D `Ӗ#"aH07"[BkK9YĔs-'(*T̄cR:1$={JQ4on8m/s0X#b9#A2"66KE.dHu(bOKP( ,K^= 3W{%'bA J  ] v{a2[FNvIaXٰhsj (T5!h8 3#ƃ5+ X ^H").gAPhrC Ӂ%x`BV;͂rjH cw7 + ޹;bcV{#Ĕ$ 8 ,QU񎰩āܦP `2%CA(®{10@g,AMRC|&E$T)#8 I%aeC! Q4  AMDeVw$,ث(\LR֘P QZaC=K-vQ"j%/?EHLi @IP `+BQ$UvTH̿$ =( cHd]=eMp$=ߒnAáP2 tpiD pyx%P"|nUb3q%ȵ\T" AU ^ N"MIYd`J:aQ<)d%K WPB 0KuӢ|RG0hȌ9S <9O`>>Gjv qv$>,up'h4>o(NNr&ax sDaTqS!* I!NmU^pQ h`eRDHؗ^ 2"UJWW`r|aK 6 `qu &yM%.b ƂS0=EB nsHf/}w A->Pi 5PD^5(,)we 0<¶<8@h_d밄;?SD7ǃ؍#ut `DI(9+LyW~0칗N)1f/i 'PNqY efѩ)o7S"o*y=A1(ֳfZa ,hPH@A>9?H$DK2Q@܁C!YmɈQ)c0'jy4"2@_LH?Pv}y Iā,U &7jeGeܚ=?V+s ṀQ[$#葍N";x M@RiGY>p&KE8 |8M~uQwv u^D0uOE;{}.Bz?m2̓ _ǫep}Gf5Wwό"L?邙-ze묀bDɘ=qQ&l1,&`O}׀CxQ<~\MtP8Y/a[/)Y. 7s&|}$  1֨ԗzB SE*]϶I I[76 "Z o42LI?8\d d$dQ k 7_;79LUJb BF*9S D!xB#BNG,Z]Mz\{2{ZXFY>rBYJѧܸdqW@&!+N@<3q˩|?è!I$]%67 P4Wn T 0eҷ,&x"tcz M#{ `0.㎽w:ρ2tn>]@Fy1OQ# $@&(a1Ӹ''y6?w!ѿ*u Jl4{? 4i48=7;Ć?Б[ɵ0"I3 FU4t0@tٝIDy5VR_'O[Du)vzeT6zQ >zLj5N*Szt֟uRh qޯ%j f 8RƑiBm]~1V@z2 LDNxaR6?n1!FkBOk r_D7<B| ^+C0D%y+zxئ}$*ˋ8U[$"%1h LGu-'a{猕BzMI"eZŁr?o5pާT'7Yw߮,)%p9=c˛x`瞲$G+|d/:{(s׶F}{2JiDwde2SA"֏^0"/X )RK7"Kh[Mb])M_+]q2 dTɰHY@e'1d9b;f":zy?II&ڲ!ޯRƥg Q~H!.ʧ!)j12H&Ԋe;}) f{6"ڏok3cscH8ׇxz1nD:VrC7Kg+ >wbw0 T(Zr^x&;FONJ_8q 1>^?+E^>p1v,|cM4} MzCbrA!c2uo(edN]=XbI5HWھSMDK!}cuw%s\H)rN3AUS\ t/8/", CrI$FO,HC*LuLyOr62:x[`C<F~-!'ߗu.;H1 ]o .ԱߓL]LBdd}8_;͐ PGZ~+58mˮEڛe}ri۳IN$&% %9}/uG1B {֋qQ$ҕ=PHD q!4O T?/"(RܬLVbun!Fqz4*5਷kj$0Nlkg6R;^gx\ybNʩ ˶^$ք+eP^+r>S!O@(Mŧ1ާϦ4x3i92*)㣯3 $&=\c4%NFEVr3k% .|VcA`Hr3(Ű,wqH!R"{q@8p 5N6z=&7Gdk h=: !/2 \;2pZO} qsS-7FE ">007y 'JE/o #zvgi,n+ч>1Hm{"WdPW&$ebuL%04 )X@s+R0̦|EdRDF> 0q#F_$<ԚylzƯ QD#Wt$bJ'%CȴO]ƅ&e5יȢ? gз$v_Kx©lcQ8?f߆^w+Pzf 2(O+R+sazX׫6<>D϶)??(Mh,6h Nf2¯IHc|0_ I_-A@[uPn`"nz2({^EY .||o}w yaGHq06bJ) 0o2fhGXd(cFBy<8"<ۈ"gz$`,]~JD~ EK P? )22{JlVLǮ {xc(W~p$'dlI1gmd@6}qa6LG'4:8$6`A=3x g-ǀYWo ]1ASG O%,y-nGYpdE':6Xr n!"KDnS@Q76\pԓ6"#B黄(.(9s⬇/w1Ġz3 U D"WqRi^Trk#|z@a^C>#*NVb\hh 2$ܖ\kSk Dx|UI״>đ8MǏ8!arQɹB'e] wq0-{z'O˰=h `Ox\Mc}{xfkqLHfRy|{іf>ӓ\4'GZr0{%4y|?8X4" ;C!Ɒ3{,ɝ;?(@:N\0FoUo d e*=sjcK߮2 "*t%m>&9K|tO5阱̯ C"G"hhq>I$B|aF=r#x,!!BDv}$_(d%yt6HiAB@PqO*\ $(+O_#?YO#AH k_A N kjy>п\h? pBtV/ "w0Jlzjls;kM 0;3|}o"m& _raі {xFμ"G^?Ðּo>"7&2cי3'1T))Ug@"q`惆gEN'LuADmBHjڲDǪnƲ TYR;Ad**%D ^>q Lx Hy(FiuJ.%ۼ@$d VI1䃧?5)e_RC Ή'o2A}{zٟ`,1hIۮ fIZ^Zyʖ MkR҉'!S|qK@7x*gQB䀣 Ls'׉IJmse[2b M8c hG 9\/xm2sq6CɽV0@K":9/~pCGS_=ߜ)lO ~r!H ެh pP+,eZY/XyD|F\B)wDOpd<'5vV~[o?A[3@z&}BOWZ @%[s58(D0jPBmi)3=04kX92[ф! ьZ(ZJM SjLYZqy01.I@Ԏh> Ѭ52U$ RaI?gJw2&n0'$@|h5;cD΢rJ)/M1Dg"XFKICjr^KYvO%ΰ*I!zB&P^<`$YnR28qQ $Ao (m'6h0VRG6*ʂKGXe04.fU!A:d*VȊrèr/D蝜ZoKÇW8tG|^ ^bp=x9M}V)("_KOrd C|aE:'=pz1Qy+(ɕW>980Z~bCٯ&06K_R4 BR90Lw(~_޲dbDw`EMVjh(JA3DR"@}ZDz(>Fc++)[+ChӦg0s!olSA(l4j䊖VSf,ueQ .HƐs18SK#%H/EÅXo;TI'iT,`$% ()ɿ<'XpXHvzFtYQ΍C71zR5 }(R y@4Uzzg$e _d)4)/<@C;yV 8;lx(j|zd^0 taYJws}|Azb/H>5(q'YMW=p,rpZsk+.m<1m[.A`q}qWDG#g,"=Dj>"?M$O>#sRD #pL'aُJ5 oP8o^s_^!$xH"~Tu&*$ِu~r}\,BS?O&)ޏ-dqrJȊbP8ADf?YK{s !{#xg$NlP'TJbPO1T@?ZWi#iBNv]a^sQ7hh63n0 .(lWdlo?l׷Hb57G?ȤDaD ̶WA_ 2}:ǒ/yhdSq8;Y,vFak}/`H# Qh=Đ*~;??>"pߟsFq1vzqO qo>ӀK" wss‚kɬ!:C &rڕaF2_ ?s~}߭wF ((ɀaJ2e8D+'r )уnh˕YrB-zxi)Ȓ!ANf*Š0Ig258>ϯ^{0"B#>O1+>R˅ @, 4IMO*#fs`r#agL^VMPzl#KpPuC0F9 2F$\RtJ >C~b=C!%댂Ja&OÈ0Iq^aY^Ֆ#壘1AeYQ% |xņX_2ΝNgq] qe>\ |^垍`_o9fn]}oK`$9m&p1}Czc0p |D%篛G."Kt{<#'([-4we'_ h$6gxHۢ5ńbtS׶L$My}Q 0='ʂH<&4\k?q}q {  AIz9!ԘdGɃŦ/?FLآc“X$tOYP,?^Atc _ٌ+!O15)I+$h&+&X"!KiO@G뾲( X(D'$LߠY#:򵏓2?j[0v>e'qVQ}^%s "D  KA=D6E_ ℏo<'MS W7:Mג;z=,g;^W+= ܦ`v@(%{vF9*V@DDd0ݒ:댅2Z{IY)gy!ɛC(&P*Bz陞, '@,rwQ`@%i %P^ksL. =d݂%˅`҂H*C73=D|ᡑc~yWuOiBCyϦ{ 54/z_k,54dBTb';#6pc$09c++N#LֳJ h^$Uw&Rڭa'g"UBny '"5^%$ápL>lrG-HGSaB kCL cl=?_UD?}#mA_lA J) g)݂}\Jqbm^'ڴy!/ DC.+cox t1QcRaV=I?Hq\TxTV 9! ɜY",NU}0hGXjc(oĔi4"8"F#Dp>3#!fj/h.9NGJ! A)˛ K`Bg\#/_?5 cIU1-rSy gNv8&>:9'?o 3텕LaNΒe-NfMQ`. 4b.b{<^(y?ْ N)R X*4[%-,f@RsDpm%Jя3#݆6!~rDO5.5@HϮHJORFC W$@"  #(7^:D?UMJ,^c! !x##>'roAd:N (<^]32CDb "<=܃ȶ.om) x? vPy/ ?e'b"(`ݬ4c|qeRT,AIYLRƼhS)澌pˀ:TA K(<g'%#ӿT0flr`bmz H Z+-YpB@(ȝg;'2*$fg#X3\}~p#%ϫ17F-}8{:~}k&$ҔzFPjD"C2L'3y_׮CG"aOp,'(!PqjsdC \-ߑ:Mw/cBcM_(B˅ꆺr֌pk\c #0#ֱ:(fCg?S&/2`"z1q$$',/\lz]4%-B@T*U.\Of ԅEBPIAHT%)` yWH9dAa!)jo@m#Mjn] <..wVyԻOy,ᕀfrKHl0N!C1 50x r4 D'. XH9sCYE3K&~LJXm\O@ )>lbXF2v'>#abצ  ěyĚN=CH"@ھǾ,'85# `B^}<*U HtᇘΥgQ V$A>؊˿?}P'ԊmLOe䝬tN]4{ K1" W(1/XvDfu_No",|b&%9}zHw>?|Kkb0 m8/pZ^ |"H@1S ٨pF ~np E\zqᧆp=PPfAsFJ<s>|JqGmgtC^t BE  EYBg B∫ UǮ1 hGc`FAh*G82XcIƫe |V93y6A#sm+!kY4wE}D_H!)d87bsD >ر#/A {"QV>>[4G6yK: o'乆𘕢C6$؆9[Tcr1-Lf9qIOTH<}8/5?_NJLǻg&pt;r#NK^Ma f(QSzY/W7U.X&_3V'qhB+̰FjkKyjc7 PLkԐ~\Z|O&MPU:ń0C0с1S5%֤~ؒBe"p8܀{?9!Ȣ*A˚ /ʽhs72TbĊγWΟRi] u >J$"cn,ۄ+h~zR޸Yxl7_Cbo-Z34*.J&Fd*d,YE13Q*)"Ku\2%JOĭX[k=aZ,>׉[@1-@%|&-KNP}w?8`vwemľA" lwb-o$`-!8L9pTp1N'C_fE' w% r4^Z=Z~H%Tgru9~ *?鄷& =Nj{7tFЛʡ ^)b3I  )χ }CU!(|S&yHw? K˨qBpawR7e?C{x~٧q(Mqw}șjp\c=8ȧ dLX߁{0200N"} pi}XHhzf&Qn!=#A, vKݗbc֣vy<7ǯOe4$bHȤf<\ 6A,%+!=_Subl*=`H̤-`>r^2͔$X 'JU 2^܂Ă7$;,$Q0`񬃪-ޕE0(">lcX"SEܐޗ$X1 ݷ#,C\ELz#`Ifɶ0eh *̅F$V4j4bi Z4ch) oud Y*>?~2j5 / %4I}vx0Ұ`KI8)g1>0,9.|rfI;}l"[E$I:c !;Q`%" &;2$# D W $8#FhPhD(i8 jU-8 *'.'Anց |FJCyB?&NX* ,ׯ^`ܞx7fD)7o9B}Vh~0LSvdz!t9C^^ԓt,)Cf23 ZtzFf\Fhhg$[#4>x!k"F"VMc<䅰X;G$>9/{pƞ꿷 Ͼc]PX @-RqdR%)!5яIBfTh \A2K&K(@͘J_6$H6!(@Ԉ'֒DPf3$lG}r40b!Ƕ 0DPxʩϙg^|jw&":.c( ?dF14nl.նɶ_CXЍ1=zd 4*zxC3QRAْ1iz*}2y*My$K!fwf"2ycr zo"p<2XAY% R ʈ" f1(p&ija.gD5#ko`!1}2; T \Z^g{Xr*ίHBKVsx#8k LKaD[9e]q;Rk0- EPhX]i )3$V(E0қ0݁UBb ERD 9Z0*B)y? dɒH0c7I5);2{Z~60D⢚wG=d9(A_[Uxd0$[5!p  GYڎ s'BT1@tAk'G/=++*7F1&M1驀uN*B)$}'g)튮QO؎,JC2x&NsՉZj _'e}ʛ͸wYo@=JF4.1r&~O#`s2M2m}0ˡogxĞGֲ'l$*{#%>sc<);g2AG$-;I@W ^FBJ@#>m=? ce)<𔔉܀򘲬>ury(A)b>>!4!?(_CX>YX!.4?bhϥ̂1 Mzs O9?B$Oӂ=>rw&W}a(e/+$Gx^Ϭq0bYX=9ćzkd|=]A+%'#2fMԙ"8N,* tJ3TcAFt%q5:d`CY˼C< 橷 )'U$I4% @Q剾k4SF(Yļt]!RZ_s)Kx󵾫89'c0B+"=;'}N}s>G pEMy,O>1 q,Azɰ7:ՔߟD+c,.  DUB@j*U FR-˖C#DRp81&*N^AI"b:U΅o-ls (HBCƫ'폽XZ>l.χ}F Ϧ7ЉKpY?o2@U7p,l'g=0;)I,I&0†i(P)V`5Ol]Ad^ ߯׌MJ O1O_w}͏w,= phJ&تN1uIf>I]55"jWX,P@>%2?e\yÄ w``Ş8,;x-z9  8;> S)@KPEUD`F:{=p4AEk"M[P DƦ*r_/fQz׿nW+<`9/A^PNG  IHDRs;sRGBgAMA a pHYs&?VIDATx^A$}9eNsEs3`8iX](K)CJ$%Sr$# jHXr+ "zB3hLLY(a>Ú}z~<<Ǟyg>$I$?Wv"; ,@4 @h: @t@4 @h: @t@4ߟ?~|vر;\CԩS7n&|b\rqQ:G/]tQ|Y.Rk9zg*leW… wO2ׯ_?~v̓c3ɓ'gW^=,yw&>vĉwl{.Nnr=Wo[74_K_ rDB}/94>hY.sϷ>ۅMO"?ޯT']

}Li;WWYH4'|.6y̲@WhTy Q<zzHePeJh9+nM7zzIt mue>z^'@owlSh[eM=Mksڤm:yZM?u"߆R}Ku`˷:Ģmϣ0xKʷ-R~>]2rLܯoncں˄zkU3Qc^@-hT#6okkso/??BؖE"􅜖K5!k}k^Kۖ2i=ycݏA.tSj[ת۽j6zӱnѼ/yƔ>gt4oŋka~cmy.t݆X&ߟkM߲uRZvĢkDWe;u}:L1tƠY7%Gs>]:]3zL+'?OhZk^GLy7y{}|~rߜEלDyc߀.ШF~M_~nJ7 q!כ_ko.m^/zGZWo}ߧe\&ߗ6qS&} Ӷh[ת۽j.{[fۚF>ck.oWZ*_[\hۆy[Nˮ{;Q]Xsu#zle1H?x`i#ߦYs%躝Ӡi|mۚ(m*$Lr}+_suŵo;k/hTtB~мH7w: k ~i}n7{uޣY~_f?y\f^}5!:]sΓU{z^tZME|69 Is}]_nV]o¼ךw>.~5u"|l/u7=Ǽo~Ơ0}Ѭ0ޚu]GwlrL>IZt~.:fHۼ2M哫~~rߜy<_둿bhT#O gbEg *}!+|2oۚە(Ve#X}k]$ohM}k.7'㐗>ms,{5oVٯ`8o%V=cy7o}IEL/K׺J{1am ˹:pm[S]k ݸޠsak9os:Iz(]#J2X]ĪJxmln_#߆c\گEjo_ךteJsS7i۹Xs,{}#@- 7 |sڑy_m7.mռX/).}UX}r/p /ʶv]wЬTnm[c-r͛U:az=6oo:ש&^'*7y۝{IRyXe6_vrLܯt,'9r6]Y}/}V|m6kNy9 4QE79q!o^/Ӷ/xr]ohG>Ee?Os]c[jW%s$lYeU5Xxk ޼mkc쟳EuҶעU0y뜷ֹjԺN,:ǃئ:enm>}ǼfM`\3_ukl~6ۻ2mu{m5@ۧ>,4MOvIw#ؼuqnW"ܼu-sann[܆xzUȏSڟy}ons;lYuWew~-L۶69˷Y[~-}K_:x}}.{y\uy\NN{ l:Ve{Cs]>lc<rϿD\}WTi4/.mns]bSȏo/1/}K@F5 `Eyan>F%Q"n(/ mKZ{Yn[.ߏuھ?? }LǼM%} }欲ݫǻoE^5󶭍JXz띷_Mx^fasak:o@ֹlΡu|;J>J/c4/n}!躍Als[W%.ǨI\}W5iNt۶ee܆Ltncs67-!.4zyZE6/җksDbƽDˢtfȿL'kOz6y/Dir'XfשUws?ޫyVb*F9B_쫾:vF۾yLR':׉6J> e?Xe󲥐n}yhh6J]ni߻e̢c~2+2kA~wa%}ڼJrxoR`lXkg[XjT|` E]"tm >}h`ERd٬ u9ϊc 6،{̫o?T`j<0 @h: @t@4 @h: @t@4 @h: @ЁIgNݸqeΞ=;;v^tUT\p yիL%@kO?祓i"@g:a9: @w刮Q׹g'I$I.gZQ?$I$״&.m|M$IXzɐ,@$Ip]i|4VC $I$ُ5 :4h}h$IǚL&@4Unid2m{]h$IǚL&@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$I$&I$Ik"@$IG~wr5M$Ix24_n!@$ILŚYNAy}i$IS6Bo>Pɚ-h&I$=^yqyiMh$Iܚwcv'o<87jbk2mnvn?#@$Ig7Űo\dM&M$)n>7=g{?yM+4Yz$I_0Z?fx'G5M$ɩ ːMk"@$IS_`7~qG9\֚@&I䔌[ ѥT#/)T=h$IN肝h}nݥH݋sD4I$z$ O|b9WtӶkNۚ@&IT, 8Br|R+4Zz$ImE8.o]=h$I>>'B5M$ɱ[ aJʗ .D4I$l[K=h$Ih!Co«׊=h$Ih<\Х] yD4I$j[^y|b(74cM @$IrFHCno/c)wO&I$9Fvrj5˜5M$ɱ`_ZY&I$96cRKWQ+4KD4I$7^ɑP[+jfnM @$Ir,Fpmk}jB3&I$9Ks4*]*߇Zٴ&I$9#FplHVh6=h$I~H k>'B3Yz$Ir>zlkKmڬ=vYIgNݸqwr…ٱcʕ+M$KFh~oh˭>'Z7хñ& `̙3gf7o}zn tεkf'N8@&IMK9)DshFRjfM&Snׯ__:@LWh$B4}9Vi[&a-$I]sRVBOۚ˗=M$LxN ܶѪC{Y+t!@};Bx5Id9ٻ?.r|idMg}X~'Pܾ}X1rW-bc"I~ٿ54U $I˄h4q.C{ƸxFT& i7ҫ5@{C&Iɽ=/'kkZ?Wm9x>T& A֓'Oή^z$<4hXQsh$7M{u5s2jVYAϟXӳa3Ts=k (@ώ?$I2l跅ߣpsrz}`-ZeM sBk>Lx!+yfv3yh$IƠLy|؝Z&x@(ZeMSpXSM-54I|ooO{|`ǞyXyNO#lο]*?4BOǚ *@yNa"u]A&IrF][}<^}WGZXou}atcZcMM-Utcݗvl89cy='J凪ViXz$INׯ=W~T,kev-pw,./ZaMݸS쮻UM4QOwQ0J&Z_xZqrUBc18Z,wӚ .@g9Mg5&h$i|XJ囶=7Osq..g٥gؚ *@FG܎)65?Ieyǟ}X\ֶsˏO!DF/ҏNS`dP:p;w @AGw c@&IruP+cmGt =k2K.{,$IӶVV|UgL+3by-ҥcU+xɠt-ҧN҅$IڶM/#14a=Sj}Nj5\"4I4n1p]*COcW+8=h$eh+kF]ZӰNy3лoMv.@C:{L$IǸ>Hym>w6x 4V*?h}>Vݷ& m5=sQI K63 "8F,Zwۚ .@7~n b$Ir/-WCi卛ҴZS;ExA f[ 0.& 1'iH} ?r4u6|kŐZt,k}~R ԦUk2}]wn];wvw}odZh$who]*M;߶A<{mSk׬?|[|:-]N-{姮Vݴ& З/_>k}Rrzk-4Ik .L{bym=%W+Y un6C ‹Zn4Ik+tF o,h3q.k {d64IZޥycReqJyZw˚-{Q$Ir}?G}۳?/ Տ>os_cB<4ToVUI-)@ _sm`ko鳯%xdCRݡ %蠭vj^7$Im#_}byWcg[j kAKh!뮻B(@li2.4Ia۳c{45WݗV,a㗎cHR*nj5jP5͟y.o{.z]h$wҳat}.Ucyiv_,Jw =|k}ܹZtuĆMMcϼ^,~;oOjf[3z?j5jw}R@ b5Qo$a6BuYמX0-8>Va[ qij mh$S_ZY~[oˏq ~${ Tm}\Mõ&[g۞1n{! @$9\۞Jf[K}X5ZK?zm!zd:|uslρMpm, tgBsr9Im-LRJj32(.6͚n,ucZD5zl$I϶8i30j>R\϶.Smhdpz$Iϋ_ёp#P?7u/挐\:6?Fi{ooC&Irb,5BAdžGg?l^ñ&[ ׮]8q @u.$In߶H͡n[gNʳ_K-|VaX~_}]wnܸq2O>2M-.7?xe<[IʳZ;ET1) gZfenm#'@${=Cj(vAMdV+f`6IAԩS+K-5Ig[a#n޶yM!v\㇈RyZ7cM-{ "Fn7VbyϿzx1?wm Y9Z[z%:unG(&IwƑم?WyqJLп>R?qުq‘>S\] ́.]t4.$IEt]K9ێ{ėƈ2zX+tD.aSGI׫o8pعG X5{#'wlzirލ϶ޏ53NuI׶ 3GA#?FeqbRyKǚth$m&7/x>Wl0~P0x ]Ϛdxm$ 'by>j8GgiZjך *@7pϳQMF?v̘*[~,k~L{UZfkosjך@&IruF/6wn]}]ҥKkT- $化#8ь7mT~l.)yjǚ .@ώ?~y˗/rh$|o ,(]6]Jszj^ߚ *@7[K:8{̙37oeIn<[8ß{Xm`k-mcS[A}ܹ8Z/QI|Gn,wE.1w-Pgj^Ϛ *@G@{nfnNq%@$9M_23~cұJfRKz]*iz=k2\p.%K$ŶPv+/74V S?Eɷ=smj^ݚ .@nj1$ůd 6c9Ŷ>sP鼉AK5\NĈyx[sB&IrmIХ: m֒.z.uؚ 6@O $(xYݻHǟ|[CϲmGRy޲& 1]Uyl5Ilۮn?-CK6-3԰azyk2md>/I,Z={s_#E8QrB/oMW\9,=h$˶\l\(KG΍!uϼ|drB/gMSϜ93y_v$ɣ=;jb&_xZe.붃Eۣ}byrZ& z׻NS\s=zZ&Iֻ(Ƴyƴg0{у8K.jnMha^EIJ(O}j~(+D]KEwnmݧ7u}?<2a[+g߱&[З/_>װg?)hr7lMgK2~{ϿZ,ߗm&tʓz5j^ڣpTYO|49|K9)D !Wg8r.5)8` BϷ& )ݦ>zZ&l{vK\xzT;u[wQ]*OVvk2%<t<|իWR]sR&W-|D+b<WCS7kݚ *@wTl:駟>} 0]&<'hr9#`\g)Ǧ /~Ga& ]& ЋBjg3.\8_#G]sw#_J]?G32>1_?sOiqe;}!>#_OOŚU t]I=u/rBr~_}<_8xoe?JZ&מ iKiyi{ D,g}?hZR.F.9,7mcSdzۣp 49n"V/mʐӶ>s沖lU[\-//+'kZ..5\Z Mk4Uޕ<=4}#`3n~pݼc/.WKBݶ;1sy\mO9pjӚ *@e 4h}hr:Qƍ?˳)}[7LѺ-"]<&r̶ynm q-.oVw 6Gn 44CnX)D7s-Ҝhe[A]3FnCj<a<']*piysj~ǚ *@Z\ri @_mP4 Y]ZK>s>>S<ٷqm.:z~xe!5\sܖM@o ܜ1K@{+?,^mFǢ4nbSaq,cs=z_ʓkr\p]Z ~ǡ5T3ЛF&-mFX͖cۍ]6N}KbptJ{q^CR+}D2F7E# Petӎڥi3ZM]4-Wඌh,ZP^ܦZ# $_]FŎmDxt/ε(wnS1Gk=#}ok}&h[h_*;Fk2}O%Mh_# M14кEǔV1qi{ی0l)xtC1z)g< 'X&ZJ$m)]wk2:F\ԒCrf2Vd)!Nt{l|?pkPi] xWzF78ѢK`<ܥ+zӸl)m|J?EC2_/Sm˗/Μ93y_vn&/_S{7BI͢Qb \,sMUyXed.MǴQ׫L#~Om6v3Z1JL~('-zotLc.|0DkyZ'w&[Ν[jM@|i03e SN.MY.Bqڦ~Y]˱]}I]~,MRte3y`oNݵcjhN^ɩE͘6O6{~˃a8fcI|&tFloo/95#s̥g2uLOArbsIrw]v53RP^dAZ搌h>/Mc*4G/Y._\=IN1^k"@wD 4`t^4P "'k8]'i8}M1}EiL_eNgn=IN1]k"@wD0oq,s~ﵟAnY=INñ\k"@y{awx=ʕ'a|-Irz_zܤ1W(sǞy]wmϥu$IdM @sx_}s9A??=~+!:q<,7`;vs$I[z\fxNƿ?}펿.?xu$InM @|~h "K$IŚ@fCcc*s:$Ir D4%<'!ß{`$:I$1ZzМ2\?,$I56R~Mx&I$#@O'bnziܷ:9Br3I$y˚@|#GnEFЎg$Ik"@z/f=>st鎮Żd>L$I6=q?nOAU m b1Xim~N$IN՚@1g/?b1 bڪXN$IYzлמ{T:ԥ$I\ݚ@='A r) ǟ}:I$IoM @SPųѥu$IϚ@1՟] %c}WI$I5[pرcwxʕWE~W*Bwi$I$Z@3gn޼yٳ!ҥKz8)u) ݺ{wi$I$7gM\vmvĉ#{_"I$wۚ~ӳSNnܸq~gLAu_-6cʪX>$I۵&tG@h1cSP$I&tG._7Q~O_+6?W6I$D@_ݷ#G]ss>G]1 ӏ߳}:I$I] H#pjwLSPr1szT$I[zi>]t?Fl *$IrDC {{{i w/G^=V\'I$ݴ&t iаnz^1W) i *$IrD.?;~Fs @w7MAJr(IJu$I5 Ayhzjǥܦ)H$YzexN9W.t<EI$IrDƈ12v) i *$IaM @>Us>I$IrzDS~#$IdD}\u ݥu$IdXzr~?[zi |-3ս7I$D#4㷺^B*SPW+$I$۬=v1@7s8ZYf2m *$IXzZ.o?T|y;gKG$I]=v)@ ػR{uT$I$&ؕ%<'BtLAg7>ރ$I$ױ&؅LxN6C'CSP$InM0}߿|u}zI$Iok"@s~(˕G$I5=v!@˄h$I6=v%@]BL$Ir[Dy!Zx&I$Mk"@] a)D $I$mM:lh$I=v5@3I$AXzr?'I$M[zz&I$ɡXz$I$ُ5M$IXz$I$ُ5M$IXzgϞ;v춧NݸqI$Ik"@vĉwׯN>=;yի $I$&t .㳽ÿM$IX:#49sfvÿ"wWn$I$&tƢVx.n4I$IcM $I$wך)@_t/wN|Aq$I$UX`-#@gt е :#=okq#@h립hx li2 ?t )0;vmEƏ @h: @t@4 @h: @t@DpرcwxʕWr;ʞ:ujvƍWߡkׯN>}Gٓ'Oή^zXb _7>ߟ?~|n`u!}Lٱ_Ķ>__xҥWP9˗;mXfݧכK9sfvÒd(د=W~I'z~r_vmvĉ;>,)5orA*۶ crvݧ_sJ#5>j.dum}bcau!}ZNݿCkN֟{vݧ{%pORT-}$\v-,Sv lӅtKO&}.^ZN6Y2eΦ>~VO?}ԾgM}Zv&>]_pmq@KuY?yri-}>S`Su?U/_:s2 ^}L)ɺ/1c6Cuɺdu?s\0- UTzsu*~J-}KM}}^3}~bYucfSuLٱOLzM9@oz[lۖ#4Hl w`|r6U"Zn֩eXV]T,Svl ۬0kMbu/Sbu״}&> MvH>}R[T. )^6]|^S 2_,sls);FYu)]glԩm9Yf lkQd۽.#@Rآ_mn~҇7mC;f6]A"iR^bYuceuL1ͺ ltZoM}|!A8F6Y'*TtŇT.}h>SbFݷglQ|A1yW]lL-Hl۾Ot/zo[.J=a҇Tx >DO~Ny kcu?)}Umߎe~hh: @t@4 @h: @t@4 @hFٳggǎ;3gf7o<,5]p_94#%Ǘ.]:|N]6;qD4#}ԩٍ7_y˗/ky4#fv!:wkvÿ6hFNɓwxm^hNˆW\9|_>;}gA>mCZo @0r3)ܦ{#6I;OT7Ct ƩL,c˶u-`hLb`ոԢfu `Bv*l΃q3@_xoh @0Vp^pMSnSfn !-0dh&By<6)=Ӝ[ C06h&B3v %RvB?_e 5@ w8٪t DX&@7q7`Ҁagh94Wt㡇:L@z=@ϛ{"@0r.ͮa>s:`\ޓ4 @h: @t@4 @h: @t@4 @h: @t@4 @h: @t @ӟeI$I,O?ٮJ:wIENDB`}DyK _Toc491768836}DyK _Toc491768836}DyK _Toc491768837}DyK _Toc491768837}DyK _Toc491768838}DyK _Toc491768838}DyK _Toc491768839}DyK _Toc491768839}DyK _Toc491768840}DyK _Toc491768840}DyK _Toc491768841}DyK _Toc491768841}DyK _Toc491768842}DyK _Toc491768842}DyK _Toc491768843}DyK _Toc491768843}DyK _Toc491768844}DyK _Toc491768844}DyK _Toc491768845}DyK _Toc491768845}DyK _Toc491768846}DyK _Toc491768846}DyK _Toc491768847}DyK _Toc491768847}DyK _Toc491768848}DyK _Toc491768848}DyK _Toc491768849}DyK _Toc491768849}DyK _Toc491768850}DyK _Toc491768850}DyK _Toc491768851}DyK _Toc491768851}DyK _Toc491768852}DyK _Toc491768852}DyK _Toc491768853}DyK _Toc491768853}DyK _Toc491768854}DyK _Toc491768854}DyK _Toc491768855}DyK _Toc491768855}DyK _Toc491768856}DyK _Toc491768856}DyK _Toc491768857}DyK _Toc491768857}DyK _Toc491768858}DyK _Toc491768858}DyK _Toc491768859}DyK _Toc491768859}DyK _Toc491768860}DyK _Toc491768860}DyK _Toc491768861}DyK _Toc491768861}DyK _Toc491768862}DyK _Toc491768862}DyK _Toc491768863}DyK _Toc491768863˙Dd@80*\  C 8A cdcwonder2016_4Rִ4k2ԶU6pYFִ4k2ԶU6pJFIFHHExifMM*>F(iNdd8Photoshop 3.08BIM8BIM%ُ B~ XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)Km" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzC  C ? ?((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((c+j_|Ch!tO >K`E#$"WCK9GƠO_ASJ+\ƒI檾\`>9 ' .2T x{xGEykT?> > fxa]vɄO0\QO@ԧ ' .2UkP~[o1wJ%}Oƾ%|)lv2[6' gĿamOSxR񝢶jdm}' dK>1SGPn𖹎0I#|Ϳ ` e?gEq$Q ɅdNUBE{W))/?E:-c8kMN>]I+ƾ|TNHeƿ078!ٱڙ↩IM/I:)>oI,\,gQW|s_b}Dg[V2D0ğ݌`q=i}77 ֳOgfXw#jvV=M?\Z7/q5Ɵy&iu5 4ͳtQ ` I淟΄.n-:K#)/g~?5O?n>kW:]hwwcE\>P,Oa_6Kxv-cԊHmϙӥ~t~0x3-6%yk{:\WlZyodEUE,g-) /.x^!6zݍ6#[M$yro#X"ۀ9sÿˋ+=~$/4H!+ao1 yt9ʨ  U$)> W|O >jqw1B 9PGZ.t^׊!ִ]#Vim&DHmtQ|@<=cyVzL[Q `,-zqV[5~+[kz]֝qmwZ֏KȬYX0F:W_=i>'5=S,Ά5q*s,db];كėM-fmK6WS/=SP dґ`xbʂC:FZnO^giu]}B,]ZȞT#rp8v35?}k\mCN_S4$t((3"G(q"HP鏪(`QE ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (?(%ǟ?J5m{\ץmwQdv#\^T8¿K6~>"5/|>m֦PyPq+nG.v%@ۜr+?3E"H#@.8OL8 'Zx_nt J"xb)A;H _gÿ2g@E:]->d>1^J/vy}ݟ/;ssBNOK[4rt*r;'tZ??3E"̂ǂ|!ⅎt>w4#i7w$EGj!~3ii>CzL76^kg.q4l.2ݎ+޼C~0~.}kKme+k+[h7II*|©'ho΢r㊭u4i \h:;Rb5!ㅤeJ9i\q_LK?E|CP%nabc+_EK[bs+a@Ǧx&9QH((( |}qsBt2fK[?Uxg?Wq6^] Ṹ2OEycU'$_R#α5iFlf__»/OPigw F\ܥY]* Cc h汩 nj!yKb<3ȯO'?ߎ(<;wM6% kb?w'0s}_}`x'V2QaBJ;|̥S*s_֯H|pi]Z ~ az~~s,t j?׌џT<>.xuOS4p}RPD778q^V#%[VETGiW?>4֬?yda so/<[ǟc!QqoulMb0TVV8|LJXXUw4fTk607~_gz?55=F] 6shóDFga+kw;*sWjճٻƞ0'>7_tخ.͐y(orkO] :Ot-!yNwd8?{|KDcNĺeb(,8 `(?b߯_}bv=&?^?.|%;EsY3G>z`=L2oE8w) ^,;[7j]K>K9gg@ڕԦ(oѴTΰ+Ex<2Id5qkrYA 0 *JA?SZ)NKNo XK>LRDbTD9ۜy\Z>Smm[NU$go }3g,4W(5 k-txxj{#NV࡚O!wk=? HdHWttT wG ciQ󆛽Fj?J诞i3ŸoX*vCu*I";p',cI@W/~}鰝ηDOH}vgp+iJ>vV+2E@UOxS犼\hŜv" W1OouIGegk__ seΝ֯KX^L^Y|Ȓ񳑵g .S?_L/gkJ]\6:,DmyG5rjc!W9}|KNOSii N[ J4̡qz$7Ktv^.F*Oɼ4[}6G4EwbUTdO+|]_ef[Z-<ȼ~8y:gF2V`~ϑxGAkkg\XDK䉇tv VŽK['MM_GvZu=<^x!(ѕFʒ ߒ8ha%+heWYah& Fؖ~ܑ=܃пc Ak:ao/NE3yWv)J$(\Ÿ>.[þ&𦗩i6A=.0ve~CWuZk3~|)4\_g4iL|t2wɯG/f|!K+ˉ+ j4z֭SÏ'v^)K;}D# ۹2A'QԊoاoڳַiPh߇VV6h0.$]<9*؈Qu}{15M=Z}oY?XҴ5o7oomq+E {ihhxi_K7M"VzufHvk;8I.IeUXȧ ]b7o_[=Kcׯ<]'gE#RYnZ+;vENTG+.?_a]riG%`ipHXJ,w'?'8~n^oCҊeyiXLQKI#qYXpA [ 𥮏i6b[DYr(P 71*NokάF2&ݮ~__Wǯ'DYWI4[5+W&|'\\z>xJ1 צ,<0VP۾Z ]a}毿O6cҋKuΝMkPsŵ̱*2x7O~Ԛ/kg^u]EhD!$%T(#h+?V~3NT[ % L+}{ '?J"& =G{MNꐙt[aC A +UU!(::e&6O8.+wo׷jX!)GݯI+ m5ׂeٔeN:]ku}pJ\W ]F) ޥIJݑVvs#Sbq)ߢ_3cRW_+.?_a]riG%`ipHXJ,ԬgK[XF Â9ҧ2+$h=+ Y7MZ>'^o> x+X) $8ܶA3)8 ^>(Z6|fӍŕ)q$izdux?2v ϊorIJcԆ·_'2;K}yݎj_G_/Kҍ)rI~^7k~ mю'Y-Q7- TܤT*Q9sViٝ(Š( ( ( ( ( ( ( ( ( ( ( ( (?(hhl5a<_xotkLI%G1I,D*w|t sͼ~!m"C+\\IdDm0ʹN:W̎< V ̐AozXX.-3&ޢX6,I^2Դf=: ^Z5yYc6%$ H\|b[h+q=>&>z g8uV>+Ƨw\KN:4):8@wme! .Xxou 0ҭI F[nS?f) `UJ¨$W=?x3𶡥A]$BL_*eS'9||U J;Q>Ҵ,rEϖX#bCx壹k˭B-.S+]5)QL]*HuG4Q@4QEQEQEQEQEQEQEQE~??{XUE @=acDWp/8-N?gO~'rKTL㧛230Kokjw|;j9w)|ǵxvmj/o[_ot/:d.1v#$~6%0^lJ^Yy$_"84߿I~_<֛ԗ/5_%,t j?KA)x[ut/kW {~Tinxyo*^0k\WGku(52O8ïW|]OW4=CPXGT{ ܨC1 RpH9ϙҫW)úI׾IڪM/^<-b^*ޥ ixFk;c : =$Adr++GUm[cڵKiW,B?s'XSneBi}c˽??ME,I]'H\&Am_(GC<]:t'[Դ3DYIFTc KxCtG<9HXAksly,[j SGt|վk xk-m+<0U *,pf4o>unFd|}u_j:2>VIO68wcmgWRo<־A|(֭ƭB'M4[aE+lko)7_?k^ pwW5NJ~~|xm)c[j6u xd˼Rv* _/[tcUҐmNO|9ß/i+fG#K?klMJ$_fG[_?^-m> hwjڛ춆xn |NwnۃW׿SO07u6qGIokv&{p^G^\js\*P-zʤmzLs߳)idr[s,![{{O$!JĜRXkM7cu~GE|lSllW|%Oڙ".G/Im[C$%#L迼X1Jf?k_ďxƟxV^m>;tDdX#`@9E>"ֽ[ڭ;~\u׿#w?Ikn ?0R]'Cݺ^1O_#vg7U. YBɮ|-j_$~P C{՗ݍ|? ?5?ܚ^[]c1I4wHD/@fOj\x; ,70Ub5u`aTJow FXP{|3ϭQQDOKhpo{4F#~ S#Y[&vg3<1ƙ=݆+S[qiv;,pgXԻb8"P]7H σk^.1{:j7vMOٿ_.~-/Rfԯt;#T7rneE>|FMk|/څ' 0n cf@;xW>m}xmĥX=0g[Եm# :>o1WFEX%>H2J,VzƓ['}S$MNc5ſ,`X{{Jԕh1־ٯ /Lm;H1yJ_r?Ilr 웠jk~-j~*ʑ/dt)1cӏj6~"˚ /{t)G}=@Ս =|[FoPS[~P_kK%<7(8!bxKHY('o~υ|OiQ\j[01fD{?~ޕ1bhmD_]%k|7Q#71]2B[aߋM_X>//.P`'܊!U=2ӕL2?dyVm/& ƊJq?g?o¿ ,rH(Ȗ$ ʁ{_Gq^eluhW3m)xC߇izhךOQ%H&oŐKd䜚c~/s,`MajT&ҽN]5ׯcLu_?e1+=O6Z|ZUio=t0(ڹd8#?L< מrW/ǟ)o(O-UY=n[{[!mqn4Pt${U3K1S~]22?l >z]96O-,BiYX괥nC/++ϊ> l-'Shs1>_~~~:-SP19lhdqq81?X^2g-7VDeqcz %>X>' xV`eGX-'ȒYI)!AjUɨ,2m_TiBav Ÿ1x{LOXK%0 &+pH&Y~!xgi.u_ruqnJ{9¨d]cH`??WiM.~iSyN{ue|}co^Qt:h#g,_Af9$IO+χ o\Zv ob<xcwCX^k[X&Pַ7id! HFC g0`zX0ki},z,jŔPH>n<>n+r]lJi;~c_lO Ym)aUdu "F=+|]~>&K7T4nG-$nbbd$!Vl6[aኂJI7濷;|+~Դ}cJPP6mn4%{c涂ZBNav+*+o&PFDZngJǰ k E{[cs':-_e1+<ːB|渵W K 2Tr:Wu~oKM}cF > 2=2x],rn p6s:q_LmN{Q-i$?(M(kVI[W GrqQõS/gN1PVGֿW^3~1YZMwtndK;%\ "& x%0pv_S<7.6%a,t+nI*,H dPp?F'~F}YtONI{m:HnHRKU'b` >lW'U|4d[FG/$#۷f쑱T㊡K+}/ Eѩ nڱbk7 5+I\mfe!Քd)#|%]|YFEwS l!U,cx{ú[? _NIҴVPă(|= [ Cⷋ5vSVna oB!Q-.~c#Å֡7Ro[ 嚺+[Eek Errv| 8 ibmͫAy- ?ćߜpXaը{)[Gpyg?~;*_Ѩs:̅X4!&ErFzJ*H?ֿHPIus~KVXЊl0y+ 5LξG8ݟ(g~> ~(j~B(4`KY>2$#2nn7 ri+t6N,YGpD:gGPCƹʐFEz}\7 NmT0⤣>Kcׁ߲u=WSKn K KbbbLq9(VUݾF傲 Gpì]x;;7O6"E ұy-I#<BO$}E^Z[ j>|A ɫx\ o) v'ٻ˦|/Rkfr?ʹB.ҊgxDy+Tmv2M Z]zV[4%3,EIVhec3#is>Ƣ𸺔')Jڵԏ,?)5[ZkG:Ufl$bn!{{YbJ0 0A*J(VVWoQ#d~mQ[/.k}*H~e')胲-%׊|MAഉo&?u>Ezpn,}I֊+<m]PW/W|5tVmq_Ń cڰ""F3 _h|Ik[%qopȲ#;]YH<=ήeUZS|˩Pӌ=GσQ25c" j&E~|~¿ 4t-ĮfFJp:*Eڣ'>EoαXVgCFl 8|$t&w%ai} o u0 Q#7)#/Do5{Nʶ(9_QαxxQj>ir> ~̚׈ {lm$nG$% ȧ; pg?]QEqqU+Mԫ+3zTcNShy#a7ӫoiޓrxZEH6¾e >-~fQJŤswGkV*nDsC /op,RWF AE~oQ[/.k}*H~e')胲$7V~O[ 'KK]##i9XL}^3[=F#2a@bII5Eiq{ybp:T_??u+[RԼ׮d5bU$_KٻMo ΥqjC$IcX8 дQD|&3 ~Q]/q>fл|S?g߀>GWwz\v_o;K>7sq(^-H?i]z?xKċ% q2l` >آUU׌ړo<-9Cٸ|S.~ ewSg}G[ֵ[O׆%;s"q"Ycz_:khd7hI6AwEnW_hߑhrזcp 6pv?_?|'ڞ m ,"ry 4W5 ujP)[mJJl|JĿiB^1{++>eGh9c$Y؂$n1?tR+[m}mcGHȍ&}Њb02?eNQ0Ps<5/ v0$qnrI'%I$I+ɔw{$(0(((((((((((((i-ڦw$qv |dƻxWzf}BηyvݱdI*w~ot Ouuh((ࣞi'ٗ1Lk~nr0ݿlgVYuNK)%|efoP3Xh` 4!=GqP-sm=~Ϩ.gE5ȟ/^B$I/רS[*쿤ϡ6*qt3n5N!P?wn3m}.{m0:i1Iv"#8&[!e?߰o/} ݧ>.Mh]2V%Gl:YW ?2/%wsH \$p+y?= xﮎ"Xl-AFEE!mnla QEQEQEQEQEQEQEQEQEQEWqx^ ki̲ܽWB6bۃ|P ;^Y ee 28ejtae9)ʚz词IKD|+1ãɣ<"*vmGIj&agIE|JEӭߗQEjQEQUD8eF Bxfq Jw6Oqz@@#\5{Qk4v4'- A.aW˽՜䮖}%#slUR݁8n]Oꚏ#[? k2Ei*$;)~YCoLV؊NݝE*RAEV%Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@(;Ǻ_ý3D׵OOå.-ڈe]v W}Jw$4yw(WCp@v G5ў&׼+KCL|?Mp_II6Y\g.>q- KH[A%[*9caFӱC 0 EQE࿵Ŗ?x y鲵`MmyΙ~&1 x <#ۛj/..沞y\k!`>1}U.Oۺhl}8矈 9ڣ]~ꗍ&{RN:PmwE\>3ek;xOW'Vd$R>}*Tg{ƿڣOY&Zjj7Z:H.K_p?t)#`gP?#ốcʗ0J_ޮ8&TSȮ 4xbZzu˻k klK?م?'hڼ?kP|A+~o޿Vg;mk#$_)h((((((((((ڳH+mrڟ8]IEfxcvUA/]O')#2' -#S;?^o㟆ii &U#ДXxt0_R|3MT /Y]mKOo]N;? =x+:i/ĵ0.k8JP=@#O?).dw~Q:A;)o3S޽ 4ZO-,"$cAI<XKbkGUM>LJԩ~B/?Zo42 0dB0_'>~+@=CzkzxQl(aD^7q7ㆵx{ߍmv+ (tkNN9f!Tu$9".UɪCaCiУk^hgRo1f|Wcg y$I{zm ks<+Eej,b_0-"AߏMoI=d|`m9`K{.X)q3F?x7=jKJO(?e?MiuT^;ꎔyu[s^yv;[c'fýKi7:Uw^ᴱyGHIy2nb)8?g_?|T,{I;gx& NY2IFI5`7O@grMgɛhCׇ^kWd=hl`-ȽN #?O~3YB>6[[1 `b>GixgWֿࠟNJnCceYfiSdD ;sؓƯi:% +؞ k$H]pC) JFW2ykVgLJ*Y=?ğد^ GՇu[SgA*E*9%K.pH?~_t۟:Ok{r֧X`C"9,]Y~į.q[w7UV "; Zlə [NwUjУZE{+7¤$׻wg v&x=G6jWPOz** y0Wt/~:=c~dV{wy1QppF+ݫ a~:ݦ浳-ܪ/ՅxF8]:u6tQ"Kl>f54H4ؤHF` Bf`1 ;?⟈^/hH>%xR Bcc.ѠX9x۔R?y+ZI >e;kVC0Kd{m",#wXК=NHBQ۠+$iqWXׅJqJ1mY$OkڜU)N&ww'oSA{xO+KW:4i0Z{1q%EC=3Ѿ/x/j0%H#4j#Q~D!sg3_CB--`.o-h(ʣMMn[H_$2WɨgQi_fr)WI%j6W5&mSGq[|FQ_+j<Ț<] p˜QM?X~ Kr164Oޒ_-'$cÿ]lh!&ef<i)YwcWx__'qPkj7>b V;qĒa6xxuSFmU%՝ժrל:p~ܟ_S_՝t=2+h#b.* 35RzB|X~,x]׎! [qԬء.Ȫ,2Uʱ ٫j7__':>}Bɔټ#ʒXY1Ҿ/e_ǎ@I|xO37ӾŶ<-|;S,v0LKF sWWiVV h/eo nywYaD@Wxd#k&%|ᇎ_>&_G֭HB*;\}+O'*ۧmFU|}7}DTOktOk6QV-qɧN-] Ay~sQx3:o6:ҧm-m+|#`+sG|8X2ncy?@k~6_#e2tkm4}^NGw3B7/C|=lm5?xC~emg}yedc.Ճ}˧jk?ot~4/]܋H嵕Dw]&0=jKJ?` _ _fhp,w[p2wM}Io~к:xV+oQKiԼ0K:I!cvԉ@W94_mx톿MOu]Pǥa8!V$HWHc'_i|b?>|Ak+PۣmA4g1 Cʰ*H?tk Ѥi.b|&+94}YvZG&vG.hT1"l¥F*|ˢMojg'~Ktvu7Ÿ5σ:ptmI6KH}JUVFhP+O?A|CbmKhn0'@v8<ׄ~k^?Q+Gn.*T|3Jo>4] ϰBlh>d8?Ioc|B>Lƣ 0 ]ZC .X|vɛ|9Z/,oo1sE++.Vn۾vy>ƅM]G_ Gٗ~qivX h5O1G4 D7˞~rmwx>z7xCSFѴ{((XwHPYB; 5a׏73D4U- W:q>k?cmkG׿e$Vvl9Q\r^3.r/¬I趻:]+T9*W}>ѿ'Qn-5SUt=z$]#HЫr;E(??5gᏆ Ėt^T̷q˳ 8"CPY?GkÏ1]k=i|X|foףJR5MkJRqW/n#U'=&8ώ:c|IӼ][ǫX ;mT\Dї"3",Hm+\k!&0 8ݡ\@./0q!D!v;{l|D˥ҽ[I`Wbޙ\rǯ~UkY=K7Xw.wkoK 3g_ ŕq_hVycˤ`F$H]X9'oB^C5^fF>Edv^i3.Is;W۟>iskmDDen2B ,z_OdYwk>VӵKh-.-aY!HM #؊=KEzV&z4&rPWRi+Wɏ/~-G+|CEφY#hY9t(0E}_~^2[xG5?0X  l72/Cw;0!v̟ƗhTfi qFDHT@$:!ixgWֿࠟNJnCceYfiSdD ;sjUq^ꦚO]9Vp۹5> ')Ck?hPCTЧKkqu!TB, T'ߴXΫ{l(%WH\G4de. Q>,j}֓~^06IUс2gF8~¿躥ƱokTv{iX¨2{V'(|hS&t`j6{~>l>}t D1O{9 Bb6D;FrX''J|Qo<'6ˁh6^y{cR%-gSi?f~Vӝ|A*Oxi7BYHP4o:h kN\mJ>H}5#~0~ώ&M,ZEQơߖFV\ܟo+KP-m#yfԎ8ff'_K+Y<'Vֻ%*U?u>܏>;,NJI$v:]*[jW{owGώ_5T֛],Cqg 0[[YBm#R$gg _SOŏ -O%Qk&],j%]Do=/ &ʪ=jKJ14R-jߩJS(.g3SY| |sxFZGo-"#Eth`7W'` _ (_UܳCʔ{+'g߃jTvҵ(D(((((((((((((((3~ u}FI|nleE&Pk=]X3O͖῅Z[XLs}-40K"NF@UԣU< |!׼+Rĉwch3 2-,ʥv>b>=- Ś-5_'ͻ"s b|F|W=Ou}Zk[mIPo2C.],0h??.|ۖ7Q)U&Eݷj?8k!xƺſ? 갈=ZZHG,{2!=_O#iq|%^/n1ط֑^1m@N(Eg?x 8ljt$Σy |weV|-x^ ׬5E83iQ]Fh5k %GVq{o ?:^g`m?Jп_p:E6ӬYjvsb%v9ۻo]aCXx  \xT+ [W kNK(((((((((_,/O mVL_/y[tD92 2=A+zؙQޑV^”bK}oN WτO$zEKi0HJ 76PX7A2? ^-ԺU?ڴF%J#|nΛ8@#:+oXה蟧*Q?`ox,4'>z1gA).#ͷ?tݼ?߳7x>Mf#GŏCv5mO yv808Y!?1T}DO͏Y5Ve Lq8=x_DXG5MOn4hGO <;e|3Ὲ\g\h`i[i> W!FڸO ze›,n0fJ2J\ ʢdGtW[1u+۵{y1i;y/Od7+_IGI4NЁqg3 Wzgh K|6HXL?e?$WAӿ~ɸ>g|ѴqQy:(*wV^F7[|9|#xFf\yȷ14E<dW>h_'ִ }Oe@}^0$W%Ӄ+Ћ'2Q5k>?c'ğ֣Ko X.RD:ey6ƑxIud($A%e(øe$jѢcVY]ӷȺ8xS\V?2,?` o8j^ aZ. , Q@Ÿ7;/%o7⾱[ԭEKm-. Wʁ}YEtqb6vW~Li}~:]k[:RkxVV i|iN,$Wؕ*eoįaĽGĞ2ޯQۼmom bpDZX~s*=ϱI$ײk7k/.{w=9ka/ïɥK w7 VEc* ;+.<0 ~4#(_b+acc5C &b^]5Ʋ}_#gɿ~|Hh|N-=Y6O7>vڟw8jـ6#w]Uud_Ǐ6-W4Sӯ#]l[a}VV ϞhHǍ/kάԴIch%^2U_|AROPmi:p+إw fTNkŠ6m^)蚸:s|_ݱ Gkm *FUFyۿ?%Ӯ,חy&t*ܛ83+ u%)u(>|7_%›#i|v~3?k/|[4l6VLhN)~_;;mnWioEҼI_{]K7S[[$IaJH=I4:=W25d9c*yj oGi5;kaaRKUgŸu_/uK"S$qn⫹ݎ0/WY0~֞#2SKN:O7˥ >捘^vM:/TSi]ԕW-Zi_ XJj*)hg~#F DF+m8u < >K2OW5>2k{cOe~{kg|K'vnG42&؝3p>xTK})R,v>F,8x5yj$'LݷO~>+bR1ޑV^)F->H'|VwO,ۓB\y=xZ/=W'2x 𕯇]$vfh@xtm3UamiRI-Um潿^ElڋSE$], cyAi=_VjxZ5Τ~v~@Y7i |.UkT3Z;׾R)<+k.gFڿhfل["&ݾn߾s g^?+oIKIwLqK SWzgh V:+N4xx:~ɭ6?/oa-O~#:γ೵%qu#1+ܾFўJ-g?i |e,|@>#Ao}@Ou?_͓9ʊyR-ᅧñwW0fC+[kŰ|JƊ+ ʜi繤iEInŠ( (((((((((((((((-CVe/L3 ,l$ *(|amOb]it+ta="HymEmJJ64OO,PLr2 e S Eq>8o{OG 4hycdYL%eٸV<*I5t̞ uۛ[˨m<4aMyu OuKjyodq<( W6mCxWw^cVI!'" O7DȤº+kwL 獈09P@9ۂ@E^AgWzM*y]{euX5CQ5~%~vg\Sw0󍦯§&b_/ɯ_σ>b>o~B]<+|>YnŚS:tm4mx|͆ p Wd&~W/I/uDA۠i%U_o  w~ZO×.J܇@S2d91',okï+B6_1X'NUUmŹ8j-kagx:mb(܃ʲЂF q@]EQES`.M̱:E8E#) m0i.Q_?<m_hZԼEus2U3\Iy(f8 G"uߵޣ/|̐z ׈|Ys *[6 (gW-:ѦImvPrk[c"Iῳ3͟ ]fo h'1W#D~>){*ռA$GydKIY|Hl2MaOIRk}%_݋KW}Ir_V(ZГE^] P,8EUǼ KEQEV{k+Kv(YQur<QBpӚKডik&oFy- @T8ucKN_U54mVln X,NabI %ާ2Z_T96jN}vyL[_zm,jwoo&k,(ʰ[J+s]/|'[|pm6֋L{k;{ n8}}o蚥z|wL5į%!&`J3#2%I Zʛm4}-u]߳/3Oqm|[-+{d\Ce:)Wa|oECj?3mf^/%/L⵲.YHfyvmU-ƊzbDײ[a}J=ߟ{X/Ú?4_|=>Tf~h>nPuE.[r!U$T@5tV8U#W޺Y__Ɣ.QEt% 6\% 6@Q@Q@Q@Q@Q@Q@Y$Wm}רӖ_}s泞"UOW_CWE{KGNo1Ey/% &֏x;⇆n<15}y-gEflx5JJ$N}:PRKtvTWÿٷji/ /-RI|+y4]2qs}+ݧ>/i-?j? a\qc`#k1,RX)ls^lU.ohI49VkCJ+ώ+uksA.5)X"[#q&;+xK_E.5m{\mhZaDya@湧(;y_t5X%g=Z5ٯo~ Ie/vQo1c\N ba}Ol(ϯ( EEĉ<%'lF$i#i[3Vo~_|@7ͥh6?䑇-"|̉[ s_,njk-7⒨_c+⧆<_+O|7AM;OS54m$5 <oCqZ#\o|*g7û&ThHd%f eUumO?S+~9i~Ж ͷ–{8.%MMo5ŽD$Ni਼ԟE[JQ+V<ڎ5>ivSm0[JCp7 fYV )on[C +}OR|A[J^6mi|ɒE$UrdHMkm>5?|ki4h,/Q9 hĪuܙV# o/Ə|I?jwa<(C3$:X s_y'//]b+/}#Exo|`5xOUF40Hn ۡ* bYh#dp֣*rpjKQYQEQEQEW|X M5lM>To 3@_.kԛ毌ϼA2VW坯nY=Gpk<.^RgW?&G7*?^/F."{?zu>0ӵY4>ex'}#kk24%W4qrLxԎK[>E~:~ZΩjMg_D3Hαku 'f@wul_S}ON? 9'ϯ\}$dU8_b>ßN3濴?u9uZՑxAݚ"ԭW([0H ! k~#x㭖Vf-ycVk(|(`*.n!y|ktI>|3Ѭ/Q9 re[ k JoFѦإ~Q_1xg'%+{kn]A+_kkT1+x wuO7KHL7ܙ}ھ6 )_Wؼ,:n'yf7'b$Z7{nF~y3M~Q]e?#+=ڿ쭬<ϳıۖۻnq5E|')nrQJ+??b/7-t6IXW#G.[0wc+y φj_~϶߲ø4˟x궲CNV[o$F%ÜUEzpͦn)ۖ⬞ZO#ѾwƯ<3o_fO|1MSOb{]F;XZ8 9c%|?~'Ѯǟ [/LM}^ 8HeUo2cEB99Wnۦ<e}zߧkv?44֝Ux;6%Zm"dT@ mݕ(|^:ur][sJ8xn}EWQEQEQEQEQEQE;׾V_Ɩ:lQP:<mMs]G/|,cS͟(\[L0 FI}Ҋ6qn;o2~||)_ZxÒg5m>h֒Ik[9bCBn`E{_/Oza[iy? [/0Wcrھg9&Vݾ𱍼;[?6.>|Y WBit]L\#Pݟ3]o_^=QO|;߀bӴ೷ӵ%in-f9TyHн9E'+-\_kf1W/3/+㟂jzsqe]@mͻj\'3 B$@ -w~Oy5/ht.Y-#;qz _ 0A(VZ7ڵߢ}BK𿗙?t Rt m2-1+ p=ڊ+̭UnovuB *(Ȱ((((((Nq}ZL[ 牴(Zx}R{PʒyX@ kjx?e=0XWڷ4xBcs#J~mccsEau{/? ^g~x?GqEs3Ԧ˥曆K4duB(< ( ( ( ( ( )u8xPT~lz(((((((((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((((((((}zTV=@E~)ؿҡOykڼ6 >/5|_pCW_n]~5m}5Qg[W#~~~* :Z*J4h(((((((((((((?OKtmy|Iy5cK(QnGl7,Wqڦ_5SɤksJqItW|߄>i6gfJʡ7(tm^iK:HӴ5S[gg H-9$R$gISz8muʥcj+'ϊ#Ai⿄wa^pIj҂ٕCfE|/ |w<6<3NEuэhM%ѥ׾$j`[!%o5qjE{|QE䝇Ig 4uIg 4uEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPUojdz(+W]%6p~=T [3Ljj1/xE~_R7?ɟ_IQ~%~~QEQEQEQEQEQE(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((((((((JUoWMjgW Q?Ͽ*z}c_K?5|S_k~\c"ڿ/)?կҤVJ ?Z ( ( ( ( ( (?(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((((((#֌ZZ)2=ihJUoWMjgW Q?Ͽ*z}c_K?5|S_k~\c"ڿ/)?կҤVJ ?Z ( ( ( ( ( (?((((((((_xïxYcYo"@0g "e<0'3X;&_d;|Ζ;Hhx?:uR('\ok2FX&FMD(NR[}Ԋ\z ?#v1)>FLa(VXH+ϼ S|kox?Iw_gVx (9>S7=={ CMV@^ _72jZ^/rmb@ )^0zk4}cIgWjvOoq")te*A"xz{;n8ԋm'4ijO$ӿ:O$ӿ:((((((((((((((((((((((((((((((((((((7"!W1#Nr= ~>F&^(fokzEGk;UPC9Y?$Ąԯ?s#_<F l.جU_k/y gZ n~~̾%5ַ{>|̞FW̡w; 2x sկ-a/`?Q%|a.L>9bd&{UV=__w?fj)>/5|_pCW߱Z*J/k+(((((((((((((zgiZV'd$ȥYr0y*Uk+l'[k)Y<ŎBV)Lkpgß 1۞.ׄmJZDn3O5/վ-'T>/kH+j z0zek^<,5ażb7=+?W>$| ƩogsǪ[qkոi`zWWJ\X_5{}mٞe:sV|6[=Vcf'c_w!Pvx&tSTIs hZqaq8O@ҁ\S|a_>wyZ__1 pou=J4`:,rY4w>xYm7W~+ȿF%,9%dW0bZrRa% ]>G+=~>ѝ4[)Tmimp:s|nc+en~׆LX@O,4A12T28J<)'_|4֫skڻ^K˒2Byi*mYT׼!{YƑ+5cM1HC1P0X9]0e>c4K ;5m [zv1?c{]j^—U F-=c/T>~,v/gjݝ1:^T{ ?fa|21&-BD滲ʒPX:7 ݂>|6'o +AҰidfbK!H@q8q\XU9B|3Y5ekz2RW['GEWw% 6\% 6@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@s~'tC]%s~'tC@>\u>\G࿃E⿋?W~~_LtJՏ+II_?Ŀ)KR UgU{ȯڻJlGM_5 ȗq_KQmeOjWh->i_S X<+㫫S+9U_ͮifYGGCZ[ӛӣ]|IV#_j_Xcy5g!},/e[ѽ28F>3/k*8կҤOՂ(((((((((((((((((((O$ӿ:O$ӿ:((((((((((((((((((((((((((((((((((((okoh=W9=W9a#Wg0Տ+II_%1?޹҉+@s#x7_>^M`gG!UFI$VNM|N"hLxW~I3äu'~\;oʰѮj|R{%?y5.Jp\ӛ[u_/fΛ2-ZۖDfm,OY^i W|u}|Sz->&CVPώvzZ[|\ޗǥ8vmߒGǰ׎Q;B=g.'R}a_k~_߱΄Gwc>|xUmEǓ[z$| e |MlIXߒ?ѿV=_ͼ%q8ѵY+B)÷WM5K ®z1w>f}]to+W]%6#(9OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((cP话]I+3I ]SWb?\gH*~r52:6'Zo51T;viokok8~#j䫭~#j歭乔F_4[B#y7IrF7H9Ԝm[+6~LڪeZVh0!}|+yq"ۆ'kJcsW/⊔0}5]Me1' ЩYts5WMs_}^~JUoğ_w?fj)>/5|_pCW߱Z*J/k+((((((((((((((̯1mh?hߴ?_|9cq_\iV -'l3swT8pkֿ1Yci~&] u߈Z~k=}v(7* w!Y"\oK_uÏ*sOZ↣·$3HoPGx|ek 1ˎ6kʼ^%JcNoxDMGTw1,Q~a cHg?|Y3|X[K*ϫç_,}>v,6m6|W?~zŋ "o DRRkx7II S|U՜mwkZ=?';ӂwK=g|wOk3_ =6Au"]<#-&`bqoj>!4?ZWwewL/q6hZ^؀Y -f8(n=kNJSSOZ?YY Pn9'W* |Iiy2 2[4P2@d Wx^(s~'tC]%q^>մ ×z:!gv`=I<9'_իEnj# 4Rj5vInC$?q^dKɋ智nxS\uu9ԮEoY q>I#IYyuyJ)Փ'캿;x :TmY>fXxK[Mf,K1=M~_LtJՏ+II_q# #d&~)sۋUgU{ȏOȯڻJlGM_3W?w?f8k}S+oC"Y9[3LjjH߆ߩ&~E~%GTiQEQEQEQEQEQE(((((((((// R%WQWwxI10GdWmlcp(ʹ{ $QEHŠ((?Nh뿮?Nh뿠(((((((((((((((((((((((((((((((((_2OMwUAh(p2?E~߂!fFdO@+??W?_YS:mkl$Hv"IοxĿ{_ -`B8ٹP=>b6%_"]؟83rmC?t] ) 3ovI<|q_XEN'm`~K^}]__8LS_E/}NOƏYǦX!fh. W;]o{?sW%_F %*4b$$IY.|UZդ9Iޭm~~_LtJՏ+II_/?Ŀ)K/GV=V{?ҿ ?K?"j)>/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((? ]p9d!+`+|Eo [y7Wo>kOU_]p~? 4hM{"ODI#n$c5BjUݯJ}/o'[mIФ+ڬE*~xqtO\m{ˢ0HAUO$JO >,. 6/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((((((((? ]p9d!m>K?/<,,ԙn#^UF?,Fwo1=pA>ZWU˚o+tя_`gjw=[ZQj弸z{gk{ [g<)pL/-8szMo,y8N+XNcO}K]W7I5W7I5Dz~xGJG5rUGJG5rU =~,_%1?޹҉+V?d&:G?Q%|p}/K/GV=V{?ҿ ?K?"j)>/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP((((((((|{I~#k:}Wڟ}a E)2˴D~hx߉|wQ~кt5mh4agI(InmvJM$O-N\UKN\UI.Uo}[z߆,/+j_0\ivIT*WP|@l59e0O:/|m䤓ܼrHH O_ڎWS滪h-J &+&v=Mrt۫Ɵ:džTݵz^߹p+}iڟ— OҵHo;/mo}nm`\4osI"w C_d\i</?+?=W9=W9a#Wg0Տ+II_%1?޹҉+@s#x7_>JUoYWMjgW Q?Ͽ*z}c_K?5|S_k~\c"ڿ/)?կҤVJ ?Z ( ( ( ( ( (?(((((((( 6[-Wc]_]MkDg4&X/v{ɧDJW>`;8aπ<fA>-T2{|.;@g;S֎m/nl/!I>-ŤKbN3zUVߝC 'q?OzG4sXyN|4Jd-ܚ>>xCiѼ62]^_-R-iR`aN \⾁be]{aM|y-| kÍ.Đ_Ik{ybFDhpV8sbJҴ Lt[Ht {xGQF6"(U@` EMLEIFRm-qKp+?Nh뿮?Nh뿠((((((((((((((((((((((((((((((H|*`mK}o_ֿLu:_? ֯_z(OŎT:W.r٢wI$ #߇?%g7X4a yv?7ee='_8UN"b/D~ Ik)=e/*׿i!vc8{KܜOUτt_x* Vsvc?_~i_ .U^܁̲;$('"A3̟6*.{\Kx"4r(=.v(2?E~3\i/?+?=W9=W9a#Wg0Տ+II_%1?޹҉+@s#x7_>JUoYWMjgW Q?Ͽ*z}c_K?5|S_k~\c"ڿ/)?կҤVJ ?Z ( ( ( ( ( (?(((((((((((((O$ӿ:O$ӿ:((((((((((((((((((((((((((((((k_&:Q}_ֿLu:_? ֯_z(vvw.}~ߞ\W8+[-dY+2S`Rn/Dodf_j# pq_o(|uĞ ԓܛh,\?~DLJ,mUlc/_tA_+ 7$d?習1G kW۟E$6wI\/'|s ?54QEL~xA+w O{nu\߉'I\߉'g>\u>\G࿃E⿋?W~~_LtJՏ+II_?Ŀ)KR UgU{ȯڻJlGM_3W?w?f8k}S+oC"Y9[3LjjH߆ߩ&~E~%GTiQEQEQEQEQEQE(((((((((((((O$ӿ:O$ӿ:(((((((((((((((((((((((((((xK¾G$ՖW#6cv1v8UJO*ME^N(8=r\? sѿao+UT}\<7 ?UD24VqO @B+q]maR%fk Jw cmc/>sXJ'bxyN8c9iIdoG~񹴥Ss$_-.ퟛֲ>=kmS{i7['٬@zz$I9&lGq&cStp|?[NeCYmgoa-E[5Ri)w}tY9a+?Gq9a+?G!/RT:J|s ?5W IO?h? 7#tW ~xA+?y?N깿:O:Oϼ?<}#߈%y*|}#߈%y*?~ X\DO_W#(?8~R>ޥ {UV=__w?fj)>/5|_pCW߱Z*J/k+((((((((((((((7į$玾"je^L4c^GfbUR{s_?>*gi~E֖W.lI&l^gw*IJ2i_oo3_7[?I3=>Ҽ[ố{v^KopHkaX0w 7AƟsA=ǖ2;{X噕r2022kZ~cz=Ǒ*KEc "dnS3ȯ4 Mc{,&;[p> U;zϱ2`+I;ÿ0BkĦ[Tp2Z#a R>7MG!%ީ~=rZ2[hLzk?l h֚-ֿv6Q8 k7LCKKK, 'o ˜*Tp@W{i'Ov2M~$lsrvoM7խ>3>!ӟ~x[&[MR [ֵY.MRe+B {Fi>!l -CN"I q$R ܮH9Wͽo^aKGV [*c GힱʪxSV`V?ٻLҵ]n͘EQc/*=rc04 ri>4D%}(>,o&>,o&(((((((((((((((((((((((((((k!>n_ B刿Ǽ҉շҿ0l wy᯦R,xƧG4QE~~J}[^/W?妗2~s~A&C3_c@u)MU5'>*㖫 =i,6\ўWP;+/ex':IBR~w? x/a(:1^_e-Ns%u^弗|x)nw߁j)m\Cg@?CgW xkU/޺"OջyGk$WzJ#c3L>g*Q䦵=WO.__{!+`+{ _5oGE}w;O >JO >3>8~#j䫭~#j?z/?Y+cJcsW=~~_LtJ?%H^ z_揰*{?ҭU[~@~~E~S`|_:j`t5~_}dzʞ_k~_߱-o??<+?ZN& P#kRvae;ٝ3W#Gx|iY_,lbX 2VE| F+z+Foݓߦ.}V;tc+T |mZω#O{jpOqy..HcP 姓̩Mdh=S^ƯgGcbңӌ!Q4i! Bc}}Eu]m4Zzi7Dм_ wij/&TIQ1j'5ݔ4^TRAn}᷆|>>xI]t &&K#3YFgbcjTޞ컕 AEW!|'YiMw|'YiMwQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE_?g<;p_?g<;ppw|x ¬<>m?*mT^O[g35u3(Sc~Z 8~Z /R' tAk? _h~E0~oG7#tW~"ˏ{m>s~'tC]%s~'tC_x~xGJG5rUGJG5rU =~,_%1?޹҉+V?d&:G?Q%|p}/K/GV=V{?ҿ ?K?"j)>/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP(((((((((((((O$ӿ:O$ӿ:((((((((((((((((((|M/ y-iX22@(b3W'YHŷ$סʱFIv8Y *JٔW_? ߋoIF~-&լg7~#*(YWrԵunj;??_ o4ZK.kYZ8ml9p RG㰯5 'u+4o>'}R9pOCRq|fupug7k?hYHŷ$>ϑ[1~|='–>0" ;7b\*ʑmג1J+6>m~2ο#̨F&(l3 gR*KvQMf 2k_~՟Ɲ^iW@65m/:79Q~8< lD(ǙV'Nyro5m4p-F~-&/k>Y6;sB-mZՖQ$.Hnws7g|.W0YBAOBG&zqq<'Yj?[Du|Z1޶҈(?=l֯_z(OŎ?=sV9k+?=sV9k+Kg*W I_2OM~x}CEW8Wk{ _.? wUA} tA} ~f}qGa+W[Ga+W~ 0_~+W$HzJ$zX\D K/`U[ZzVr#UNW{$~F~S`|_:j!|CMb+ udQ|O|.eU.Hb6AL6_N0%(_Y|+x.+^fh'~#ujjy!o<JU#&KN%˱U*ZrE6޽ 5 *ȉfu<%B~cTpG-hN9BR;I W[_Z?i^`͜da_8tkw_ĿҷuKH1jJ`+?:Zs =?/iy}~~(!t 8kQK7|D!umFAf_r_/-׌\XTd?t~7I4Q({$IzJ$+7?)g5ɓA#G,vׯ5axSAڡN#ހss_f}ՖaՃwPqgw}Ucü k.)IY[)R޽u9 V㰯v)m[D+Kύoh|W>6S'D|[~-_ ~Dz}+~8~O׫-W_o(k_&:QxY/GG OEW)GJG-~cA~xGJG-~cA~Uz?S:J|s ?5W I?h? 7#tW ~xA+?y?N깿:O:Oϼ?<}#߈%y*|}#߈%yk['iK3@&c SNhnK3hM|?Ꮑ N4P7 1_O$w¯ #2a#o#w==8<˱_FJQѯ~~?\P9';="BnD@zǽr/x,l C>Z?enu_O_ |33x0[?Iv?By 疯G/w-7lW6I"xQW]%6seM6]B4m׻wo?x[:rwg!},M}c_K?5zc"ڿ/)??OVJZ*J4h((((((((((((((˽_NWϊ-ucgir[ngxPn Ȭecl]]j1e+|gVn*\/g4?CE5̅$G1PXpp⼋_v?K+OuGsu;f9$ 8'NNܷv3x%TW_}]Ƴ?ESlGR+51~i-̬>p0F+7>!|F3C%~vWpj@m.֌Em[<WK_6eսVF~_j/Mf~<7+ zXC%?yff!d%Bc?d^&'A'YGk-曨ʀ*sl@9p1XbrN\jɮW_f<ҵGtQEyI|'YiMw x7w%r_1 sxO}MIyx;i֨SWƽxR7dm;d$/N̿<??GOw|3'F{7)$qnj{t珫p=h_'N='uw+᷅/a4vVUiO"ĻC/9a~J%+6QB.Rz#2YHŷ$ լg6/߶?_kolZ;RXHmjKpHPO8㱯QAke*qoمҮ+}Q\GPQEQEQEW|Iy˥k~'46\^C.w 2 o.90V`4ӳGoo[4/xw}RUm-:+ Rі`qZU0"( xI2LۢF;FM`j-ƿw3F4m/$ɜyy{/ Zt7Ns^O +OG @F:Gٱ7g2n/9gx=7Z;EyN.{5Nߓ#(#4?jO,y GzuڌpTR&f+Uuʧ gkj?4u"duƤC(9_ ?=96}JYjPwXq\Y/3kV= z׊*h~N. 5{[Gè<Ҿ=G n(kߋ,4/ ]Bȩ>]Fdq8<삵:| ,]DvSi$W>(o=*x %6֕j{W0Mد|S/]rP3'?Hsl/>pjIs-lIJ??;j7G$!_}??>0$aԇ.߉5/0}y?G'p[Ʀ2kߡCsŐ>Ao,[ѢefmckiuO Aɯ/I߈w+ɱ<جۛR/GVM#o&mfsAG ai'SPQEGeV O J0h$5bbr)9?~xA+ ];߉'Ǐ{?sW?'Ǐ{?sW~ϋOSJ(OՏ+II_`WW#(֗W䌽c>>\&N}¬d)䑙K ~V?>ӖL zV˿qEyĭ_T$ſT~1'K֢.{~.q彏hZ^؀Y -f8(n=kNJSSOZ?w\]Ƨi}כk7M?Gp,-$#Kz)?~Z||@aP' $k3x]Ĩg$UgzƿAa>O RGk?*O eO8z<2LRĩ_;#2oVڅ2fq` +ҟMF"_k珏?|Mm!D҇OJr6яzrwGIA˙[ޚǣ`8*T*)bq Y܃d/|k[/-w近z7Ċ~ֿd-/%U`x=#WͿN|BĽ jMNrt{$v+2B<.a93G KAHi?aÌbqH?ZZ9$鴾HT8c9g琝ۧ:v~U;˴_ Υ YOV>Ӡh;W K}VgkG/rFTɮ?nN_e~9a(嘺E/vkE$~cx'[3Soޮ,ئ=N<VVJt'>x]ľ?lh͖=B[dCiH'<{ xLpb"?6G)0ؕ*= ?#2kUaR I?mK[ēri'e[d5睺GD o^m=%/j36ŽߍxoOF~^ TSXl.sOͳlxF/7}y!CHo>+޾ Ŀ :hO##mw取QҾ{{۹>*74$"$\I>vڐNsst6aGr~r#w{G gȯF?-~t>E4S='t叩iȿNRI%Sw?^=^JߟIֳ%*}ZT` Y$Z> _NiI]z?J?J/I߈w+ow?]覯J[_QE~|QoG_2?EwU~s~'tC_>_'tC_>_{j>/?O9*(U?;?V?d&:G?Q%}__LtJrZ__2ks_zx5J?߃I㯦Oc%3Ǩ|?W#'@GA_߱d1W+N%~Ő/W!/?5}/W!/?52Y5>_>)+#SGJlGC__J`t5e#>s^_ֿLu:?[DudkW/g=Q_Ч[9a+?Gq9a+?GW_ƥ3N O_+$tc7%꼫,ЁH/[h ˿𿙯&{ ʧ+bkFZ=ދǨWXRTdz>^ecVǴ{?\z>%8b5u0U|~827z[񞾯Ǘl =%}+G eQRB7j]~nNb]yK,TQ 5끪IϖH|5~-Z"JO >(ӊ-ۻ8~#j䫭~#jOz/;Y+cJcsW=~~_LtJ?%H^ z_揰*{?ҭU[~@~~E~S`|_:j`t5~_}dzʞ_k~_߱s^_ֿLu:?[DudkW/g=Q_Ч[9a+?Gq9a+?GW_ƥ3N O_+$tu\/'<>"8~pCEEb5vzQO?x *>Ȑ+urQ燊Rp:)kfg'~uZ.;ҥB^.2ZYiշ?OJ?Ȍ?>>\/5|_pCW߱Z)硦E~G"aL_߶wc2M~ ՟gA^JߟIa%sW &yW//z?xYz?x_G'~?NG`_:E5~2W8?P+#2?EwUA+s?8~#j?8~#jU_|i*~QE%1?޹҉+ JcsWV6~ӕ njC_?x?:?OϏW^OuT^n(C(P?ɯlsYNBWG#&5}BQ<lj,4g-U8X(+$t׷<d0ѧ旼d'lf؜Kz_ݱCEWoG7#tW~"ˏ{m>s~'tC]%s~'tC_x~xGJG5rUGJG5rU =~,_%1?޹҉+V?d&:G?Q%|p}/K/GV=V{?ҿ ?K?"j)>/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}T_RWAEPEPEPEPEPEP(((((((((((((+wt&J_N&Z GOdlewN}S颊+GJlGC__J`t5e#>s^_ֿLu:?[DudkW/g=Q_Ч[9a+?Gq9a+?GW_ƥ3N O_+$tu\/'<>!+`+o~wZ襯Js֟)kKG_jz~^2} jV^2} ~R~~.||xǫ~>\/5|_LS`|_:j| >OPc? xg毊koC"Y9[W#~~}SCLZ)硯O֏?E};1kEleΚ?-肽?^=^JߟIs:s~L2__?h+R+RO)f>=ǀKv-$jw;3DI+^hc?߉_oW*=W8ǧGq^WV)i7#*??$PIȾju5ӑ~J5pta}?HcSd|/ iV) `FƺC_Fe -*?p=ˉ}O ><}#߈%yauh-wS|[xWeX/.'|d3.@C}wj%_4_|pnk^,/!y@s_LtJ/A>U3k`+r ֽ?WY\%*SKuxSYlw9_ߴW>&kCjxLV_hdy{p6~_]`Mד\25?ZucᛩEכHϳۖxzzG Fi%6rY-/NY2*8YUi)y[KHuauA}gWy>O󯛮nd&y?#?A>&?uf׮t0lQGܿ |Cx/M;1Rݦi œO}'q$5bJkcQ?뭗{'Ҿ7=_ovMʬQ^fmc¦ʮQK̰LJ:tmrZscmk$WzJ#8W,a14)aiF掑I-EcΦIwz(N?=sV9k+?=sV9k+Kg*W I_2OM~x}CEW8Wk{ _.? wUA} tA} ~f}qGa+W[Ga+W~ 0_~+W$HzJ$zX\D K/`U[ZJ,`t5}3WMj(g=B1/)c? xg^1m_gg_RTq_I_Q@Q@Q@Q@Q@Q@(((((((((((Kh-_> 5ǖZjCKKEx3b;s'>MOz ?<`X$RH$dWU\HANKOUU~빌+O3(6<GOdle+wt&J_N&Zxku=K __[Yy$H®>95RA?Vj.\t?RQO{ u۵-{[?훵B  >°;CK}Ay^N7:6;PfcXhu(Mk=_|UŸnyYkJ+R?`'J_ʮG7LZ-/ ]sQ\'g;q־֯k_&:Qy9_q4$rVUケaeJG, ՝״m3L)iïկCN+O>"]T?#SGۍ_5텝tn yK>38k-'ŦliF2$_N|:cm:#'y_>NC$JUj;iN?>φ398'ӦGSX> k6oѳ ecim?X+񮕦EHYŒF7V㕶qM_>C) / ?d~ )?ߗוRwXK?m:iܿ?V:ÿW? z~"?u+U?(?xcLg7rX[C:c$d+GjOE?M:,>jYe1.I'x쩼^}J8hc7]I> IۭGE z9?Y]R^G :fE{'~njC_\a/q a/?||8/GxS.[,{y3QO NUݳ>jɾ uߵ|J->KT6; ϛ/8R9~)^xK_|\pC=m~)fٿ}fj wT=]>x_HA_A {NR/ !%}+2/q!٫S5)`12K%<Ibs*:]GdYj |y>#<SIfǬ솢?neE-ƻ"U㲁VOC_g/-醧~-<~3m+KnV`,n_WΟ>'ǯE0k?E};1kN_I=X#F>x+qylds tnAvTmD0%}52 wmܿ潇?^iTU?Ӵ[jqz=^{AW uݭ\\ףos_u!7]a+)x90VO_"| 6{r3>Kw`$쇁< 4O^d8EI83ozsK6% 0B_6m6:O sOK;XZC;©dxk+X>>>\U{ED!Uu%a}Fv~_%x,K1$ZXQ.㵚$\sҴ3B-4]+>$QUP0|f:.KM7d֚뿑C(_eu袊~xS]oK|gZG6bQi8B NTp736:y4oVx1H&ǗXp cJM;Otm+Nm,Ha~GU\)U$f*Sӌ1o ?o&_b]X/ QQe?Smgexјr|C-XuQ3^ j]?0ajv͜4O[6#`pЌWZ ZEmetVzEɈUӫ7+wmgE5:J◢GgƬ-t>A/u-n@vrOپwQo|mȇEziQjQC$ѩS#n|u Cz[=? 'E#شWX_&^x[Nt/6Q&5`*:+Y%V3z8:T/D+UՍ5fY$Y*esr ba£pGG7/uSO%[ L17#/К\A a sa.\[7=qҾbjǒIIvmhS|I1}ž^+jsiWq,ie H#qWJ Qu鎕j:}ZKqiy4m^9) jqG,Mu"Y),#QՏ8s?? 'E#شW},B]q˰nR1o ?o3gٮg .yu>1([4ԋJim_B4t!P޳Lt@c?|KW8ՒUnX%bHPO$㹯gzveVYĐԎ5 = : |B'oA2l"ÀTf:W&_b]3,M(R(ɴrШA7>:!MA=g-4{}{BֵkR9kKIl%3@Ǭr"dBkΜ)9IݳQJ1VH>:β{yZXVƽZS$mnڡʖї5)8'oζER)5sb"!MA=g-Ţ?_3+ >z7Y,}fd32\I̶nz(lGoZ}K$YBD(`,A*HwOQm>Jb[KȞoȥYO\jrs}YN`b,3,>;p鎕3/ ki_=fKMQe3nVk )ѯ:rS&bJ3,f|u Cz[=? 'E#شWw3Krea|?O>Y𶽬^4f"e#bKVTs׮AOk cz_RnUi%<[S^xVI"5+@#KeѓNpWo _ish*f{g>>,`Gd0 {e,1iwڝsg*MͶH25t#V֬[xYDc^Erb1k4G N8xŦiqq k?OFi{Kw?a ]䜓6o꺔fk2!<0+^}zڪDwqP'4pj}js&G1o ?o-mc?'gV}GG_? 'E#׻;t6^6cAyZav&:kV3+8~#.M+ÉX_i۱K[H)6;n' `su-j3ώ5CyZXV5>e&+],1K̍"f1?\ȺaTmf[^i_ζ]HŘm'? 'E#شWiO᛻&^/Ѽ+f |ɘ<+FaZo5MSO$xNjT~8՞Iu 6Љ y{ b|$%{8=++)GֲA:W Wm}jPK4I,3nH$YcoqW+>`gjk^oo12?I`1yk!MA=g-ŢfEBd3]r8菎~OYG?s?+;*) s",(ɠg*DnsFzSW??Ûi /}BM|Wkg5͔o@[] ,3s?sŞ~_5NZjZcE\<4 /jA!tUZnVd9-F3Z((&"TI"3OJ-m-⼳'tY#6 28 Ako Sji5b/>eY'hݛך׆<;<{P% -d[VzQO5l|) z򚓧V,dc&GLԬu6W[;裞 S{ ^[V (b$Z4 RSm2.Ŵ1@ C.vH( y7~LĖ=6b%Bd9݌s_Wa^"t=*PKw-7"PF</u):%};|1*3ק~Q^;/4=BN4˓Fw [p2\UJ&Ѽ&EVerx6[GN2Z#J#v8|t8xSV67- (yJ}#ngl߳tv;DvbA鷃zF8p`|I50p9Y_3^P-~QU,/K}KOn-nIUVSAn掐(4Is2DӰHðRz*n "emaڿh Smλj[Ɩ\K+}1`Sͧn =Gυ$^[bn7%wOW~Q_#/E=c1ZYڼpyklt*Yd΋ pxrkJf+(x{XAf!TRM~}~ ~ҾYC^o{{,G\%&[x lArG+Iޝ1W\ -> |P5V_x[RgkkFծ>trhkk%2~\T1. $]ꅇ+_EW QE|qj2i>𵾵ysU6c˫YFW*aIAta0HOʵNHv>ÊhnKr7)qT?W߳unQηq$f`I-MF7F%_B˥xrkP\s\bq8X*9^/Mֿ-uɥY%fuQEqW/㋟Y+~7}@Tv1r| wV-KNYCu%F$,AA:^3=kguF4kUT]+(i hfN=@Q_f_hgXNi@w40MĺR[+MB 2K!*G<]7f+6UմNK͸Mz^+ENzu_sQڔm;J(((4HHE|:Z? &:|@+Ď_6BMl|*[(goCRi@6/m+|/sA ~6M|#v'M2%DEh^܀Ŧ%I.دNY*H>I/VI|Jį;[ Wl$@ YpHSq:c$QE ( ( ( ( ( (?((((((((((((~"xpw!^m6UBf!់ C@q?⻚]IuEG#LY"efHWeg8xƣSw׼{gfy^}kr:DŽ|A8 &'!#K  ~"~4e0鯣1MQ,\]A5̬ E02X ~*|FoIԼEiZMo4}7.s9kio-yZR~kV{huТ\ײz_Q^AAqsmiT1Y*9-(AEWz3*)f 2I|A]z=@ĺ~# fvsAs4d~ v żӎÿ%WYFkg:tRR\n W|ttmImW$$w -dbvyVۆ ʝIJW{.KmvyغjQKEn=7˯.{I/>ƌ.D5͔{ \^X弩LNpjvUƺL_"3/tk[2dr#Ec`x~ ~ڏx'⮝E-YK7-tk؁,*j|;xCzO(nid)b('@,f)CNJsMO(+E"ƉѬ4 &/"Lڙ]OH 9Z׌;8Z j֖qϋ찟-LHr+e?'[K4Kt~݆m3Kg8tsF=|MrW+.k-.DqbjIޜWO+*zG؛Ug k՜w5Λ}F93G9n@+O_E졫WW yr[y }uې*-O_exWִ h߂|OoqsgPHc[pN2>) rMIWPu]FDXR%3\V5g8Tu@'$XdFPRhZڒޫC¨x6MmIcTյ}JDXR̸\jN}U'$Wի)[ՄUVnw"Cqm ګcnw~ xOߴ 2;Wk隔N_B0FHat\_~.7ŗ>׬m_MX3[ǵX<|)r_ cxō^Y׊㵶2NڬҰ#!āo4>yg-|OC 6t|*7ះ>4aֵ/ku`k-WAqj(Unrݻ * kq*Df`cW=OvM_$S\v#͂7s<%_j:WF mwew[]weZZ,>.>^w k.h6rMZxz[x76 37T| >ê8D>*mǛi2f>hpNyMgό;[x(nx6Z/upqdd[xƯ|Dď#:.sE[^DחOp)X]Ň5ƚRɥ٥6ZuN3̧M[5O0xwuCYm#GKf# \r,lmMۋW1z%[#֧IEhk \ȱE;'R }jM.I^G:P0#cXkn&D׫ [>kzM#t]d!F8,ZϨi֛?gm{PuVVo>D'r,[q?5䗚jYý5)j]˖ Y\,IÇ"gCƚ]t|7h,Yr5.I28',M}4*œ)WWV;.P+}GZZ$\Es?POzu\,WZiF'2%d2Nx߈ZŞq$ְzm-M,z1BB{ LsyUDaozN2{JOdv4yrRڧB+o^t3ŚH[ݤfR0p6#Xz3kKtӧIK (-^TY/RS~i*_}յ@k^'ѭ&h,u-; WxdF#w#t| iM/xtj6ڝW[:+s'wmۭC Q9_Gٷm,Ŝz"]sDO%.]9<2b9v ܳ}h,?:Ěv1u9[ӳOmwOPͦg"JTKmQ pЍɵ¿foƺM ~Вy i6NDK-dY$&gq~o{aicj:摡XM$NE$Cwr4v"~ۮLF&4Tx?JU*+5_( kD]J0P]d=|CƱ-Yخ\.&RC~X`0N@וG|kgmZEn<,6YJ5 ޱ$mo~ʿ%n|Ku2ڊtˉO2*}^uN|Z4ݝvTyj%hO[]vQx4ҧХV9{fRe_-trۑ/!uwş'~(yM{i֗&R}u.E ۛ26g죧|S~(xN𵕥M$",clM (bC; @UsWJ~~v֜'5j?_($$K+D1u$)O¶B}N[syIt]9R+5<VI#[KBRx-.uLt*|o4n(Z|c-S#?jxQ,!y d,e@yy'{*kGV81վgs(kǭ6-Vg$ZC*G1q(>C+7⎨.=:= u+_.Iյ +;y0.[p~њ4^M&sKK"!d -,=[sHUUs{>߀5x;|ZV°ZB0ƿ$KI$iWŨS rjkWA‹Q]-- I4dwiG @];1$$Ѣ[H+ľ>x_|&s_ V' sߏ}|;;OqnLֱ)yR$גxlJo67#Yh`R#aJ %O|3^_ O?5=Vڕ=ĬK3aFp+LTMZvqӿRR~_m_O%?  |?F{}Faii`2gwN3^Eԩ)Nv*)%QEQ@Q@Q@Q@Q@Q@((((((((((((;_~#a2N4p"lD[+8n $ ?Z~VxV&iv.u-J;K9\I*{@ Gjwx/k8%aIdiw!W""$ kʱ#ME{=5_N<](uKO_#̼c>{ dv?xZX欍>ylL 2Af/k0]ym[D a \rK1)WPm7n$XuET{;pw&sG+1_j1[)s-vۥite䓣A_y]B(0 _/ğyjV?-R >ˤ6V!y  YA+׶{Ch9hbpxmv}WS xVC/D,i6+[I[U >PqOn#[`:t>m/IЭO鑮nyS"( e:'.h.ۋ?hv%pֶшnNR-rM~[ii hQFUG{8#ܓ/v^ϣn,>{} |j<^Me˽ Y5Ρ4~RY3FVAoI6`OTVz.xk؊ԗ+_A?o?λo|=m-'Neka-iumwI(B;1~qSP;z^g>}jמ"Ӭh'72y@?q@%sޱ-]2Y!9̣bKÄGN74m.?.S$r~gwbY݉fbI95bsƢrVNiw}ץ)an-Y+붝?j_ÚW5KAhXN[FF=pkr+&mW|tо#a~tKY#Gqe2;aG )yG3_j //ċ;.[n/%{Kf,Da!W!Bm~NIjM񮋦h KwgMtX[H@mb#$ 蟵<߁> g7+~Si>"n>4Q-r{%TRo&%TgX5*Q?w WOp)O7K aee͉X:,u{wg/xñڮZZF#Wfr8y~#.,|nZ=vP_5bRH@zFo-+2YMZNVTӡ*Stu?x>%?:ŞEkk7loXo0ڬ#/?CQExuʤz騫 +ρ<]_|s񇍾1kZNwe cЬ-eE2ʹM9`[6|-gKS_K;_BcI#H<72BHb;_?eEqmǹ> uK x~Ėu=jw% qo!2 ً&;roK4]ONjᒒQ{YӯB_#z6?t[-kx/"[۶vf,,9\F&UZr鵴HIAYQ\gL_Yn@l;-<]y,mF"Rv~eSIDž+~u+᮱l&ƿaπtBm':,>zN0.&ؒ2|$~W֗j? ~(xn-Q!8R#1f`XIldE?SOƿ|QioWֺ#i曩y4mMmq<  cT${9v1yIF-?KٴodG*"Ww_vzw~||}m9~)2|=2hVj:^ 9bVC`co|>~|?>xd?g#;pw ,d8 >xCv&yf2^]K72YnY(z-scqҪou}~n(( (?Ybe+oc<m,rN p^(@x,~?G|ZQk~!Ӽ=ȯ良]Z YO*fѓ!Mk~>i --M>gԢ]/b+ A >lex-2zKuq&溿o|8T~ۯ֣II+wY환#v׺O}FnK~-dȆK#X'd0"I8,NXKj|]CAYujEd+-XCccul+5v[Q^a2C J;A8o-~jߴw|EZ~%LjMlpۆ0}b_$% S\t;~yr{ 5eїv]NlN5?|3-K|)D>'JhuY,nmX[3>cdE\vz> _|gi4m-X%,44O"$JF6Qهr񞃥C_zEq0B-KۅL8';?rV?rRKKۥO{凣YZnQExpW^<oL;OAA62]IpQF 5ӅԢܩ>WZ1?6|H~=|b,7~Zo]] i]dxbuvĘHl0xSP<_z/WSӠleQ"ba̱@ I€|ǏC ƶ|/>/ԼIp8q_JG6A9e|@UWwzPWc$JIeߢ}:-ņ+ZߍEWϞW koO3P{Yu=MT Y>[X|n_PQ[.xoyԦe~-ž?yOL2Y>hy,G'",^'\jZ$}41I,9|14㓴m|Z e]|5jKu+i,e{;AӤb0v+>׀3x;|ZV°ZB6h$KI$kf.)N2MNڿ)7ࣆMdU5 =*KĐơUF}QE|g'ǞӼ-FM kS^[hw6sڑ9På{}S[ge=/~ Wn[M[N[佶P7Ipyv$s/O| Y|5,|Aѭ#4C-#\4ECMsMw'Ï>5~xYAxgXK VV3ZזH2mwc 6j5櫪ݷ{I̗KW/+ܭ?eiɫ4z{|0˝F=Z9M9Kw.lo'ex_2Wf 8Q5Q^ JgQEQ@Q@Q@Q@Q@Q@Q@(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((AHQX`kþ>4<9i۵՞Y Yx$Y]V=OwEj?ɠRŤyi\"G\dIZĝSυ2QjUIHڥe2ev,P&:6xj1X=|gSL:ޛ]*naHD?1X̠.rI"س;&Ckȧ]8 ~]λUڏoZ|KGÛ9/I-=5bfIݿJq\ď7Y A+DQ.ҊYl 溫x*MnAs%K 7:H[k*dP|.U":+6|}~ x[F:sk/acյ!QgDB~f!G^=zx^ZvŜy٭msy G#1NXyUn7V VS2xزl'וQ3J|MWIhzZ<1IC:Jalf8ZъUbgV7yx~VT]_xVF=jiʲ!J l_{M߅kG46Zmb,'d1ltfz_֩1+o O^(u}7EWKkO&+k$u#2ɮ| hCknm~Bv"vci' j/Kuhr<g.aV}>ZHm.%GC#X+7zk{ ˥:Ս 1$iFUq9N-ŭȥR-]3[/%:7z`l !uW nlwyj 8砯NÇ\>O7^|iNw|bEM oktVo Zj2*Ӷ6r(c$g85,OW@>Um桭A}m.i,d-m, Q~^2km]o،,j[>+>,xO<]^X)o4MIo&2"3u`ϋ>i/]g>d>8񇃵!K7^p^^9BX.I"2UWV[E~?_3ë??_:?i_ 4g_A:4DsG-2 hȑA_0|BU'/umsV+7aw뫩IEԦY*Aϒ d*yUET^b_ uױGƯ*쭧?_IՕ<2cKon'D>ϗ$_6~|pѬu^#j !6__Kݜ?پ \~ּ 鶺S]YK?fbKpQߴ7c|EYKhVYNֻ~Mk U>?w u`E/K۹>/cD &U$A]?O#E'uxv }&S[AsY8n\Ϋ.A*[k+v__?/3t>1x /h&O7Q76Mh{-&%P*sNz|1W#⟌IIӭ. -ln7r'~:#A*IBHl nQX*NnswM57{\0QTSzk[?*⧈;j+u{/kzm{]hLshgjl3 ~^-4_?un\h\:fǝElQI%kungBw?!bcXxF"iWsIoBH| fYh@.`voA?.:^[ZDٵ;X>ɧj!{ސBX(tSiߪkoA,?s/[׉ ݦ[VTto&XYHg_?a l d|ٯΝ蚗`xX_7[7E!Qi,ʪsEaC8NVm *`)s?o>T ;cÖ%γ^y焸`\+oW'6t[񿆼_j!Z3Yi,۵ZnU1)srE8gU9=d}XmF=GoٓDŽ^%⋋MRI1jOGs}Aγ6x?&Yt=gVMf g35ݟ=)cT"]cI.Um;]y|w:k7IM߯x/|ei:Ꙭ$OK %KaD3Z-+_~?(x36.k$7VE`T匮J_ ,hKHo-7~(>m ,>|T&@@E+rYmnK{s iw7kx[5cIqqۆ!.$ _ZQEyXLTYκ4"QEhQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((($$IfE!vh#v #v#vU:V l  t6,5 55U9/ uqq/  / uqqBaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ / / / / BaEpytT$$IfE!vh#v #v#vU:V lh  t6,5 55U9/ / /  / BaEpytT $$If]!vh#v #vT#v#v:V lJ  t(6,5 5T559/ uqq/  Ba]p(ytT$$If]!vh#v #vT#v#v:V l;  t(6,5 5T559/ Ba]p(ytT$$If]!vh#v #vT#v#v:V l;  t(6,5 5T559/ Ba]p(ytT$$If]!vh#v #vT#v#v:V l;  t(6,5 5T559/ Ba]p(ytT$$If]!vh#v #vT#v#v:V l;  t(6,5 5T559/ Ba]p(ytT$$If]!vh#v #vT#v#v:V l;  t(6,5 5T559/ Ba]p(ytT$$If]!vh#v #vT#v#v:V l,  t(6,5 5T559/ Ba]p(ytT$$If!vh#v#v#v#v:V lJ  t(6,55559/ uqq/  / uqqBap(ytz?T$$If!vh#v#v#v#v:V l;  t(6,55559/ Bap(ytz?T$$If!vh#v#v#v#v:V l;  t(6,55559/ Bap(ytz?T$$If!vh#v#v#v#v:V l;  t(6,55559/ Bap(ytz?T$$If!vh#v#v#v#v:V l;  t(6,55559/ Bap(ytz?T $$If!vh#v#v#v#v:V l;  t(6,55559/  / uqqBap(ytz?T]Ddz N  C *AUntitledbB]m*qz"qW.@]/Yn]m*qz"qW.@PNG  IHDRssRGBgAMA a pHYsodIDATx^{kە P%T&"b, 3offfff} j{ysuW]UZe{;k־!t;-bļy'͇9~!'͇pf|?~=?Ǜ|fg~W?,~(sfe֤e!k$ZiBہ9FqP6(0O~eJ/Md2P+I9,ggsF'-xȁ<)!FA̋flՕ,Z<9ƒE]2eeb#/شVM5|JS4)HEhTڂAU2i( QV˻mZ1*3&U֬Y4x6*9,R:R3&MB#O-AC/0 ,cQ>ie.ګFiEQֵ-uƬbi^4#_S.Xж5myMJzIIQԴ5<]%-}/=ԶU-%R-ukQw x$`>_Assfy(AL͊(X7k~d@/E YUx+1x=F| =1ocQQ*Vi$}ZiZZ$K15^jV䈲AZ1E]GAێ"L8!*N6ZY^- Y957kI^G/&YMUN㏄ˢ;uo,|EcVuK ܎M0QR..*! 򅘗KeR/ 0jI/hZz5KjʥbajqMҧiе)DQU/yMc H1kw  uSǀ ĈcҵhúQCǰkp 7Rmx2tH/4utP+دTmŎ=>Dē ĩ -^kt8[6<ԴZ֊k?MѤZ~7b¿HB*~`|K(\m j[MW-do|aE@#|`RUGLcQ-„o>WZj`\ʸ#-80K0?:7K1C> 0,Ӄ~-|YȆMMtJꚶ!½c(cf)O(:FjI]ӂdH:fTx/Cid "_B$FɠY=60C Ϣ}94∲?=NL+drg@7/5σG#F`0HA P@֫ @gkyY4D{kcwF$*)+{Ā(3Mz` ! mMbN|xcx= G4iPˈu&;S`߈߈ok%|n@YK㳚l:@|KE(Fu#eg}6y"ȼMm^do}}]h`VuЕ% w kVNsv&dQd6{$cQ}۸Avi.^ td A6ac(Bbz+6F^C'<&9~AW#/*Y&|p%u|$E `U->H1( @RȠ>x'l'eUhQLʅ?_z m V48FXg92w!qfv 8B&[|cg6Uxqbr>d F0f7' psp7IIo iq}AA|l4pGց pgq]ɸ_H9m&A̋Y8pHJ/GlFdbɏ AYozRz~2i;y^$'+EVbVdxȸF@R6ְx=y&V”Z9A S/O4Rh 2iu۔U>M,m A:l>UG Ii'7)Jq_),2x{A ^KEgTr]߁dh))[ׂ AIIߞ7I$`&h;Jjzrxā;y^ i9)qMÜ@qF 1{U˰r),lRp4arX5oA+,Rp`1#2dϘeSF s+y)M`ސ \:,qjª&Q1ՔЏ3Z#Uɻ1K;O|C5l! $@_}p'gm/MNw40u.ߦTl0Ǒ-8T_7ėQ :s**Y˶ wHRPA\H\"(Ljg9X5K-p` 1mc"~D'oq #p^8Lfy$"0+iXcϗٔsV 3g-8"A!^3kYex |& YdS@qIUK !XC6٠UO>ǀ%d8=>0Z )AYW [O TƁ:>Ɏ⿩IQ.hjh&иX=ܛ_77 ʂ^ڥ=e٧g@I<q=Q$:)-dTF`j8 w(:| pA< 8iN]+tNv*2B#Naϙp$Y3DZ:@*mYg ^S_L8o,7 -ꆿ#lsizv<]=O7,x#%Q<:v/s Ak<``tҘL;LmtrkSrLy dR0ܮ˭Y zM¡\TaҮ8g5}'řALD>?&=fiRz¤*m6v5Θ]IU1b :qhCp5t!UdlhaH^FK:08 JzI֤pu,Yʙ}US~o63?_lzܤ/)*?|T%%'dN`EmQ@/7p94C'MQdH6- '_*b%IzIǷb!-ՉPt23²aUۊK?)=^ vF)@S>pc`S&55ݥ _A<@Gs#ը3A-df9$Ь u9`G#  π309qЎ`DŽ}E@ f;Z>| Hp 8LpSk]*Ӏ)6 ou 'Uib!GPl`i&*Zc*T")>ܺqzҡmd(UO/SR-BO ()k@-18B,RrN!4^B Zz̒anSO,k$u7ohoRQfp5p|J20⦶Q@m8ȠCŹbշ׵)c;%U6K~TO{D@)hzD- >LaMb^:#QLH E~v|S{(^Lͤv$Y_6,XJ|Ljlab!}] |aN\T/D)uLx. @kF B.,ˆK0t9w@ -gšq!o1o3Ђ3 8ЫdH/`i8 7)Kx`C`7ԛOōr@|o_ ?| W;+T:}L>e503.ͬ!,Mq>-^Bx'3\g;;cM#d^Cija6d%":t;ߠ.UKfuKIY@_|Z~R| G@OY>c{ez$UJ>v|qPAD]EQoY2Y nʍ6Qric'njxu٠(٦UQ |Q ,FK(.`q< "Y7{:R`pU-.bW)l]ѩ, ?=n,*rYv΢5fiz81Lt[mתMI䬚qm(+#x2W5A{kӰ7Ɲ}c'9YN߆,6W^pn-]mb!iqb`$Qh%OwW=|1Ч6tB#:>R0C##ê%\&Usv,A_f̘[2H^U܉I s"[N79h[gW!(wWCuo~9pg1{pꦗ784 7Ad)̀rzC®FbҤ|#Ua绑-Hp%)|.+a6I(s":7bm 9 ^O^U$.v$~|0aтbn>c,>BȹȈ`-H+q;nM~.MvP(:ЯI?C`2 ]XW,V,(Oh[aߵ-H+aɫ^d4bamb%?8HL[e}M^II#h曘|d[ӯRmh0nq*U[=mn5bĜބgP4ݎ,\]mX-wai*,lK?eL;T>cUPt&~(6H&u@懊}̐D]k%K{GGbmtm A|[E/}/ LU[IG\TgEӷxmS%lp#TTcNLjN v="gB`2XBҮ\Vc ^t\'_u7}:ϣ`nP.lK0mZbݮ w!F@YDSGy8u&Glwj5ݺm.u8yAx 5;tWyL6͌A5MrO©[MiϘ:ɄmalNj<֢u*jC7"gmnhъ,9-hZIV+7~+]-t=!\o wxJL1?SSim1u"Hf Djh-+c%{L2Z:X2' u딮Yo$ 0-s)Y'K82kΘBvl AMlWm)7ZaH^#xm~pãs0{G݅9^ wx5*T_c^W%ܝju~װcX5ϙ4 ~]̥uh >f#,|F/Ww4fO4" D  )g !r/?.7ce5=ؐ ʎ0ϣ^@#7E} pi5΢S4[cΠzC) `m z~֩Hs>6kLnۀ;rzɴFnNFa]:8hr.aCQfeQqN%m 40+LjӧCr~[wb;ފOzW_7:zG waY! e% gug!,.顗էNqj"gIE p@*G~ XlNcjVu);L<~˿ZruCا!uc5ZL¸@O @<nu"*γ>_:el2@A6/'-f񌡕-WA \"՝or߀ENsfmuj Žϣqw~W@~ 軼>./&ZLv՘ NfSաlWj7.:zOvW_#g5*3F2+)I@|bV%Zǔ-SJ^87F- "$CfɈU&䜒fM%JPՒ^&[x)Es:xŬ/_Xud_>:ɼn)F"5cB|_'9Ĕu_:l3@bHtnV.,i<4"I5I SSňv$uF|UI1Ϻ p1PPNuȹzȦq&/{D4Aܩ04 3aG׫؃£gs^I {>AO )LpgWMCL*X)m @ܩs)kiø#2z=L\ M=}ca wRt:9-L [O&)BGT1:6C_?0ɂHD8ԋ{ %%#Đn MD <#RW]̫ C95Lr賺2] c;^2LȚ PMuCB^ʕ\Wdѧe .p, /wtww'`!8g򦺳'_G: ~{v0y0qi; OX)sIj܆VլV6/wi+9eN5,v po,(Fr;xscNV~XF5-62vup(eIg qa?\ߕu3fB7al ܁>uD]e]t;X7Sj$ueZ-]Ʌ&šG7.3́xM+p Agp]`n;&(7rDRqV7,xt;|r[=~N#"zu{!#7 |cd1+z1; зcۯUrq 'ʝBȏ[\Cg&q_֮Cj餓ezJj[W@zf}!|c >/f1ְd7qW f! ɞQB2 ?Oͯ~cS^Q7R|xj^tAfi]hTdXKE6S^;8DJ @_o]o[cl)Yd[Pn;WyXNrQ1z !H@1|+ϣ!pBAN~Nz%a,;szOf)'?3ß`>RT|s L5Srլqh3v oY+;M:h=B!ۃ}~- ;2Ȇrg| 06"VY`}JٲҬX3ڀ^,aPݽR4ZklN1$8h!&ES`ֶXA,=>mTG!ЊN @>:.hD5~G{]вoB sF.ZfSxdiDw \ mb?38~hdI}ڎ~m~OcU+)序17QGG KF)m!u%I{I*gIJ1E?#5roW\=a٬u )ha9֛ek5]'eY5yF4I'Mvܧ#ddZp Aqo<G- pJf_D'@pHG|pϊЇރ晉 n68iEii opWsFz ff}2ң[6rhW4C;uYI]5i7V&ٱ(9fiC0]Ӵ#73@q_K*j,X=WYk03 :!Xf]#uQ[$A9݋to<4:uq#u0\MGTghC [$,rd]ͩ1 ӥ F)Pd<A6 5?$< š_OAӡpH&G8@7N@8!T7iӃ]v'-jV7w6yk,Z2Vtk8ZYsWKoW-siГs簙 X#b U4،YAI&.W6i+J;!`x~஥} o,j>٘_7ʂuI{MX AvM%S];}_@_7q fE5ǁ;79DC --\~]tϊ*&lWV&bMա܁5=4IiC1Dpa#g|198!E,h|4`/dobށON!!΄C!  8 ';Iz{"6PMo@l  rm{ݙip_rlMKV+pGL;\ =&E<)O%<ɾ !$\ >0xYI镴XBa_m?Xs>JFwŇLxӠqC!-vpg6)U*Tv@ljYԱî"40*; .dcB|Cq#V)py4lr nI4X?w:pہ.;> V}v|whF +OVqCYcSo7EmqN:i״ʤ+**ջ˝ZJMo%5 =R1N[oъ.A)m*nZŝ| x%5ڿ ~l --¯@|#dKӨ藀rj`| U)F5K`2Nr ;ƸX|icsYP.ȵs|Nzn+Ye]NZ!,^/p/$A3&cG(a.+:nM4춞NE q;T!xn'rg$Q pӉ47,$G|pU|H^]j:u%8qVΖƴm\*Z'Kw7vZ:A"&3¡^.wx= fڢs%4~DA=vv.pgA^Fe4F9t,L>Ǭɨ_J 틪?kds>J2/MJbty}\5$$JL -:7pCr 0pU;t]rCë[ Iz˥fG{PTi΁FM]V&#A?sAθ7"LXqAzH~?"tBǎHs;"&qIE!ԴCa(01< .Z'B'qm7-luv e6*\]YʁBs (TP[(:@g1iƪlQ#pOQߪ.YK{ƴ*0Xb ]DTcHA<] P5Ԭ}2[-AG&zjbig,mmvyM(yr^*bA%.ȡfUӮ~#p?0:7Lcr OZ4d7F0-\q6nAt/Aϩdd܁ӀU/h2<h<Ja呰?mVIEUij w1nDXYtZwF[CFaIuLXփuv+eP(QP. 腕$ 5W;%Lp&^3fWwDoe{]KcPy~:*lLPqܧ]]HXR#x©Sn񄉺vٴb"Yq'E-_+|-)#.¬wQ \hͥ]K8.VJG=.zSۮbF |Hz#pob̬#$2I'!m;XOw x< gO%|ē/A?L`YpHv ueB:bWȲ=`9|f@n׮16TĽcɖs7YOaLL-BɎ H>ll29sȿPR)|Co#;sІ[iP.ÝH5ڤlv9`Ki C D:^ K!RLs{ x2N{6&:.z6qDžIo(zu>mBן-ggcN=Oǝp$9r'b5xH(L+ᰖt.G.V¦]!!Vp/->6eM(ۄqN{ AoLx~FNkOb2r𼙰"H!" F-*F#YE էo4)u-'i t/|qp+>|}@߭>P k*/(O]J!|Y:Ť/NzΥ<R.i[ #އ"QIu*8p ~44XpSO| w$plrp  D,T)@w{ŽaQ,17~3 ut2l֍~3ܯx(=mb#V2ذx 湃,M6h&J! Ňlu얎BsSb,m-wZʿoGp~-g"v@׉faz!F6 9Y +p5R/"7 ~$Ao23\dc`BHv32W$k] vuӨ9^KH vOic<$iu=!3oh3O.f+9ߍR^XNGlsQ.nŸR}9\xJ`@Ϫsdl|e糾 Lʉ|07JO9XBA MG/?;ސ#E{LJ(Vn]ɢ1l Zi3 GͯWhfԔ]Cvjr.7):Q&pGŇ)$E}jI٨lWs eQuF*7Q.`7Z KF4:&$22c#<MYa`0W q  .\;r&*dZOxG~~A%;3x FdQ)0-BANq6d=2XEm.p%幚^N9oǛt`ޏbw'tuPCH7TO FW;p솮Qxv/:Q]I]LVa2Nē>g½ ^tqA^-: Zǃ#V}:">hB wL '|c1xg87 ] 1ǵq=y5O(X1L@)T 苝7k]7c!|x)Gd1$M#ՆƋ;{>l\B.ZjY٪i0q0FӞjOk #@GNy':}S~N٠|PzXhb|co~7U?.b?Z^)A9}ddLmt\˱x1E8a7ٴMFpGʸCѷ̛zt7,뼦VPNCy 4qQs3b jrpVjcDpJ~Fw; 5٫5~y\,p~ӊOM3b7>5]LD {(}̄N*[0MgESMu2JO=*)<>-?*IJ`J)tG$g?[:R ZX$uh_|>AӁ}ȶgnBI8muf ~~6~]b:S̔͆9F(Fb1!_-/),WPAS//wNJ/w-7zqb!jf:̌A9&*9HMTsr:a)0|7b|| ;^mof)"GȬfFP3rb0TSDx"`gx9.":1;m7^9.w;ĜKQո##΋~-] P\ղñ"DLTN=q?|F_N 29p".{d1@Pu''#vL{|]d<A+pqg7 V.X77xڼ{< E ԽMM&:Ğ 8gC3b!)C]m XoNz't?;*\{HQ|Z>[ !yVzz+E I q?a防IbYC/( #HΙra4~QlM&\J`en*A/S7jb%= 88S"H!;aH=DvMӜbr)AWi/LHw&R.Ow9|0lfjTBofz wDzpb<DDnfoZ D#=wxL3EK,LXjo^q[ݪjQoivL}G9y4>"gW/Zk(=~pV:503j: AJo#Nq,s:"N+mciP j%009t9uTL*/:%/ \{Ҷ5=%=*½WE3M1i.ԝqCwZL@I'Ĕ tг{(:C\c*TU*}GI~F,2AN| ~S~2&/.gӞI*P6k5Q#p?mcoD9tg]6oXt9;K;Nw&F}[; ;mτաEL5tuA0t{Z%2C polj N-?kZJ%q_ޫ^$ ݑhZ~\zy* r>ee5GPY4!ÕGkmdܹ}[˨$;ZbGG$tyOMK:h*;Fw;p?{uYڑh^J:.oj7kY͂#AH=s`y)ty<[ )oz]?0?7<)o'p\V/W_Ε &nT),:F.#Xj/ ;:-`}Gut![ZZ~Xm- A<fdGˮ]1>SӼC˵qKO݆,2j>aauĨ+%%_KiA-m:IBޯ }?!~[1k!Ջ5풪gH;"ɐ gΈw1iteThwS)Gۿ8ڷn%gCԹNKKZr+<+DXQS{,`<7jM|κN6&דk ʹvz(^ĭ qy[TrFA-ih^)|yjF =;<,{>1C8Icy4s=3C4>.;/}^NMZ,/ETZ"!MB`ûCdE#]Q.b{ĎD`$Sh4(X׭vR m]:s Xכ?wT[v,;wVw^aN |ʤ[_ 馯Q$nL7\a)F;?j\C!mah7 9dƭ;膌6PhY9u;ɀM)%Cݛv̩Q:uj{ǽ)k0DyX4zB0QYi_ '㞮GRBN'黝Buo`'p Gŷ+MW֞U`o͖L1?b?8Osn䤊MzpGXjnvS]~ău!xz}SgȂ^= ϥ9]Ā;(F9m#CěZI;XZ}6d,eq/dxρRQ-B>~>믷MY7ֱOL8%1']/ǂc26>6ft(9H;B#sb<"+hθoKQQlw ֩PcQUĬdǵmɠeXЩ}c4x.F(>4bTStcw7iozqQ7Pxv/0$w Gͩɘ7p)`}~NO۩/5.GZ߸V8zu\;e 4@oؘ%*z|OJ&N'LD8@V<;qeoM`@yoOO=K>)GAēƞ eg^OW\7vkx|o_rۍCOg˷6HRo|M@du2>̕Wa]os$:1Ȭcdi {bV㷈I"~C!7cʠ,hF%5e-0ʶ! 8 z4e/! H#^uG0 !{#6K#0r휤 F+%F,]k65w1J7 l2IQFTc0օ /-mm;désq$֑4b~,?2"l"VeǛ*pAn yu=-`e5zJ^Eb`dXZ"/JWțn<wp9|]OCe}/s_/=Yz3/6 k 3iOgJrRɸ><@ry6FLNljx~MWs,I~,y0>s`eQp=`zskaoX3aEqƸE t{XxۨSI`cOh$s7ݡ;0T3dm: ޱϹh?%^Z,)jw={- ͓X#~p2:2k嫰%kILV ]Ё:sbEkM7;7 ʩCFwV~셟IZT].54J*2԰SP~FxIq;繓z}̸ ?V:ë^Ժ %_ &>J'7/ˡypO 4G-C4J~į狩)e0B;ӄzAvM|~fa ^ ȳZ@כÉ/R_O@j=H[+grדWU| $ar ^ f^ Ub]wrzHt 3s?]ƑkW Y=H>ܯU"WyɜNG΋Bd҃8>`o032#)q$;Dly@/|XbA̯ŠMexZa彙7IV ]o]4ngiGB:m㡇iT! t^GPdT8%-? $/K KӊEY";m7VxyGLuh(Iʗ)QBH;;,fMNUA<]Qq3 pl՛mw)do#iݥTqSN.N`[92ï =jx~wu[.&WYFbsPLLAJ~v(z0 co`of _Oz:zzm_Kb}VB3y;\O{pҟ|ZO*ǭ_bUߗ_NS̋ҳʋÉܝzv_J_)Aੇ|KEIxb)xRP xq>= vHqLDXw4=퇛^,R_ +y !!;I~AǩSE\xWa?QϽ/&~x;[{1Q~6V|4x4p,`4w/~_w^(2WKz`ro7:u1g@SޓiD49w9{*qr͡F?}#|K&藻 ]H6LY3hh_8hˠzńA AIeqgtVwgvB?ŏ,+㊥Ybk@z3u"GuΘ%Mly/ϡM׸U2XhJux Ŷ[* uHR,6E,GzHAc:Er2zy#bG ⑭#d9F)uaMq|1|?j<4<# |8~(?]Ͽ))+vzj~1nt?g=2V?S"@91P+@|l)lw:ҜOH"u0ɯ'_0zd,|Ѓuףndϻ \ 5C4g{ +GY\)/)nTUcw& *] 1Ɉxv:9E" Jvr8Ѩpu0}Q03!}Ӳ5Y׸Mt/̈bnVB:,[ ?cU'@OFx!8M}{4mɒDgRU|?K(dUK7K\n&E%}E7nTͺU3S6甀xb ]ӪXOvAe+mhQqݩ[:R3  y-0Gb3yX.E#^\;p?6}qp?7CEj `iN&Pݟ+țW# <|}7?,#Ӻog_L:Fc_rF?iBt=Y _LzBR!po,`|k,e0yk(uu94`x`{N|' ?(P؁;m =T1ҚkЎ:6u`Ӿ+ n*ܦ_fNe#pq'@כЅxb$N羞H== h? pcĞ75؋z| j(r>>6>Rofzgc73kIߍtkJ?fuʝFCOQn lp QqCt9:!;ΐ03T$֭J~ϸkaW:s&̈́J>&kF%NF/xH;  >6~F/~PECNpB{I%llZ ! ,#b@^e,%ܭ>O9vɌMܑR &]ᔮtG U%?#jaHLک[GnBΉ)k=F}A;;U5o+ɸڦuY3Ui-*@&QU;=57ՒN w_M =措גطt3D [Fm4["[ z1ӅyB ;]s.SeFܿ}Wͭ"HCJY\!i]#O`cĮSAрXD]z|Ben+(G\I8Dخla֛I-xC1yu!}S=EOeI TjԯS |CqEϕ!_ɼ _WRLߏߏ_ u|'؃RDt ֳ_.x9Z9pKsYx}PKYzmjz_LL,,Mxv)Oz?aN#i<vdtkfA;0S:;}ΨsZg襐v1`w#働QEQSUm%߻  vj ӴTM=~=ewq@CȃC}Li@w]A 3vnۉxqp*۩NLָ I]\y*@Zyty5)zw7&;=C~@?.;,;cqٸC/D-\+I+Z&4sn M<^T^>H#odDv2՟џ}6&ąc6?+BD@q;B~fG 3>Ƹ#z̫]Uv^5|Yª]n̚!qdD+M;:F[4qU-i{uRO3~5p>ED()Y}֣ZңXQѧ =D}H -xm~{S FXq!?#p_/6K$Apwvupbwm<2PtvʃJLO( q~"dd~tY''/vID<\; #PwC݁ES@Ow<|z8Q$ƒDt]Sϫn*Hˁb}9yZzh4~P''0o;j`pX!^ܟ}Л_K</ZV/fjz7ʱ jOj7ԝqGuw!Wn9xNa;CawF\xHeZe/7ig4r r u}W@&H;w~= W!5z)LpIJݎDq/ũ`>MI够+ʅƝ;01to*A@dmIy/X%holA7ޠ0 Rk2p,b*."͏aĕx=>஡]Ow[a`:-0 @ 5 /n$t݌AKpug߲"WwCc|^ 9Llu4#W#*NЋ|K̗T,/ޏ;X3Q| sv1~OCo{[:>*!Zf>hlV׷xaiIN#3g%t036._b^ npCh* a3lc u_ǡGW}įeܩ ,f;tz">`@#o"Yĭ1i'5Tk>03/zCM1R2!+pj$iw3y.n}/1轱~1xb(hXe~,0Wc o' '+ &o+_67O'G*sOKz_O=X?+Ǔ=zR33.{_=^Ld:O}x  0s$#\aHwN1otטe: bEʦY.(Wujfm363 =FJ %?k&T KҊ%;7Ac{?u4.Q8d{zuAoj6S04A۸}™+I;;xl'Í`}6^&´ocPO;w\^zK߭c֏vR#gNvdN\r.b"'wN[_p?5TNƽ{57/0w# qJ!H?!kAWSse05YoƊ.+ޮ{6sC!~9pt;{<^]˜Kϥ|/f6Z[7Q\χ;"'c 7;Y:fFtm6m۴_mPVkl:a۰`i"G楝՝C{#LYuQ3І{ lqJ0\Q|VRs#;>oymYy *Θ:F,s>f=`iW;xx8_됮w}QjM: 'Mcθ-Y.^7B؏M`T$ğԞφr|t-fF7Xaɋ`]Gts[w~Q&ø}Os"{|m-fU=-u)p߿.z,y{w<|L#[+דW=g{ýVҷz@HTӽ;C;Y Uo֏^7rk$PKwIv@O-!U元ग5}4!pN !vkZxɿͿ/xɋ"?)|p}[%4w"OKH?_vC{nVKy?r>$eO<)G~CI?muF]]!&[:;[Uz lIeXwk!.Vxdgt<ҳ5m@)Iz YsQÊ,[K2ŐvpѴzQCFy.`6Kao{;\+Ui7Xln6YVjt*;l{i4c{'5|;Ɲ^NA y;a/!q?A!ll(†a#X1_;,;TW!6^R%?E^}TMq<=60<$=(_he/_V#j/)4gu3_f $pq싡,; H( (g* wG}هCg3WOVW{Sw[0qC7E&p6?03T1r$?>j:wG=)aHz-[]H*lMM[5YǸiK͸X}G4 sθ7Yueu;_A`AHђT-m^QFyd<:U-p8}%Ty ě%d-Ǝ)#t*qM_xOGm~Z4^%Qnw # VCbNaX@ WÔl:k p Fq3W_+tm:e/2%$\?#3/rWпw,;he)S>y/Z I{$$+p}E߭•8TJ%zW]H[f"mMOeB #p? =1޸̇;֍Ҏ9qǛu^p_E7$:gt]Dp?0 5ڪNBHGDwP{ҏɸ+drπ;oj빛=\ypjHݫ܃ Dr>>Z$vjx쏽^)DB?-ppμuϖXQu^nRbs`xX``ܳa_کM2_MޮNTߛ._%L^~n馱g'^l=Y=3]Oݮg!8WɆN麾lh&x4> Մ'}#vG\{#4m0a{Z'y׺e\1uj[twk<%Tb;uu~O+-8*,.j [%B[Mѯj[q&Ү!]G ЅNc$S~N[1e69N%Z{ƑuYWXh|V1a]Q9]btѨ +p,CC4ޝ ]͸}Ao"[ wIQK07s/ҿ];v*/'$p>L9`Yz E"[<ˉOR$E-M쯗Up }>[ھc׫8}֟|>B<##scylu熙{= ~՛35RQ/^zie/L2tULσ}|\1PͅOg;䃧sS\DX? 1S^G'Bwd.#fg[6q1-iY~ԓ7;%zC5m5eՒ>5m?&\+8ӔSP azLǃurV?F.r5;Izzøތ`RK4mI蓴S+Gn68֧b0I[ 9Ro˴NVsz  1[7qnn8ט0!%| 3W X߮t)wyni@ykH^+{l$f^&۸AI g\Ha_Ha!O>OM͗g+_M_oSa&^2o0Εvj'أJQ@HOS)wxx(ʑ ݷK[雵 2ѫZJdWۦ^R<<Ŏ'^_%8] ̇& &Y|ƼC>g[kPnhz}kOҾcYƠ+섻&h4HBmwz6dT-Ďb^VG? K;GXǐx/rbY٧\Axu8#I= ISJz}=C;4l; ] umSJ#S p'9_rj0Tfm");:42ǿi,6A?_w)&%µ;~]y/p0ѫ#ߨt[0 8z8`'S;]! XyF;XwЖlfc7K[,m64*Vv_;CݏvYNj ^t8/g1&ǟX.Dǃx.kʸn{ԢH[!|]o7Ip_<'Ê̔^MnǝQ(.r8?~ƍZ͊Jɼ!Az>z>z?n{Ų*N'8pgH`a=i1CKNcY{}k=\ܪgn|qߞۣl=]5Qz4W><ܟ>_(wbҪ7;WCD\xB ae33)Gs][ KB<եdmAI*rV-303 AK÷(#`cCI;Z F@O/s;k9jw:Q.od; ^}Os` 𧢮b0Qno`Zzt;뻕pM{e:] ~Z>bqLԩo^_z)~5~f~}`=+_b3ϷO=:qȭ}'KNj'z'|rbfR=ݾQ/F@n\oRAvX7:mt]NV»+#uVw>iȸuQKzOD+}}os˧19.S:jJC&^ +OFC.aN; c um u׍m.ፍ׀uHU:GS_$A94yT WPl@j \7@ކZ$}ii-$;\ |7;oߺh!I% %䂇akEILH7WutHiU7pꎒAf \O6X'tr2y>m%܁>p[2]h0uLLRN ZafD6¦SDU6-{q&i\!N[F:-w.ONe.1zվ I;xN]y6]ƭ,hkȈE(8'CJ}Z=]8s.e<.ps-W 0|0R"MifNu?'x/罍skw~ղ^l8xQ*p2{2Y{_M2x_3wh“죞$p6{=]}1S{6pt'y'quu0h@wW=8hז]7|wȝ#K'zÕ8~'~Ww&b>7kvE`]`Cuwv&A<:OHa5:愻mĽ=0"_ c%Ig)g1&%*eDF(xU#sE`u2%xڨ4u@dq9#Jp!]ܠuvfzK.`qwu(ٸ`>"4Qn\ ݄1f;)ޠuVa]8E 绨At46I$+9ϭjוR L|=/|#ڡ)D@w;/}jGso1x-I7sǃl͛4y||;9R^DHy=}R!40L7N?;ø Oѳb=Vw،^xܟ}؛zXRK&V B\׮t`WsGܷۻӱF/mt[DAt} 2wB};5ef팁vĦ#qdLӁwWhmiQSuT5\O[8.$%_zWuuwHE!''j}@͸C11ݻv_z0XVkmtgɍv}˷M`M1y"Ҏ;BzY-t!#% QgirvQb~TJ_덂xnFbv!Q<ȽZt|=y*q7VnLy'W 1}]O?쉼&``^UHv !# `L~Qk@HK_Ly6ָDҽ {mlύk//HOI/:;ҡp2N<:eհizw:\;b]g\ЇY~@'?c ~J'XWwLh$ķ fUay ߫lS˒JiC݁{@Ғ*јH?|JJ/bO}*씰 ]4Pw: q3TcgfҁTjB=~!, 6ZdYե\V@ˁNn50tPZo 5GBc˱dt>%= i S՝Lh FmRg+ծ˕Lu6q W۰S{Ùl=ݜ5=a^/G2/C;abt>Ltaf0-StU;pW)KƄsY$ }3jFف#ԳggO \Ζf..Uo./NVfKLgLXo VZm͝0˵)봬$u']t?JyF8e3ŬA1gT" Z9b\-H^XaVʸu kbтK)(|~ќHd`r2²a@|w: u=wш `i 탺EHUZ{f3,RZlvbZ߾Fw6j_x,>HXņ3]('`&d^61L T:r]"ʝ' ൾsEߙd0^Hýĝ|29+ Z[l}ŖtD|O鋩_xSGrgtJUafh)%u;|vUï~fydbco^WΔG3#Љbpht&nm܏ OVRԞ|tW6+Xﳯ6m[nuPA3Fbz6dfY˙)dZ(giWR!THtJUvlp]XMohScήMucf )[wuBݛ~C$[$tK&q`dۄէVBԡ{}[2!v SS:gNEs APl=*bg}W{Ts:R%|&?u [ODǻNRe{cȅ\q9F2ム]Ox&7еQ_Jfu=]AƑ߬{>WOE&r`4xQ$C/Jm3$ LTʁ߭~zl{10wo {/[>`vvУcWDP2p?۟j;'nn">ʡ}3YɔDuP D'D}:1zds_SI7g1}L!N%͆Q]_lrƷk?#i'7QFw{=px N9'gz^/x֟xn{Ctޣۣ{ˆ5w'{,9< Hw֎2OMUfN =G on P={3afXWck:m*D^=>TuT/렜[>W6 HUSf@'I)Z;> IBA9 2jdYΛJd-=:*M>Z/D >cj_o^Yڛ7[eM)MH!Hwb7j[ꎌY"Φ]rYdh:%x5EBѯf=W2^˺'"t)  tEg;O&=@h :v;n籄X{c$tuӕU(==n\ɅK.K#nOr*<})tN|2y9᧳Po şMåx8{t/;΂zfDdLlŲg}O?_1|ntX3\9'{j @Atׁdx*x=94׋lhH#≡!rP{W:ЁoGE6FC oA2 ]_!,;3( Ns믁:F@٠nށ@]'g{A']%uF;>aacEF8pCy퉅 :;^XUѦʸfi2w Vs0pk}2TqVp ܑjv&Mt!9,}| <262 08T\)tǓqbL%hUځ+!vYOu8 1nw_JxVc k9?f9t5ᅳހL\uI^wUaiR}P%;uHS/d335be'ޟQ/^,`~kzy/OU2SātH%vfʲS3csS#ù3ChO|o&5Bllyts!v'ܙu:oªo֗3F;{H/xL)R 06ziYhQ}'Oaf ю_}@ =, 9嬼T@><&9%u׵Vtfvc'cj# m:UXn,7Haט$HR79`]lL>MtN/z-/-1Cϸ#VR.ㆫ`s Rb=>tK81WbNAPt4bSitT8WzkL/#09 [8ZOGa|8w>9qO`f^us0rE #7Z3lԝzn9 .{> OO&h'S=Of3O v+m:ElV\923`]Gu1Nf 2r4ۉ?6h81 :$:r(#aL<Ɯn7Jdwq_6c3}U!$,[aw0V;7a5lLB$]Qh3=܃x}o@ĝř3 ǩʁ;蔒 0x ;=tqXH ܏mG@ps֗jh?\]=S<8 GBNxz,h!lgP}9^}!A\Jy4j. n*|:SzvWۦ='c9;G{#I݁$~ʗF æ{>^Q;M]6{u]g~<}08Y<3[Cܞ3{{DHP`HBof"ۇȾ|xw* ;t}Bc, b #&E9褠qGjO{W<$S&!EJ*\'q&DNٸ6@GU}/ pG:$"Owַۖ[ځ;RRkX]#C݁; SNNFl*^ܽh Z W4~ DaVO8\ 5Gr~į=lkؙA? 4nu/`<^>X"[Ǯf =ÖAN>|W, Z=p|R|IxΥ|3Kiq%yx0z6];zˍc"S *^M{nd| Vbw`V-v?[>-)//V~ucNY=v}Y\+Ӆln\PdTdhpNp{0/s?{/w8.u(EO`">$ AZN/h Uf͔Z ,f/$LiQEAjȤ2aT p2z"3wjd3ЃH' V'uSu.ÓQ,M zҼb kq ZF Ii3t/VXw O;*#t"^UݍF1KaCAt2` ,wҎ]֓vW}"j;M{ćx|ȧCОL2.ސyw| 8ǜ"ֽ˾uoЄ؇ybr>HVc]c]1GMz>^LQcZ9 j_7U EvK j"vON#zVpv={ 110ߝZ>pk專ˇx1;xg~gzPE< Htށ`Pv-s'I"S3]=T,v˅t.-`~ Mfls [ĘIr.#rEݢ4Qz#`cS1*~JW.,%RPI3N46Pz!ڟCē !5-m+ -=vCJeaf u}yPj2wl)}fƧ{6#ELcI~6`qX$(#L\$nEI=mU@44hИz833Y/&H4 @)DZ@!dI71 w4`D%<{"qWȺ;`ՉgM4 YE~npyӲ׫v8s8u ϕbJ%z/q'zR;^)c7{U"PCčԭz`ppxύف[BW]3NrsCFf/bSK.hܝ` A|xoʷ-"]mX -$͛߆~Y5nQwĈYt 儸IcANհwt򆙱,USiWHz-´j)q/qO)hQ*H{M ONC3֛̲6,@:a}w5ER7<\YPntڍc_#JC7r!v"a $4zn+߶[`6_&ٙ/n3hJrffgf `fff̠d.Fgu?umU-i48in_>{fuz'79qvٮ.pwtl7nݾǰ"8>ƍV&yt>=b+`daƻ;~ׄs@xyHÎ(mu$o2^ȏ~ċy:x|՝4 o133~xfɮ*$o_ZIvܢ3ͪ!ΨUǭ1 ĞXwlep2"75zLrNyQjQJRSFTQ:y!#O Ν N;XSR ^TIRvS:Nw$BVN5aupGz:i!ghFK#CIaǴ9+x yvpnUzٞ>-{:+3xNOxa갥ch$$J_F1CHW6Oq^Ba8[6ՖpߦfE٪El5`}ݭ>#C5u~oա3ChXS:<#j;폳ޛL+p_ҭO^YȾyzWAbe9i7X䬿-6ځ G;b 5?l/~9Xߏ{*?|Yױe2i!>돽1tB {%y5.Z-z[jp.M7bAT#8HU ?]B&"VR w_G`Tϸ&"On^t7,1A\~/! 3~L~N#[˪m?j@[jݭYmխk^dbG۪7xth'耙>39uVa O3&{p{@lb?JOstu {gA羿Hh_/Jpir2ݙCuQWx_x? rG-lqs0ᮟV~WY%,y=K/ki6-y1r%_WQܳqmKv&cݸS?b#ƽ|VC:03f%LQ{N\ӈ:Z"H*am^/DC]#w "%s/~?" =ڄ>sс#8mߩmt1h;VHd]qUd oVEoT¡ %Tip̄- \29S5o6Eay2M8̒8twráb ܂`k.5.m,t>^j/3Ts׏\\[Ú lZ{;sHЮfmҭߤ|FtXR]| <E_ϫq87,>6X~=tϏZ_,j/fzzC?)T+'a_oI<8wZPi// ϋ+uk %eck5NU=fSñٴD\ItRNƝet@A<[wŔek-yh rN7Q C{AtXK/#uOr(hl;3( WC&^ {WM!g1 &ؙڐvr2li#8l- w5lTo2v^ yXؘaz3~-iz>*0Tք,|_]Ys(`q\:XP-uzC,t[JiUG5 zzљuANm@9zsalnliBi.z^<+Gu_}YihK?ۘ|;~/A_z/{5B/C]ms_To󩛈QЅB ~lBʿ.DÈ w^Z-yI~E@939 10 zʺuBy@oT4MMu[떝p? {>@/}NH =|}_=1?Ptu?Tfi?,_M"b/'~=ރ}_L/%?mK}YeGB_U('poy[!J ܧ=p2/)(O"`!,PalgۭOy*obѺ.y vM+k?[([mtRw=.$Y1yc\>![Ɲ9vbsEU3 1I-z ijǴ2I1vrSM8`i;{sl{uH;WiH-MQ LI:iq O$-N@4$ ]i-Ez*b*&LItƢ4Kflr>TO%Mnmt£ti@G,zuk!*Fƀq;l=v85GA 4aox sT+ߤm1x] T+jdǧ_.t} P>϶xzo?߮ xX_uj=3;o Wț|})e9J*mFU5Z=/oyAҍjF Wg V H~י`|U 7*]r Y4Ko*m[QaC}KW o߃AԉH wir>ERM9Mm Z J4lw}ˀYd~,#m#sE W'\yʳePvyr(U76*6~~[FxqH8q1èaWnM1;,NIJ'mJp#u (L%Z>e#&2g*tvҥp9V͌O?ա3` y ܩdw Gvt5F!ZӞ~Y]Q5+'j6F2į8X˝ٿۭٙ:7KqaozalF:~_eWZ]!l].y)Aײh(%~RKwe_Wc޽s#h]f̄C) ;p9Th9SU"D}/pzC* w;NQck{L?~NDPftx߼NFziFq!_TceecAcB 3=;t[/0%MByvZӪS[UAOxu'E@rcA˹?5 X'Lpta/f;J l͛!NԺ K[w8z*oY]9iWxX YVi~>hsrԆCb֋DVFԚ,vq5l%Y{q,F{w8`zb*Goj bb ߏdѷs06_mLro7{3ùkko~9VjEWԗ3ֲPOKKϊAڙ^#~ڙy}Q ]d;a{VfO;)dbuS^zmTƝ;u*g~lG}&7@C?} > >&9e3yvnOJq'9e3H+eU#NZAAХMRM"v1 ňL;{ĉQS gro-TeFչNstcg7X,z9t^^ W=|gx= , 1Ο /EWGk/kR Nu>L=ZJr_fW1I؁{Ԫ6^g̴>lҪUz̨t!lP#H>We\{4uMzϖU))1Isw&nC=-q{D\OUA 5&(.'Сd i!n}(vucQ >hslDFY(Ց`+(p"Ie/-tV"}\$j8@_yCw=Z=H>ĭu%A_VZ*V<L3V/MY!:nj7lcg`(=e tY9L:nAf=gy1tD/*Z6PHp`L?>~3_oބqkXgm_u{W|AlY**{~Y|j2JaHx\5nph3--"ެ>W dx@?SrσG&S)*ANqoWTmQXL;c7wc>SS6iUMRU7 C-(A>ڒ ΍{ q03Cf)1 'Lz!5lRd@Cx20r;qTu EܪFz0,Ё?a+UР 2n˃VKWB:T8 ꫻lnco fwKcƭ@;M%hzQ̹L*f}p_U+=3ݼ߸#a][#tbh|)ڣ4~B+e-yHt_;lG 8\7~6:F_Nuz'=/3mdHOƃ!4} ˆ?G?+DB"_I~ڞ|Q[wpFbeu`>aU˪1"a_vK9:uֹc;?}v ($jw-?ғb3:_Azh g ҃i%dAD@E%9GbtߋΛ³+Z_b"=ҝu%dIӨIwo}j;s[}Q߻tM:yߑ|Q&—JwJRi2)RU>@G|X)0 縳ISE⸳O0ؑ5UySU!()a~*.n.煴A]LN{ɨCؚWC+Sdiq MՌiZFz\a:N7UfLbpLS&ɴUFCPpg94-bɭ/{՚G Ku(:I"0PV:Ew (m!b"8@ , &r28RQIwJ\=g(aE`S*(p\:UfnjZNϭv<^w縓ĺYKC=pGpl jE;ռ{A,.vT0 OEV=@ vw30ͪjiMl)A]YͰy Szs؊އD&_Rf['ʿ*p8x˸;)Z~] [:BA7oq<8Ј9|%Y)=b#.3Izң fBy>d +1&s'ڎ;aAzp%["#N"]+/V?_{> jɳjў Vw_ ?h?)?u柴gAJM%J1We2B㏬+e1Fk. +\ؗY11;>bQ»2P)Z&S:sN)%%Ub!k 'T?|%n!. sA OU<#֓fE'i;Ww ugSl[2`wtQ5K saܧ9Y2-G@)>)@mVWr[Oܯr}Fļr=qwk񠜹 VͲFAGCVad-ʗ̈́a#n(vK ~U6LuP>4Nth"ـ@ד ohtN<4~?$ӞÄ :JEޏcSW=7_L9tr՝髮uOpx瓉'S'yoaweWe^rowRy.( zd߄O""yNC.¸T֝;߅X']}B[s2:ifsJNf#;u:Z:#]!c٘Ӫ`6@G!w[.bD{>u2@-EzFè"\ K@ X ݴs7<]D/:G͸y=lbCwf}z9UyTh js~ͬOR8ViPv):(fBٰ-wPs;x}3dym/fe눽;HS^q>H5mWUy:X9.Pbhj fT?4zY(dvS~+6@'ԚSaKp5ۈaf +!z¼wyü{7qg㧞+R@&ħ(,G!bHk Ga]AlHτusl41m\:Eu-zwtVK$)j:uPtΉ?J#m[W?-<<lCb.PXz<콞9jlSVx\NfR'|E)~S"f"Omv.M~ݦ+0>+}g'IaE+`iJ1ܲw7)d:, m} ޥj rs! ?wHPM;w?BFP%Z_+)*mzrB(8 'iڛ0GI̼k;txdf|#uRK}؝+?n2u= 3s=}5ځWga埍<_WU[榚}Y|?X}uGRIT7I>Z :AA cZ 3p^˄`w%`TdӨT帙IqV`:})BN@tj܋I-Q?] V/Wˡp >biѾepV#Ѯϧz4~eEg骘l QS jԝֵC^!NZkJaI&!raNԈXψJ'}8Ή67 M03vh%br֥).~ST3J$;OU+fk!<딡2N l*|KMܻ Fd 8\y>(si!wO0t@WBigBizS iJ<i1i~:hDLt!aKYHX{SQtB?6Ά=Þ'!~W/Г=/ ~JK1raTdG/DR --~QM.;3=px{ q_g}mˈ p8X!mM =y>3z3s]FzvR".FڟW|v^/mF;Y <;w2ZbVca:[Ș{#'Zp+Qڣ}hpx6Z>j;ɝt3!JUwa5@~ q3RZul $9?l;/r}r6P>m;>|2?@>?lf!~[y;;YWa7~l`ǣ@#ZLV>-}yRKС9dՎXuCf , 7`V ?CK- I+hY/s2PZT7LwVܘ4^J[W~޹*$zD5"=_˛{Rsy'mKĐz yPNSK:*>Bi&̵KBBZ-ђaεĹ1ioA+ <*ZГ,*uOc;+P"u-bc9LA3EÖ }!B؂":Sw\>v>eXa_r\+6ڣ=?W&'ۯ:/';':·ףǣGOj'aM<}:bpG8'c0>SP8n*8±  >t7SFM <8\n:ޫˡ⢯G^6kr¿N3>8jP*:UKb;i\;>`:.٥~ac ly E}])lWzI&Eว--en;.N&eQEsH .)eKZ%@Q 9y'plӂ{. ovvқ=Ñ>_\?Z@ #~ (4KFшUFn:'=uVFԟr*:I;N()O.{TOg``VB:@1!"C -{6+킺/mPwHR!Pt r/K֥w)[/G֪ՎVvwmv6:hk̓;s7)6mL߬>Y{>vwp4ju Yy4jqZ i6ɖ }놢#8gb~xDGq{9ԅpCtW;JQ{qZ~6T:8v)Sg#1+Ib³.$+|?6F9f 2w nR ԰1ahj@K%=615a"1x.yqsVBO!(J!Z:Ge xfi Tnɔtm$ ?{1QZH!Pww; &@Aݣk1or.%yw/SwU$[ژ^٘~9ds̫W[3uhv?Xŝ}'l UZ`C4oB\Ci}L+d⏆`7p'Qo/kў멁oק/ƻz{qg!s9۪$sj)6CFmB WƢaޮhђv]%*D iɋ@ tB:@ѩ!;` 33#vH{x&+>PLXC ]w*'l)7/t)g\S5PAS>>| Nts jL8i2o'ܛI7ߌ1BHc%/E1b9Ѻef5v_<Lt_7;s7{X?xv .-݅7G^nͿؘy2xi?]z: V )S7PwdW̑=!&'{t X2dniFL ތ=y4bnfd_ttt>^tg?֏V1`vbhǛA[&%l]O%=+IRܽ lBAO`tw7}=z ?dk7_l=Ƿ,?] ܑ]pNFZ}b F }`թc73C7Og>;bfNק[n'CVޮ=_x<;jux5;8{8ه{B|':Ȝt J\ߛW/GWv: I nPKjCZ;1Ėp'ëD : 1\QUIiT&h^ &4 -|ﻐw?EQ(U㹥CבTºW"[m)hHXAZ xqo ).K}F1(}*(OeAC;{I܃u;1_sګi$Cbm pGw#eκvIrqVrR-\grw-0 )R ޻g;m`b|?Y|=to8xqn8~}r/_8Z{|ׇ+/v^l>[z4|y02ԗoM[tc tIGa].xwd"ЫۋAh:t<Bzz5 veOVotvt!;[f9SIock f* kq/v9ˍ7Ư{K˙Д>0 [ ~a{"p?q$=ZTI9uLyt)l m!HUM~_"޹UK!*td`HԕVz'Q}Ϫ:_Yj vgt 03f1}Hl2@\OXD<a{`z&%]1'?T! CAӃrĬi{-U܃Ũy3Ev*n_O;Jö^Îi-Jݼtm&[!)fƻ lC[^{c헳Toy>lk W'[6Aˇ;oˋ헧gogޞ6 _N^X*y12dc}bݗ'[oη]:~vx|巇olͿZlCOȩ?y:a߁Ł+OlLXNop:̎?8h?,uE_?9T ҫnRmٝJv.R}5H:}%ⸯFZ%PZ:ۖBQ/HU443j3I%h5CjyK)iM u <`.H0-nA?/&M{ToЇquqt!rd^'⸓Q7"O(B7qpE~NjƝq$({}ǝ6ҡm9.vJg3퀥9,vsn~ыvl X609^=XZQwl;8g;p)/^o@I;};v_}r{ܫ[3őW ϧ=Lu}y" ]]hO/G{OGC=}툇=ӞQOmeb;^)-w 6Xzd;략x+p_ ru_ uk]í dmap&f>嶍ZcC#t`TssܩUH r@:1 X!'|[}'isS&< M0iz e q'3cYU#%^5Ah,7KX! R[GQB`̥FoAQG˂zvۥIM !3b9n'l%l[ivƹs v^H;=U+Ev{N6 G퉃J+s1\+5-_z'O7aZ"H϶ޞn=@[/7_!&O7+oV^ \Ыձ/;l{eÞIo|o&;4өW#{jmj^)IRv~1>(Gl| /(_cY 5-vQ耞;\:Zg9TPֻlWT#A?b--dIIi7m.QN5NڒnMKw,,|rjF䝛Yn[`+AYg9h ov1xP·7S=OGXpjvfify$w'kto"C̽?\twC`"T400mN~u뫝_o`>}4֯χaP'RӁC]gGΏ=_x6ncCw+Bv+ͥvIྕ d|9~.g;IVܳk݈xka;:!2_68͓6øE7a%ڡI;hЂQPTe,+e?ar!PS椸NsO4ƥ|;o~}F\U-)5YsE(kf`fxC:Ww*јDp^5Pi; +d9|T*BA{%`[yxĔC;nULUSzT1B؀xR`-bΫ'S7p=Ig?$ws!gmJ+u1Ry4u3OJ{ad|g@ < ԫ_.?}7˕Q`ۚx˃Usc0-_N^}nwȓKTt4wTY?=ۀ~!o#v*ۭd`'[MdETƟ?m7?32NXiInaΈxWRʊ-m͍w-UL-]DsIߩ#1o ֓&d g9;p; n&ܟ-ZtgO7_.<]~0juۚngzzzrbxbמJ7;|;ݎ7^ vm\A'Z(_Z3ڹ3 C;}ʪ0);u4b5 fmQo4]*eI(5G$~I'I{FYasFhFu03p;h@ig5"{ZL+[S_GuDVђw =KpFII6 {̢.ϳ 5!G߂յ *Orla-&C6{XqZ'cLh)+)ZνulZW"+ώg:dwެLd{s逛1n!;h퉓YWB?&qv!] Aax0*gӑDzq5t;/V_ݚx>ɗk#opWdxv?g2-^x9w;KVf^-\e?]>~wvW-tvѲtx3 /Ma``Zc;D\ח6H;m@g=&k:uu7k( /!zР2k-~ՈvQh~)Ԙ/yn0GO>|C}ohny6L߭_oa}wZ) ,;"5mS)eJʆ>^[;Ec&K\A|Aԭc(=lGJ98-#5:O@T*Fr(::pg뺬IPfdm=턕_7Su˕/O>;VG+R@Ô*q{Gm:RqTKTcmj;LurѶx|dLi?{/>ݞ֯j_>>ïȻT(ʧ[ p8H[ _N_Lt]M ̎<[x4tytZ^g7 N8ÎW#[f~zĵq"CvH#p`--@*p5(Q&Nk!G-W'2n e^DGqmc>qAsX&oU6poVL.bBI9SP z| 2TUcIbЋj>CsQg^=qݩtc W >6%C跓c$py. {]IVb$CcV.wЃAj/Of~r㳅/ON?ݬP>@:@)FВh!#8&Eozos֕;mO3a_?{=Vz4Y)\WMTd/ϖ?r{g+zWϏx{W/~ӽ+Tߓ@39|vf`Á \IDAT޳񾫩~s=kJ2\`0 Wrf:7~+ۈ{#7٫!FI/, ⛌B{T1joL#٨S%ޣUU ~Т5i{V^@|R\KE$bL!jHU~w|߽s S0<u`&Z_^!Nނx gޮi$ fz>]m|}ç˓=|M>PeǣEw FzN59p׵Q,nfSV.]ĝߖΆ7~@Gt*;FS:ɹ}6=@!Pt@O.difؘq|L1r_vNI*K-TI j.ShɫYE+/*LDsI,1|T1D}޻wso߹#?ΚihY/`|IbW9ܺvPt&J<մpگh U4 ؔ,r e߈K3F-4ہf &s։'w ܇-!^a0D<=Ҵ+ n~9.^l'S7;㕍Rp#<*qXznB ai`!'i{;=Po!}q5p5P|9fy χ cW W@r|˙`Q?mk~{'?}ty$Ǻoz u^TvO,#ڏT|^Gj&m$[z2lgiz³"cT\FݫJ 7 k+abA-Bȉl}Q1eӌTc6z&nf}^ݥ`_=z94\$MY(#fCXFB%B䬱F5!Nܨ +z'S!e%E x u:J_/M_1Hē+ؠ5Tѷ0:bIpϟQha+q;++tbg4p2ɫ=o8`>ġ6; a:Ot(%extbTt y|p#}R:>륁g3@7{s1G'xx4Tx:Rz>vݛ(\ͻ/78g;oW`e_pR͜TsV<GM\<\Ox`3G* χ#Wt/9otw/ Ab)\M.=lm03ՔYjH=JOԽϬg:b@⻴rZ߫Q%R6F| $ŤDϾSGz RzEN\u$F'kuW7C;i LkûKniIQ6IԚ@Ma!Vy]1ۡF20h9 tMdϦ@ӏی,ft`fY?m+tm p3ow_?*o(O=šh/DQǥ8ww@Y-yZ%u4jtї?<ix1~ij7oy1KC0-W8\;/Ǟ^vv;g,ⴒ+$Zz0⤣ɬCaZԷ#߲eτVc:rnkar؆ˑ:kLp5X/D6K\h%6Tq4PA#̺fĮj-:*T:%]AOoNY O+dX_ >/[B2O}N֨.j% 00gO˺6i>v *3*>_5ԋp jɿ;Y@`WD9|| qBj t@X-xw;b$𣅇#]/nPwox4RU;bS92Ot\Gwn \1X'/# O/Kc]`_vg.:s@lVH{+׽UsTLf;v4n[7Bu+\8\6AF|%V̷@`}5 !V!]Nu{KǃճG/ǟ2hrvҟÿV3gLȝ؆aG2;tRг o-l̇8/Mp kҨDܷs^T4>6@*~s F |^'OR&0pxh7ۍҚARS/}% qS3ms9e|>((BAOOsQp_o lN3GOf;W+nAOb ioη[Wc'.8ea8| 9ʆOX19㨒KH5A 8CvMi.$#{Օ=oOUˎy--}؞j;oo;OBo; xV[>FKo]v%e@& aiBn8uusIHRa`3:=·Wsxī'i2hU|Ȣ7zT!2\+ҫeVx]"^!*;830"Z'$\acЉ+%٘/?)70|G^6U}2ږd0qӌ|4Pq8dbDE^5o#;.Ck>08=CAK\fUi<0OMYF9xНN^ޥl`yc{ HG1_ #c| <̄1{5YOda{pz :uX @Bޞ=jɋe-uRNn rYA>lBi]tXV5c#Z:pen^rq"?}ŀiV%uW=릩ٕ3^ 7sCOw'mX 0O[#*k% ]C~]#iemhȉ+yx:oq(|o}[ {wdM"͏ 2(g/(^⒲P6ynڮoMgpum p#.>oRt#2ca ViEBaq-`Z'|| nG~Rzjޢ0HFNL^,T80'{prL!%BܵۑiO@S팏/e/E`E;STg,sw/ֺt=),&y  ~&xMOb7wz+) ~ E/%ے'(:Ga6Of=&RQ .z]yqa٫ sZm9aΪiY ±D)//.xl<=XOi;z4?xi˭7Kpˍ }/V߬\|:}=^9Moy>FRwnޡz۴R%_-s?5洼%FbV ]GfRO AE L:VP .MK-D|w0 uT'!&-PwODEU bi>h˿H0J؄.\9B<χ\m*+9Ԏun\ /?-|Ճ4틔4v˱νFY3-+V>`%D"G藢g: yd4 yU{ޑ"/0nG E>tRd^^&A9^CQ*x qN:I[z4N۲j^vY ]GEqƨ61}4E\ hUu>`Ȅ*hس3ﯼ?\g&->ĿW#Ӟn[h3Y9izX#P4}F 敤5#ҢZ{^"eoGB !OoX{#oI䤸HFq% } Tw)qE|tb<АH@6bB݁{$Uf!wyf1W}oGg&A+S^ߤ7,r;j8e6d[HT-8msIf5כ춧7KR `.т=kOi Pk:(AjKCkKxn4RA`}VH'|a>vƃGaܿn 6P+?&dx+X a!ހ{CA}`7I@iGm֥tpmϟN:`:h&Z@w33zk泃WPaGt+Hp}%iڮzYIp2V55YFZXRTs29+jkV5x[d?o-HLw!uS:sOOu>AϤA(CMb| pGзcXxL%V9&#?F>:{Hxk?@9-m`[G^G'Ջ3*؏948lp#^Kfgvo|8FOitrH4{lQ{%AƦxs넻A^`[æ@z@Àk?hvZt)HϧB9.q, V/HEIyZ?puGL,s yѓ/Ԏkgg:<,?~ä~7S- *9x#Rգbl/'1vnEr=}?6]5eiZkl]QE<c\ Ѡ -_ =9Osn(c>[F7I}БkF>˴:u΅hr9ZWfR[mI5vZ m'k!06ͨY1jRxڵ]''3MXkZNw[ *)KiA4V}ni NXwɊ3t@}kun\~&:ǪÌn˦Ͼpż4[nƽu=fܦ KGqvԤnCvnm刃饰mojg}i}:`gieN[u*A#FuF)kш4V"8':VpWGT}ZDgT=De~}'A*IAm'BGOF ,]Ag;sޛ_ 5}|Zy}f3hU'RWt *_&vpZ7۸"-@rN$B/L}g[;E/=VGOs>ǔ6TwJjfjf|+l4jpS.~Ə"pa]NZfZ;F*cFZc'Bn}uiiR kR1a>")l9~SR6+~0ܩ5PoCstZ E!uA|;pҎo5A3mYH FID9N9ȮkUFǮ@tTv+RzHdS9UT)i=k5}; ʟoN<]}8t5 ]?њY5~T>_NvCmRh=H>|ԝN#qٝ^Lv]98ފzs3Iz^> ^|aRDp?7ܶuv|Ƚ=KpġLiг"Y@]o.rس;m =-~؞f7R/Z8_rʹ~C:9fgP6>xH;}Ȣfg ɺбfU};_!Eʹ磚/`@E2Tx!WTtEM-I!a˃??u#>aw-Z f%'Yy;֫4>ud3w ɽit.g`AEEvqû' 46plU Q1Zm&0?ܓ]nKdeLJk]m1HmJܹc>ߴ0#[ ӭ9Y9;Fz7wq! J&t6c > 6l=0^O{m+v :@% !a ~#.! 6o"GFhBbDtTa;U3Ո?UM{NiIY'R`kK;ǝZ=T[}F9ZΏ@e>G/8NMԮ i$Pw.% 4aR -&ʥ9* |fܿ~;^psu6' «mMIJW=2Q^iQLdMDm$ehӐZm|6*6¨@{ǘHswhC+̊!9L:4M |k:Qեo͹KE7"֝s?:LJZQO`V;[um@h?'Onɢ@ˑ.H;uM l5pON{!DƹՖܮf: QW=oyW梷xTK1`(UL*hqʦqIIΙ;鴰[uG i6ڮǕ1l Y \F2T\7)8: ԷG-I 1p0`'t:s,%I%rq@*}6w|n`i̬$oqߖ}I\R 9:3ʲR(4Xy;x| CY( ܢ^G OÀAܦ9] \>X'-.(O.-4. dok3N[ Y3VȴlGiY)tRg/3CmOo;z!Blہ^m D>`Y4Oy-+r"-2J oڣIm|d;aA B% 1`YvahHIMx\p)G`iz(sG MIg\Yl 9r.[#JSCx*ܽU$\RbƤ%XMO ;wmfU$6xtJVEKEM3PL㢏i.( 7H:qF/vt"_E(葹ҐZ^DǪ]r- \a@IJޮFN+\Ӭ4;{A=Gq@6]9;ŌM9kS]Ԯ~vȊ#vcݤ &9:R}U?Î<z*\&U0EOG;^Nu=mh{4x9CȧOڎzsǝbh+NnŜ!jj\ry~ΪJl̨B>J s4#7 k;)Leo-\Xp#kaksvInt@!H: OYXv/Xwj̈́;I3Bk%|uv8 uh|84u[lŒu ~1}*#&)p(hĦ)b֪)%;aVжN&g[o';A!xXDbMxܐcc]Y6®ݔLy6p 'Y-y(.?;>zR!W#\p-[N.io9aƪAYdCg-ޅ_ACj0;zBPߤ0B5ܣz0ңv$քv-nRRV U l dw| =(mq;l? Dj`'.*pZv1p5326lR#$f 눺)hI1J w|| wW f|??cQXd ~37tV=/J\g}`٣[mpQ_qU~k;փ0`Z?H_i >Vg'[tRܽs!<6L-{ڢEN݄M j}2QTЯim㮂E!;YpLgArYx$4xEsܡ| $m7 nP;3;ɼNJTJ#p_cTaVlXgِc.l Z9uiЎ3.VddW!41,tZ%m haNRvaTHu/i V>[v^|DK*AeQwNG U"DK1XWeM!iSP.04œ- H?74-aLt< WP}xCE|2`Rj}+؜]D : jmJ^c> h`PF+IillH:s9$MrfVu94`IbS)׊Q| 1d+;dx *vS }%qcA+:uu5(ur}?ֺ-t f͒UhׯZֽ$TLA0ﷸwX-ⳡ$1u ?aø!A;B=>>A ^5*es! 003mz0JT1˻tP4uꎘ0``gbĄA4eitަ7w5e~Ո#Gk9[FFh:z /!d)fԻk]=k%JO`pG%3~ﵫlۡa/ܴ5O-34& 1p<)㱂#\ :p;F+JRkg6C%p%>TԈjqN+Y'B#CUE6kpW>Tik-!M.)DFeD Wh/e iG kAݕ$t)'10 6"9;wE%l^ܩZaKدh1n:фA2i# z8xj3]WU0Hٞr y-'b k'tijm/: sV"pJl;ҍVrWb)G;q;mRgSMt˭Zq`4#XGcFeL.jzB`}YT A%񍎞iZG+y<RR4)E%5܋gԢJ*:dbX?#>1(Trz b` R|[E[ rdCM☩xƤD Q5Цʸc(9H8s7u$F^|#:IFΨd-)O5*zZvdwĝQAޯH Z5!` ҉wGpu69 +uTg5>O$~mZtBUur>c`l.Ӽ UV +] ;rĹm].D\ɽm`}cFLi};ɲVZEKQ--Re# t8-t&n "rf%9 L9$\+(%#zi;:M*;Z5u& Q'ZSR6ƭc|a]Ss=ն VZ6_d-ԝ\ Tu1CTi&M x L'4A hR' nJWWIӣ4! Q3 :!pg3½W-'oP6ň1 ޝ <,-(CE Y'ye|˼C?oZ\qQ A<#H@o,F |fX=zto_o %EGu6n#I7]'uwh! w֑%tR;L SFlKSnOY)+w>F<(.7yB!̀!œ@kW X(a0Q߹֝\*6eS{^GӥM;-* d|C[i):RR0O%1dRP}D-y"{R+ugw(:A$":h3zŔ@iXG+h0 tg7H{T-}nICJď uH;g)izE:qGnJF|GAѧ"ΥmKu:x26n>b5tΆ\>g``zvFE<.f@m4O4 [6AnoCɜ=eU\wˍNl(e:iv:p3֩> @<4Ⲗ- ӰrLl ;LZ&P{D%լ7p݂Tvt٪jȍ26DDh2 @*&7d[B)`Y瑶(Rf\a@|L#FBU׊ԉ}_ҊwMW_V +6v} rNiCiP+24 ΥSƢǞ!BH;p'bQzҠ2`[ 9f^KNOx#em]]`῁;O—MXQ&pŶE@]^u"gtʚE ƻ{UY hiad]4RVtDm(M)ZP"r2*iL% *%V==x28H[IڂAD;!;~|d+ VE  qr,fEH1fO[:bϝ4#zZR iG PeF/3ޡjP5!X4AqLJ5Ixt pFٌM mЂV#i8WH lh.fg,1Nh!~(iIekk5Vq@\9tV  =!j)3NS6-MZew;e$J$im KR<7/ ;A 5g!-:ZUR +:YA)̫TE$!iDɁ{R- +E!oK ߹sG.W$´V;*DLS(M(2V% ~Szª3#==yB;UbJʦf'cjZ{k;-]AFإh7 EYC'm ;aMg 'Q1fm \ZYNOt4#  ;tCfmw)֣#Qp5\׬=4miV?O4MPn`iQ[ t) Q8@zT/*b$!.d{&hrN̨Qʎ_{l,F>#m՘Igf鴇<ɴ$BϨ );0'&liY"r4}ТBaQ[Ļ=-EAGߡ:Jjr>uI9qgг`֥Tp$㮓FPCZ+nøG ^e:/J ߣI2oU[X"Q2 'CE[ff:#b1`QRxZ (:Ai+c#X afkP0iCOZ=4֫t`߅T` 븙Yd?(:9G!  oO28:BFK^Xza]F\\9N"d0)aB4=dVP-IgV+0ENL٧jzj!^o$ACnGyqSE BrA%[W¥at52X^6%$$4DU2?Uv|[nC7wzE֡Y`SzN?<4`5(f5w(标 [ypc{ =L} (6#z$:o&{B4 LO=5.U {a@#QGL!Y0Pсgm*+>ēk7G"X{|jMRpjMĦMA8r`t}ح\qȡz =;G|N1N`͑g3Msұ?>[2u4ěΞ3M Q 葾3.[-3w3 ndi&?iϯ@0zY ^/jeF)>aD܉#MGׁ;pQ$Ft4Z70p8=<:U*bpBNwD#zF/MjDv& n(~##**2j.Y#G<# W6;e3Y>VY:/aecrjǐE %n(phNC쓯΅fct'vF\9t~.'U A3ěD]/VS)q#(HafrE)=@/Z OIi$l:OZ3)y^'j%duV3Z5 ~Y'/j~k65"e%oG:iHтA(uVc@!0I)FX+-@<I-M?5 bJܳFl /[+QENډ<ƗIX ѣv[:%T醴k`~d!඀V#>X1ٳn]fъ(㴪:| (6B3ɗ[z}sczoщ&l˴vІRN6-`Zv%'9( pܩ g8O4onO~KXG:gֳzUJPRUʠ_'^/zk65ɼCU)+eX!D:" !'RCw ^Fb\"h!JQHQDPڄHC2-1qH}=fr5H": ~H2xE3>'obF\P6qF<lx7VfB\!nDW`F0 gEOs9x^Oij=`,2`[s8Rq(\ ̀LVzYãg` ULi{:rwȶnq t59>@*.['?I5[00-vпmN%M/ȯSids2:I'dKK>J8t)&iWmJ'̔"O:qP# tx>h*Oo@< i>}A@p? ,Swr8Ȍ9-\M)¯VR _-܀8]RAC&G!nw*!P/H M'0s(L3Eݧ+G}zEZңkV!,B/{L]|bS$Jى)DwPQ#8xF_ { :KNҔj{qF\R9#X y)GKEI{RV+uncw$ 8:ڸI/!-pkҊֹ:1IR%K::4>$m }PD|r#ȼJT7Yr<B3 kmAJ˲F;Bd*h(7/5ޭcIVDwMnKp;^/~MX77):}vZ];R͜>@ת MJ|EoA@p! ZOF15GNYQKJ ⛆ۙPîlB5&[#r79u -\imX/`bf@tAOhܲo>(sOZ˿BoYЎ4|4`@ X У SMGMaYcz7@S*qZ-v%(L>eM+D^Ґ?@/IITe-5u%ISY*_>Hj,HsyPw=!"7j5hMq^VeMK/zGgJ:ۨ@K^XR@/FF}: x)I5{|:׉ZH5 >üJ=nk$+k&?")bޢMAљkOI%>Oq!j)PīwVuܢ9uH^|fF,Za,h"pq=>pF'xq))xQ39←b7xݠ_ M-IqcRؐ5wm ZKʒAYRzExC_ޭyG v1svS~,TCafu^#˪ TvAh(A? A9@#aPp-ZQEo |q+2i2$OaQE5@O (:90|/tbA/ qƐѠO,=&kgO8$w¤wŹ?%ܭ@M̕ V*SmCsR[IЋyXpbO¯#`omu5(! h-jHC>;f٪ h<=L-4bKC[KCU֑B;z:;ەU#onW66+!S$-2oe@zbB'ҦNv[ܩ'f@|IFr/|mOZ-̗]00OfDVc }^LU,@R53( #y%a_hI,Yv tLS[ox_\ ^IܮOiSq~$dM5dC!eVsCDCA|Tܒ{ -:?WE"E݂@%{vv "iej ѭ26pc$t䳪?JN _^U C}a8HF =f ǝn21[Xv2lRԝM*!-eQ6C! 8 _#^-}Jr)1SdgIF|hK.diƔYdz^7*{_m(@cVZ 묛 $(gw= s5(Љ)4]MSOw0$xo-"{Ȱ40IsL=D ,nEi7vʚaفu7\fwiUs׉(:\`E@y>;#;I8Y{^AȚRMA> rwoV4`5r\R园]kHIpj!~ķ3yCc=p 7Ŀ'=Xz OiiR%"HQEG{zxÐk!ø#>@N3NPCU*\M@-K$TǫD4ߤMK =to8 w zd}|QG)b-wč08Қ*RS4#-! :mS<$:߬ W`]7)Z,hڍN< z8uVKaW.RO(M2h\&SN77"^IsGN<{z>T !DAn1Y +QB-DW+1J3io/Y+i [jF9K@fy, 1)gՋ@YyNļ }ĭ%k< ZMTA B8xFMUD-"ȃw<ɟEydݜAA&m"-:YTW :šM"H]㻁em qWȂܔz)w&\CI* n+hvh@ցl.ST!$AJ h.¯$C30ixU$4])IR7BSL6Y)"n7K|s# N;I;):XG{~K_#DsG;e AH@w/AdM)Y3rV#nȈ ΄i# Ä'b7 fl]-sEל0!y` RZ-#?zv5J>+r[UYF?4DΑgeM8R_(uFH4 ƺ- miIp7·`1A-?4˪LfƠϻnqyG8&D]C.U(K3qODD?SŜ^=P2(D};a. U SڵArƺ r~dAMw F<|7) ok|N=H+Y·Qq{ruYlSǃz]L0o|pػ[vTèJݍt $ ;]L J$8vO:Vqd,DKw:(<-}(/4RWCQi։L&{7KFR|Dՙk)%Ph6)֧rŢ ιڠXX  vYZkNM$;.gU`mGe<[In*ǩ@ϔ4P|K`}1w8 ^/ɾէ޹hSbfvOWEܾ?x@- C;c u t]{$֏ItPJ0*_YE9 St^e[!H]WA]G?=7** 7gZ~ThrȠ܋v-ѕZf뗫sDIJƒkDc[ˡ?IZ?'!Pw? -:[+ת*{u~;7x{x=L^#ff#>QRt '>Gju~Dױa?;d`*DOzKݧN}] 3*:LkqJ.C5[]Kɋuzɳxɤ)zgQi;d[Jq%cQHvpNp`hp싎4+nݛӖzn7K|9gډ9nݼ|.ǹҷ0OrR.rpWqW:|+Gu8D,IL3o[B4oÒq4ݹa$0w 9]Ґ nO3d 9k!rwu)S)❮/Sa h]);GxJ ;Ճrj$Zهq# PNSk7 &u_tf_{ ;-Mx蟟}ͫO+0⃻߯fpfg'+6d. U꧎ oua;oςjƁȻ= 0{oÑ+It 4^8؛. w=WunkhIYR*Qn|ϙ]G,]ɰUp׃T\+%NCv.g~Fe`: m%w$AMYӅq>g@o~K[~n\\ڵk^Wgx6Wá:~o+]Nǹ7-IT!1ocovo;n6I-ipsYJ=:v1ȼKclHH`女`]k$۴YIYF%zfBb)|~KA%r:D s#UXTa7VW~Qi )NIٞ9c˖ZW.:]Jی6.NqAMPF0n}{cjd>&$g4+ٸNUEvYaOhxw{w'OOa!o=e_{ 4󪮘'K}4!;y. q*e)6%Jkݨ.rʁқQQwSG@@핎2)5e&WbK曪=[',9Ԍ_R(#v.>L81. dM =LOWƛ瑳K?lz X) rre?ȣhFmT2ew?yK`#Y$(<VsPlX~n5;tLv+Z's:eح:V8tMt\~T٤H0 `Z%wZ0 x9`ʹGe^2S*.umo OR:cu2ȧ+dCTNxlWٰo)buLVVM}=(T3(\fpl֧ČT_~/?qiYq|ieS+ؒU˦OwiJ|'*ER8M\jД-X{6^kwJ{VXL{$[miw5e54[_fK6䞓vmi?tY.5'QM˼'Vʽ$O_/azb\t.:[/z8^9z+W;׭aZ(^yG{Wh]\yWE\)!Fr6:q~,~|_y||]I\u^zS;-*Ca_lrk_Mүoh6h6h6h6h6h6h6h6Bq8/IENDB`$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855k55q5 / uqq/ / uqqBBpZytUg?kd+$$Ifl Vd*  &EE E88EEkEEq  tZ6$uqquqquqquqquqquqquqquqquqq$$uqquqquqquqquqquqquqquqquqq$44 lBBapZytUg?$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/  / / /  / / /  BBpZyt^kd0$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd4$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd8$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd1=$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdvA$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdE$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdJ$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdEN$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdR$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdV$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V lZ  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd[$$IflZ Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l1  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdY_$$Ifl1 Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdc$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdg$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd(l$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdmp$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdt$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdx$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd<}$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdƅ$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd $$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdP$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdږ$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l~  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl~ Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd3$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdx$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdG$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l?  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl? Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd[$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd*$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdo$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd>$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd $$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kdR$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZyt^kd$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZyt^$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / BBpZytUg?kd! $$Ifl Vd*  &eE E88EE EEq.  tZ6$$$$44 lBBapZytUg?$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ / / &&&BBpZytUTkdf$$Ifl Vd*  &eE E88EE EEq.  tZ6$$$&&&&&&&&&&&&&&&&&&&&&&&&&&&$44 lBBapZytUT$$If!v h#v#v#vc#v#v#v.#v#v 9:V l  tZ6, 55 5855 55q5 .9/ &&&/ pZytUTkd$$Ifl Vd*  &% 88 q.  tZ6$&&&&&&&&&&&&&&&&&&&&&&&&&&&$$$44 lapZytUT$$If!vh#v%':V l  t 6,59/ p yt$$If!vh#v%':V l  t 6,59/ p ytUg?$$If!vh#v%':V l  t 6,59/  / p ytF$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 9 / uqq/ / uqqB pւytUa}kd$$Ifl" 6:! s3t|!%EEEEEEoEoEE'e'EE'E  tւ64uqquqquqquqquqquqquqquqquqquqquqquqquqq44uqquqquqquqquqquqquqquqquqquqquqquqquqq444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdG$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd)$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd/$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdC5$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd;$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd@$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdF$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd?L$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdQ$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdW$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd|]$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd;c$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdh$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdn$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdxt$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd7z$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdt$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd3$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdp$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd/$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUaJ$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6,,, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEDoEoEE'E'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdx$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd7$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'ee'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdt$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd3$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdp$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd/$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdl$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd+$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd $$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdh$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd'$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd $$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd&$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdd,$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd#2$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd7$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd=$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd`C$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdI$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdN$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kdT$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd\Z$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUa>$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / B pւytUa}kd`$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444444 lB apւytUaL$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / / / @@@B pւytUa}kde$$Ifl" 6:! s3t|!%eEEEEEoEoEE'e'eE'E  tւ6444@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@444 lB apւytUa8$$If!v h#v#v#v#v#v#v#v#v 5#v A#v #v 5#v :V l  tւ6, 555555o55 '5 '5 5 '5 99 / @@@/ pւytUawkdk$$Ifl" 6:! s3t|!%%oo'%'%'  tւ64@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@44444 lapւytUa$$If!vh#v/&:V l  t 6,59/ p ytf$$If!vh#v/&:V l  t 6,59/ p ytf$$If!vh#v/&:V l  t 6,59/ p ytf$$If!vh#v/&:V l  t 6,59/ p ytf$$If!vh#v/&:V l  t 6,59/ p ytf&sppp000002 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@_HmH nH sH tH T`T . Normal$d`a$CJ_HaJmH sH tH j@j  Heading 1/$$$ & F 0@&^a$ 5;\^JT@T  Heading 2!$ & F @&m$\]P@!P  Heading 3$ & F @&a$;\P1P ~n' Heading 4 $ & F @&a$m$\NN [ Heading 5 <@&56CJ\]aJDA D Default Paragraph FontRi@R  Table Normal4 l4a (k (0No List <O< . No indentd`4@4 [pTOC 1 `5;POP / App Section$$ & Fa$5;HO2H /Appendix$$$ & Fa$FF Appendix Title$ & FZOBZ [Bibliography Entry0d^`06U`Q6 vt60 Hyperlink >*B*ph*Oq* /Heading:O:  Preliminary  & F44 vt6Header  !VV /App subsection$ & F^a$;<@< [pTOC 2^`5;:@: [pTOC 3^`54 4 vt6Footer  !8"@8 'Caption5CJ\aJ:: [TOC 4^`5xx ' Table Grid7:V0dh`<#@< $0Table of Figures DV D G0FollowedHyperlink >*phOrV^@"V c!0 Normal (Web)$"$ddd[$\$`a$*W`1* !4Strong5\NBN %Ua Balloon Text$dCJOJQJ^JaJN/QN $UaBalloon Text CharCJOJQJ^JaJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vc:E3v@P~Ds |w<v dfy !%&(dfy vGv '''*Oa6\%)28%!,/4#8;9?HxRJ^jtw|߁َu]i.-[5XB> '5   )./1469[wݎך4V} Rrˡաڡ%-͢ARwٮ9 {d3mT[aCqY/l7wX/qC)Y D    !"#$%&'(*+,-0235789:NOox !=?@Bb    ' N j l m o   4 6 7 9 Y w  7 : ; = ] w  T p s t v     4 D ` c d f %<=]*-.0P7_{~ 1o9t<<<nnn|ZprH^`]suDZ\  X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%X%̕ X%X%X%X%X%̕ X%X%X%X%̕         T !$*!!) )/XR$@6g#Jvb$+<`9/A^&Wf 0e0e     @  5% 8c8c     ?A)BCD|E||"0e @       ?@ABC DEFGHIJK5%LMNOPQRSTUWYZ[ \]^_ `abN 5%  N 5%  N    5%    !"?N@ABC DEFGHIJK5%LMNOPQRSTUWYZ[ \]^_ `ab?@A BCDEF GHZZȈ@ ((    s *C"`? t  3 S"`? z  C S"`?  ! S !c"$`?  " c rA . Eye_with_labels*T`T*T`TC"`?Q # S .AChart 1C"`?PK!@A0[Content_Types].xmln0EU*.۪`5~c}',JAb(=';۲"6|"rio.5{ rFA|1Qa³k hѪDq-j rR{,|>+R6^L"ac* mJd*;g~Q#APr؃u4Яs4`*7eICZKZ|U5Dq9Fsݺ&6q:#x4caaV Npnw8d`Eٖnl9PK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK! 0drs/e2oDoc.xmlJ1nRjhEE`L&$LRW޸-ROB/|984W  &Zz oOw;`8@(áI&qĢBBVs0 4a^D] K-qi9M \iwLyq.S,5l-w vgL7g1x }QGẀ\*˨%;2W΀zG缡.Dlf ٮ.k~PK! drs/charts/_rels/chart1.xml.rels1k0B9hPJ% d6ݺV*KFbh Хt}No{|b; ECڸVq>AI9w(V"~;3Ą).J舆W1:VzE| TZe?3i aKH'Mcj\ܣ#xx?aM UElYo۳k}(~S7d"wҔeҴXfgk Se\q!!ķSg8ɖ PK!F"drs/_rels/e2oDoc.xml.rels 0nz&ЫXIFooЋqvov1ONGgYqh{كYRC׫La,Ų!F@3rnAE1 :´;Au-S[%"oPK!_drs/charts/chart1.xmlXmo6>`ASjvĈ]8NK /o4Eۜ)R%i_,٩bKPLJ^xu!ӆ+9H4a }|<mKBYJA:ZYAkU2 {S bQZ&ON}rJҠ 2s^M E[ 0s^tIJKVD vB rL>{VK|kG2-AXI o ~TAbYRU`܄ n7\0t H% R"|FEVFMk,h7V'z}c7y)zھיpI@nj [>x }MʛN&l ]*_j2렬2X XJI@El1(F 1_EQGq `T߽ |Fg,5OT@ cUP'g;imENoui7H}% ) AbnJ62`&Ȟ;U[:$8fCJ>58 !vNjƤZr)gD$()vND-7ɘ0d:'vv|j,(s@K+ dUvJCT,z &ey FPv4BPgP%t(>HތP;urzmJlx_wl'W+`o)h.Z 3oPix+F8yaʉi|1_b03JYrY|ÕA?ߓCp`됿*g '. 'w $bi̤]+Lcrtݤ[a&Lt0Gۄ90&̛ sԄ90Pd{;1 ŌM=m$<=ǰ6cCˬ%1{POa 3Rv^A *16stŠwzW;[~$E l{*egzΗ`K]X5 GBC{Ns|w8iw;o#w+E81C?dրv|&[&ĉp{m#&lNeo|Q ?2:OԻ0y .!|$|܄M.7-FQ}P Nf&1ߠ ?pBp TVKQsݚLHpZS1]ʽcD;>?GW_ٽRA;l + pѸ^oԛ{ rofOPbl{k߽Vof kꟅנ} ?t!^r|c _u A9oUzנt6jKȄ'ݨZ[% .5ńrS%( Egx.d̉wHXiF|(kCjFOd_P/~|GOr食s_J#__Ͼ{+7^_ta-<؄HwxwXkӁ1;Qebpݗ9Gԅvqu$oĉi?FrI.1cn̅46)(n31{gJ7V&e735̬a2 ^'$=S.dq<+b 1u z^~bPiuOl<~OC9P`P[%.cY ?N ,\đ8c+'(\G˘[vVx:KX:k5uC 6q1l-oR{69}d6mbPI߯!hzeErH VfNH:~&`&Dqz]wM* _- Xfn\Zg"aMBGF0#),6Z46eJ-z*E, VR;L?;L2NF+    "#!$%&5 $$$5'17<B"Ocejn@w@wzw}Ҋc|<W=>>(  !"#$%        9*urn:schemas-microsoft-com:office:smarttagsplace=*urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType #2|_k;G.8:F_p|& 5 A P ^ j %%%%#(+(0(<(A(K(T(`(l(t(()[)c)**;+C+H,P,,,(00050>0C0I0N0S0\0c0r0{00000e1k122::==_=g=m>z>>>@@HHIIPPQQQQNRZRnRxRRR^UfU VVfXrXXXXXmYyY ZZr[[\+\\\\\-]9]] ^^^a_i___` aaab bbbbbbb}dd llRwaw@yCyKyZyyyӅم;C>F!.8yɘ,5&0dm؝ޝ؞ޞ=Cx~-3bnۣ(4ɤ6> X`+¯ȯ @F*ۼ8Dq|#-}OQ6>\dv~&(mos{3ART57@Bci3;ow2:px/7|?GGODL&U]&->ESY?Fcj{:BBOhu *-&/ !#$&')*EF  cr &.&9-F-//00e1r1)5+5668899::f<i<J>M>HHOOPPTTHU]UWW\YyY[![P\h\]]` abbddllq ruuyy{{ACÄńɒԒBLPR÷mpTV{ !#$&')*EF{}7 9 L N ` c   33333333333333333333333333333333333333333333333333333333333333%t<<nn|ZsHa]v<<==D]XO > !!#$&')**77EF    $ 6 7 7 :        r s        %t<<nn|ZsHa]v<<==D]XO >!!**+5778CF   $ 6 7 7 :       r s       |}L5~<rDgw8& Iv%V1 NVr<zQ` ȱ6C<P.E+% FhuH-$g0hPO  Q `TVS HWDn5zX ^`.^`.88^8`.^`. ^`OJQJo( ^`OJQJo( 88^8`OJQJo( ^`OJQJo(hh^h`. hh^h`OJQJo(00^0`56CJaJo(hH.0  ^`o(hH.^`56CJaJo(hH..^`56CJaJo(hH... ^`o(hH() pp^p`o(hH()   ^ `o(hH. @ @ ^@ `o(hH.   ^ `o(hH. 0^0`56;CJaJo(hH APPENDIX  `8^``o(hH Section . 0PP^0`Po(hH() p^`po(hH() ^`56;CJaJo(hH Appendix ^`56CJaJo(hH.^`56CJaJo(hH.. P^`Po(hH. p^`po(hH.^`56CJaJo(hH.0  ^`o(hH.``^``56CJaJo(hH..``^``56CJaJo(hH... hh^h`o(hH() ^`o(hH() 88^8`o(hH. ^`o(hH. ^`o(hH. P^`PhH @^@`hH. 0^`0hH.. `^``hH... ^`hH .... ^`hH ..... ^`hH ......  `^``hH.......  0^0`hH........ 0^0`56;CJaJo(hH APPENDIX  `8^``o(hH Section . 0PP^0`Po(hH() p^`po(hH() ^`56;CJaJo(hH Appendix ^`56CJaJo(hH.^`56CJaJo(hH.. P^`Po(hH. p^`po(hH. hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH. hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH. hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH. ^`56;CJaJo(hH APPENDIX  0^0`o(hH Section . P ^`Po(hH() p^`po(hH() ^`56;CJaJo(hH Appendix  P^`Po(hH) @@^@`o(hH) P^`Po(hH. `p`^``po(hH. hh^h`hH) ^`hH) 88^8`hH) ^`hH() ^`hH() pp^p`hH()   ^ `hH. @ @ ^@ `hH.   ^ `hH.-FhuHFhuH%V1 %V1 %V1 %V1 FhuHFhuHFhuH%V1 %V1 %V1 %V1 HWFhuHFhuHFhuH%V1 %V1 %V1 %V1 FhuHFhuHFhuH%V1 %V1 %V1 %V1 zX`TVS Q0hPOzQ` |}~P.E+#f/1v1Dd>$5$5#&d(.`7o?]?wJ"LnW\4_KFa$IopG!;  dZ \ dd d RT 3XGk-_%{V n'+"YLd8:=Q\ck:j/z |T $FI^dVW.   D ~ !c!O"Y#u#,$)q%EL&'O'}g'~n'/x(Z)w)~)"#*/*+M+U^,--k-40.b.k."/P/E"0T2( 232pL2k2z23 63A3|3S4Q5rW5OV6b6vt6 8#8eE8 9d9O :X:t:;8Z;(i;m;g?<}=u=iK=4c=d>Ug?MW@o@;LArACCi;DtHDExE| E?EuEbIJ0;J"K({Kh4MzMY;N+OIOPAPQ!SaSpTTUTxTUVVZqVeWaWqcYdY ]ZP[*\L6\gU\ ]c?]T ^v/^_?,_^_>`-aUamalc%dAenef)gi.iuRi^i yiWj$k Uk.lZxl;o:ko p4q9Cq!rqs0lsbit{tu9u v[vhiv85wHwRwdy! zQz5{H8{`{nv{I|YX|^|Gg|| g}88~`;vH0 b+k+2Af=)?7=P\d9HN|AE 8g|t V %,e0E)+@mx2C@ az?SmVH.?!cJ^hVST Z(iRZIs_ta1!Bd]`wKKa5Zpj,R>/l_LO!0;%k 47D!(M8$( Lv [m.3!4 ACo\!uOvJ0O+G0M=#L aSee5jKVG`H9;)j.J`{X0U= A 35t#0#r,QBct* *$j$<dkHa(1-JY'~+H.ty} @ @UnknownG.[x Times New Roman5Symbol3. .Cx Arial7.*{$ Calibri9. . Segoe UIA$BCambria Math"1hP['['XG'E'/E'/!42QHX 0AE2!xxM2 +D:\profiles\rlh52\LOCALS~1\Temp\ETDword.dotrlh52Pegher, Joanne\               Oh+'0t  $ 0 < HT\dlrlh52 ETDword.dotPegher, Joanne6Microsoft Office Word@r@N4 @!+b@"3b/E' ՜.+,D՜.+,X px  University of Pittsburgh  Title  8@ _PID_HLINKSA;_Toc491768863;_Toc491768862;_Toc491768861;_Toc491768860;_Toc491768859;_Toc491768858;_Toc491768857;}_Toc491768856;w_Toc491768855;n_Toc491768854;h_Toc491768853;b_Toc491768852;\_Toc491768851;V_Toc491768850;P_Toc491768849;J_Toc491768848;D_Toc491768847;>_Toc491768846;8_Toc491768845;2_Toc491768844;,_Toc491768843;&_Toc491768842; _Toc491768841;_Toc491768840;_Toc491768839;_Toc491768838;_Toc491768837;_Toc491768836  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-.012345689:;<=>KLORoot Entry Fpڪ3bN@Data 's1TablelWordDocument MSummaryInformation(/DocumentSummaryInformation87MsoDataStorel3b0ͧ3bVQSUCA1FJGG==2l3b0ͧ3bItem  2PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q